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Summary 
Methionine y-Iyase (MGL) from Trichomonas vaginalis has been crystallised and 
the structure solved by molecular replacement at 2.2 A. The enzyme has a similar 
overall secondary structure arrangement as the search model, cystathionine ß- 
Iyase from Escherichia coli, but differs in the active site. In addition to the 
holoenzyme, the structure of the enzyme in complex with the acetylenic suicide 
inhibitor L-propargylglycine has also been solved. This has revealed the 
mechanism of inhibition by this compound. It has also provided insights into the 
catalytic mechanism of the enzyme and allowed the postulation of a scheme for its 
action. Particularly, this predicts core roles for active site tyrosine and cysteine 
residues (111 and 113, respectively). 
To test the hypothesised mechanism of catalysis, seven site-directed mutants 
were produced. The activities of the mutants were determined and the structure 
solved for one of the most interesting. The resulting data confirm the mode of 
action of L-propargylglycine and also reveal a proton relay which activates the 
important active site cysteine which mediates much of the enzyme activity. This 
mechanism is substantially different from that proposed for other members of the 
same family of enzymes and explains the substrate specificity of MGL. The 
structure also reveals a potential role for the enzyme. The active site cysteine is 
positioned ideally to form an internal persüiphide with a sulphur atom released 
from the substrate. This implies a possible role for the enzyme in iron-sulphur 
cluster formation in an analogous fashion to the enzyme, cysteine desulphurase. 
ll 
A cDNA clone, isolated from a T. vaginalis library, with high level of homology to 
cysteine synthase has been subcloned and recombinant protein expressed in E. 
coll. The purified recombinant enzyme possesses both cysteine synthase activity 
and the "activated serine suiphydrase" activity previously described in the 
parasite. Southern blot analysis suggests the presence of just a single copy of 
the gene in the parasite, with other closely related homologues also being 
present. Antibodies raised against the purified enzyme revealed that there are at 
least two isoenzymes present in parasite lysates. Cultivation of the parasite in 
medium supplemented with L-cysteine has revealed reduced expression of the 
enzyme. This is the first demonstration of part of the de novo synthesis of 
cysteine in the T. vaginalis. 
ifi 
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CHAPTER 1. INTRODUCTION 
1.1 Biology of Trichomonads 
Trichomonads are flagellated parasitic protozoa that infect a large variety of 
organisms. The life cycle is generally uncomplicated with only a single stage 
identified. True cysts have been seen only in species parasitic in reptiles and 
amphibians although pseudocysts are found more commonly in other species. 
There is no known sexual process and reproduction is by binary fission. It is 
generally accepted that only three species infect humans all of which are highly 
site specific. Trichomonas vaginalis, the subject of this study, infects the 
urogenitary tract of males and females, Trichomonas tenax occurs in the oral 
cavity and Pentatrichomonas hominis occurs in the large intestine. Only T. 
vaginalis is considered pathogenic. The taxonomic lineage for this parasite is: 
Eukaryota, Parabasalidae, Trichomonadida, Trichomonas vaginalis. 
1.2 Cell Biology of T. vaginalis 
T. vaginalis in free culture is between 10 to 20µm in length and ovoid in shape. 
During interactions with host tissues or cultured cells, however, the parasite 
exhibits irregular forms (Heath, 1981). Figure 1.1 illustrates the basic cellular 












Figure 1.1: Schematic diagram of trichomonad cell. AR - anterior flagella, K- kinetosomes (basal 
bodies of flagella), P- pelta, C- costa, N- nucleus, G- parabasal apparatus, PF - parabasal fibril, H 
- hydrogenosome, Ly - secondary lysosome, ER - rough endoplasmic reticulum, Ax - axostyle, UM - 
undulating membrane, RR - recurrent flagellum. Figure reproduced from Kulda et al., 1986. 
Equipped with five flagella the parasite is capable of rapid movement. Four 
flagella are located anteriorly with the fifth attached along the length of the 
organism to form an undulating membrane. The parasite is also able to exhibit 
amoeboid movement when in contact with epithelial cells forming pseudpodia for 
attachment and motility. The cell has a complex cytoskeleton. In particular an 
axostyle formed of parallel microtubules stretches the length of the organism and 
protrudes posteriorly and a striated costa extends below the undulating 
membrane. There is a modified Golgi complex which is integrated with root fibrils 
to form the parabasal apparatus. There is a large nucleus and the cytoplasm also 
contains vacuoles, vesicles, ribosomes and glycogen granules. There is a 
2 
conspicuous lack of mitochondria, glycosomes or peroxisomes within the 
cytoplasm and instead the parasite possesses hydrogenosomes (Lindmark and 
Müller, 1973). These organelles are peculiar to fungi and anaerobic protozoa and 
play a pivotal role in metabolism within the parasite. 
1.3 Hydrogenosomes 
Hydrogenosomes of T. vaginalis are double membrane-bound spherical 
organelles which, unlike mitochondria, lack cristae. Around 0.5 - 1.0 µm in 
diameter there are typically 30 to 40 in each cell. They are normally located near 
the axostyle and costa away from the cell membrane. Their name is derived from 
the hydrogen evolved from them due to activity of their marker enzyme 
hydrogenase (Müller, 1993). Hydrogenosomes were first described in 
trichomonads (Lindmark and Müller, 1973) and have since been found exclusively 
in protists and lower fungi without mitochondria which inhabit anaerobic or 
microaerophilic environments (Snyers et al., 1982; van Bruggen eta!., 1983; 
Yarlett et al., 1986; Paul, et al., 1990; Fenchel and Finlay, 1991). Also unlike 
mitochondria, it is largely accepted now that T. vaginalis hydrogenosomes lack 
DNA (Clemens and Johnson, 2000). 
1.4 Evolutionary Position of T. vaginalis 
In addition to the interest in the parasite due to its human pathogenicity and 
prevalence, it is also studied because of its possible evolutionary lineage. It is 
argued that it appears to be a representative of a very early divergence from the 
main line of eukaryotic evolution. This postulation is based upon phylogenetic 
trees derived from small subunit ribosomal RNA (Sogin et al., 1996), the 
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possession of 70S ribosomes (rather than 80S) and the lack of mitochondria and 
possession of hydrogenosomes. Evidence based upon the sequences of heat 
shock protein (HSP) genes has also been given (Bui et al., 1996; Germot et al., 
1996). Arguments ensue from the question as to whether hydrogenosomes are 
degenerate mitochondria (Cavalier Smith, 1987), have evolved alongside 
mitochondria from a common progenitor organelle or arisen completely 
independently via a separate event (Whately et al., 1981). The situation is far 
from clear though and perhaps the only fact that is definite, is that, at the moment, 
nobody knows (Embley and Hirt, 1998). 
1.5 Clinical Aspects of T. vaginalis Infection 
Reports on the manifestations and frequency of infection are notoriously difficult 
to interpret at times due to the source of the information. For example, a distorted 
view of the prevalence of the disease can be given if the data are collected from 
an STD (Sexually Transmitted Disease) clinic or gynaecologist. Patients 
presenting to a gynaecologist are likely to be symptomatic and seeking treatment 
whereas those at an STD clinic may be attending because of a symptomatic 
partner or by contact tracing. Thus although certain facts are apparent, the true 
pathological burden of the organism is very difficult to quantify. 
1.5.1 Diagnosis 
Diagnosis of trichomonosis is complicated by the broad spectra of symptoms 
exhibited and the similarities to vaginitis resulting from other sources, such as 
bacterial vaginosis. The most successful method for positive diagnosis of 
trichomonad infection is wet mounted microscopic examination and cultivation, 
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with detection levels of 95% achievable (Kreiger et al. 1988). Despite the fact that 
this is a time consuming and labour intensive process, efforts to design a system 
based upon T. vaginalis nucleic acids, such as PCR based systems (Riley et al., 
1991; Paterson et al., 1999) and fluorescent in-situ hybridisation (FISH) (Muresu 
et al., 1994) have gone largely unnoticed. 
1.5.2 Pathology 
Common 'manifestations of the disease in females are a vaginal discharge and 
vulvovaginal irritation at frequencies of up to 75% and 25%, respectively. The 
classical disease symptoms are described as a' frothy, malodorous, green 
discharge but this is seen in few symptomatic women. Dysuria is often present in 
sufferers and less common is abdominal pain. The majority of males appear to be 
asymptomatic carriers of the disease, a state which can last up to four months 
(Kreiger et al. 1993), but complain most frequently of mild urethritis. An added 
concern is that trichomonosis appears to be a risk factor for HIV transmission, 
through the effects the parasite has on host immune mechanisms (Laga et al., 
1993; Martin et a/., 1999). 
1.5.3 Trichomonosis Occurrence 
Trichomonosis is the most prevalent non-viral sexually transmitted disease in the 
world (McLellan et al., 1982). The most recent estimates from the WHO predicted 
an estimated 170 million new cases for 1995. The distribution of the disease 
varies significantly with the local population. Known risk factors include multiple 
sexual partners, history of sexually transmitted disease, non use of 
contraceptives, black race and co-existent infection with Neisseria gonormheae 
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(Cossack, 1989). Transmission of the disease is only via sexual intercourse with 
no documented cases of infection by any other means despite evidence that the 
parasite remains viable for short periods on moist objects (Whittington, 1957; 
Burch et al., 1959). Infection with T. vaginalis varies widely. An estimated 25- 
50% of females are asymptomatic but up to a third of patients develop symptoms 
within six months (Rein, 1990). 
1.5.4 Treatment 
The treatment of trichomonosis is essential to avoid further transmission to sexual 
partners and complications arising from the infection. Metronidazole is the drug 
treatment of choice, usually administered in a single oral dose: One of the 5- 
nitroimidazole'group of compounds, others such as ornidazole and tinidazole are 
also used occasionally. Metronidazole exerts its effect via the reduction of its 
nitro group by the pyruvate: ferredoxin oxidoreductase of the parasite and the 
concomitant production of cytotoxic intermediates (Edwards, 1993). Other 
treatments have 'a much lower degree of efficiency and are generally more difficult 
to administer and thus not generally considered. However, although there is no 
direct evidence for any carcinogenic or teratogenic properties of the toxic 
intermediates of metronidazole, use of the drug is avoided during pregnancy. 
1.5.5 Drug Resistance 
The extent to which drug resistance is a problem in clinical terms is difficult to 
quantify. In 1989 the Centre for Disease Control in the United States estimated 
that 5% of T. vaginalis isolates exhibited some form of resistance to 
metronidazole. There have been reports of at least 100 metronidazole resistant 
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isolates in the United States of America ( Müller et al., 1980; Kellock and 
O'Mahoney, 1996; Land and Johnson, 1999) and a substantial number in Europe 
as well (Heyworth et al., 1980; Kulda et al., 1982; Meri et al., 2000). The 
consequences of widespread resistance to the 5-nitroimidazoles are serious and 
they highlight the need for further research into the organism and possible drug 
targets. 
1.5.6 Immunity to T. vaginalis 
There is no protective immunity from prior infection with the parasite, although T. 
vaginalis specific antibodies have been detected in patients (Coyne et al., 1975; 
Cogne et al., 1985). However these observations are complicated by results 
showing the immunoprecipitation of large numbers of T. vaginalis proteins by sera 
from infected and non-infected patients (Davis-Hayman et al., 2000). There is 
also evidence of non-specific host immune responses being activated, such as 
neutrophils and complement. However, the persistent infection that typically 
occurs in females highlights the inadequacies of these mechanisms. It has been 
possible to induce a protective response in mice after subcutaneous immunisation 
with whole parasites and subsequent intravaginal challenge (Abraham et al., 
1996). 
1.6 Biochemistry of T. vaginalis 
1.6.1 In vitro growth 
Studies on all aspects of the biochemistry and molecular biology of the organism 
have relied upon successful cultivation in vitro to provide adequate starting 
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material. The parasite is thought of as an aerotolerant anaerobe and yet it grows 
optimally in low amounts of oxygen (Paget and Lloyd, 1990). It has been 
demonstrated by many different investigators that the organism requires a wide 
range of nutrients. These include carbohydrates (Read, 1957), fatty acids 
(Roitman et aL, 1978), purines (Heyworth et al., 1982), pyrimidines (Wang and 
Cleng, 1984), iron (Gorrell, 1985), vitamins (Hollander and Leggett, 1985) and 
amino acids (Rowe and Lowe, 1986). These nutritional requirements are met in 
vivo by the vagina and environment (Huggins and Petri, 1981) but interestingly 
the parasite has been shown to be able to phagocytose different cell types 
including mammalian cells and bacteria (Francioli et al., 1983; Rendbn- 
Maldonado et al., 1998). Whether this ability is used primarily to supplement 
nutrition or as a defence mechanism is unknown. 
The most widely used types of media for all trichomonad cultivation are undefined. 
They each have a similar composition and contain elements such as peptone, 
yeast extract and serum (for example, Diamond, 1957). A number of semi-defined 
media have been proposed for various species and a defined medium for T. 
vaginalis cultures also exists (Linstead, 1981). 
1.6.2 Carbohydrate Metabolism 
T. vaginalis has a fermentative metabolism in common with other anaerobic 
protozoa such as Giardia lamblia and Entamoeba histolytica.. The major end , 
products are a mixture of acids (e. g. acetate, succinate and lactate) and alcohols 
(e. g. ethanol) (Müller, 1988). The parasite is thought to be heavily reliant upon 
glycolysis for the production of ATP with the end products able to maintain redox 
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balance and generate further energy via additional pathways. For reviews of the 
parasites metabolism the reader is directed to Müller, 1988 and Coombs and 
Müller, 1995. 
Of particular note is the fate of pyruvate produced by glycolysis which via 
oxidative decarboxylation is catabolised to acetyl Co-A by the enzyme 
pyruvate: ferredoxin oxidoreductase (PFOR)(Williams et al., 1987). This enzyme 
utilises ferredoxin as its electron acceptor and the reduced ferredoxin is then 
oxidised by hydrogenase. All three central proteins in T. vaginalis energy 
production possess iron: sulphur (Fe-S) cores. 
1.6.3 Amino Acid Metabolism 
Although it is assumed that T. vaginalis relies heavily upon glycolysis for energy 
production, there is evidence that it can utilise other substrates and in particular 
amino acids. The following sections of this introduction considers relevant 
aspects of amino acid metabolism in the parasite and in particular sulphur 
containing amino acids, the main consideration for this study. 
1.6.3.1 Proteinases 
The presence of high levels of proteinase activity with the parasite, both intra- and 
extracellularly, has been well documented (for review see North, 1991). The 
enzymes may digest extracellular host polypeptides, generating free amino acids, 
for transport into the cell via amino acid transporters or alternatively act upon 
phagocytosed material. However, this does not exclude other roles for 
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proteinases in disruption of the host immune system and modulating 
cytoadherence 
1.6.3.2 Aminotransferase Activities 
Aminotransferase enzymes, as their name implies, are able to transfer the amino 
group from a donor molecule to an acceptor. This process is intimately linked with 
the synthesis and degradation of amino acids and generally constitutes the last 
and first steps respectively. There are a considerable number of 
aminotransferase activities in T. vaginalis. Those active towards aspartate and 
aromatic, branched chain and co-amino acids have all been demonstrated (Lowe 
and Rowe, 1986). 
1.6.3.3 Amino Acids in Energy Production 
There is direct evidence that the degradation of arginine can be utilised to 
produce ATP at a ratio of 1: 1. Arginine serves as a rich source of nitrogen and 
medium used to culture trichomonads is considerably depleted of this amino acid 
(Lockwood and Coombs, 1991 a). The excretion of large amounts of alanine, an 
end product of glucose metabolism, may account for this need for nitrogen. The 
breakdown of arginine catalysed by arginine deaminase and catabolic ornithine 
transcarbamoylase leads to the production of ornithine which can then be used for 
polyamine biosynthesis. The subsequent action of carbamate kinase yields ATP 
and ammonia and C02 as by-products (Linstead and Cranshaw, 1983). This 















NH4 + C02 
Figure 1.2: Pathway leading to production of ATP from the catabolism of arginine 
The aminotransferase activities may also play a part in energy metabolism. It has 
been observed that PFOR is able to utilise a number of a-keto acids in addition to 
pyruvate in its core role in energy production (Williams et ä!., 1987). Thus if 
glucose levels are low the parasite may be able to switch energy production to the 
use of amino acids. There have also been described alternative 2-keto acid 
oxidoreductases able to utilise these deaminated amino acid carbon skeletons 
(Brown et al., 1999). 
1.7 Sulphur Amino Acids 
The enzymes investigated in this study from T. vaginalis act upon sulphur 
containing amino acids. The following -part of this chapter considers the use of 
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sulphur in biological systems and then specifically in amino acids. Finally specific 
enzymes are reviewed. 
1.7.1 Biological Roles of Sulphur 
It is far beyond the scope of this work to review properly this subject but it is worth 
mentioning some of the enormous number of functions that sulphur- containing 
compounds are involved in (for a comprehensivesummary the reader should see 
Mitchell, 1996). 
The"most familiar biologically relevant sulphur-containing compounds are 
methionine and cysteine, two amino acids that commonly occur in proteins. 
Cysteine especially plays important catalytic roles in enzymes and because of its 
ability to dimerise to form cystine is also crucial in protein and tissue stability. N- 
Formylmethionine is encoded as the first amino acid in polypeptide chains 
although often subsequently cleaved. It is also used as a single carbon donor 
and this is perhaps its most important role. S-Adenosyl-L-methionine (SAM) is 
synthesised with ATP and can then be used in methylation reactions or in the 
production of polyamines. The synthesis of glutathione'indicates another key role 
of sulphur, that of a reducing agent and scavenger of toxic radicals. Other 
sulphur-containing compounds such as thioredoxin, glutathione, metallothionein 
also play varied critical roles in a wide range of processes. Non-amino acid 
sulphur is also used in proteins in Fe-S core formation. These use a combination 
of cysteine residues within the protein and also sulphur atoms to coordinate iron 
atoms. This may be of particular interest in this study because of the three 
proteins with Fe-S cores having key roles in T. vaginalis metabolism. There are in 
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addition a large number of biologically active molecules which are useful because 
of the chemistry of sulphur, these include Coenzyme A (CoA), lipoic acid and 
thiamine (vitamin B1). 
1.7.2 Sulphur Amino Acid Metabolism 
There are certain features of sulphur amino acid metabolism shared amongst all 
organisms, other aspects apply to only a few species. To understand the roles of 
enzymes involved in both synthesis and degradation of sulphur containing amino 
acids in T. vaginalis it is necessary first to examine the available data for other 
organisms. 
Methionine and cysteine, the two sulphur containing amino acids found in 
proteins, are synthesised and interconverted predominantly by three mechanisms. 
The existence and relevance of any individual step in these is organism 
dependent and the major differences will be highlighted here. The three pathways 
are: sulphydrylation, transsulphuration and the methionine cycle. Suiphydrylation 
is the condensation of sulphide and a carbon backbone to produce a C-S 
compound. Transsulphuration is the two step conversion of cysteine to 
homocysteine via cystathionine. Reverse transsulphuration unsurprisingly 
converts homocysteine to cysteine, again via cystathionine. The enzymes used in 
each direction of transsulphuration are related, but the presence of those 
catalysing one direction does not indicate the presence (or absence) of the other. 
The methionine cycle begins with the methylation of homocysteine and then 
generally incorporation of methionine into proteins or production of SAM. SAM is 
converted in two steps back to homocysteine. 
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An additional point worth considering is the origin of the sulphur atom. The 
assimilation of inorganic sulphur is commonly used to provide the sulphide 
necessary for sulphydrylation and so the de novo synthesis of cysteine and 
homocysteine. Briefly, inorganic sulphate is usually taken up from the 
extracellular environment, phosphorylated twice using ATP and then reduced 
sequentially to sulphite and finally sulphide. This then provides an active sulphur 
molecule ready to be used. It would be wrong to imply that this is the only source 
of sulphur for incorporation into amino acids. However in many microorganisms 
and plants this may provide the most abundant source in vivo. 
This brief overview is an oversimplification but suffices as a basic introduction to 
the subject. Figures 1.3,1.4 and 1.5 summarise the steps referred to above and 
indicate the key enzymes. Figure 1.6 shows the chemical structures of the 
molecules involved for reference. The function, mechanism and existence of 















Figure 1.3: Mechanisms of suiphydrylation to produce cysteine and homocysteine. The acyl group 
attached to L-homoserine for the production of homocysteine varies (details are given in the following 
sections) , the production of cysteine always uses acetate. 
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Pyruvate +NH4 + ß-synthase 
L-Serine 
L-Homocysteine 
Figure 1.4: The interconversion of L-cysteine to L-homocysteine in both directions. The left side of 
the dashed line shows transsulphuration. Note cysteine is shown as a substrate for cystathionine y- 
synthase as it provides the thiol group for homocysteine. Reverse transsulphuration is shown on the 
right hand side of the dashed line. 
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THE METHIONINE CYCLE 
Methionine 





Methyltransferase S-Adenosyl-L-m eth ion ine 
(SAH) (SAM) 
Figure 1.5: The methionine cycle showing the production of methionine from homocysteine, 
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LrCysteine L-Homocysteine L-Methionine I-Cystathionine 
Figure 1.6: Structures of the two commonly occurring amino acids in proteins L-cysteine and L- 
methionine and their intermediates in metabolism L-homocysteine and L-cystathionine. 
1.7.2.1 Sulphydrylation 
Sulphydrylation is the name given to the process of synthesising cysteine and 
homocysteine from sulphide and a carbon backbone. The enzymes used for this 
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are 0-acetyl-L-serine sulphydrase (OASS or cysteine synthase) and an 0-acyl- 
homoserine sulphydrase (OAHSS or homocysteine synthase), respectively. The 
acyl group of the 0- substituted molecule is replaced by sulphide in both cases. 
In cysteine synthesis this acyl group is acetate but for homocysteine it can be 
acetate, succinate or phosphate. In vitro it has been shown that both enzymes 
are able to utilise other sulphur donors, perhaps most notably methanethiol 
(CH3SH) (Flavin and Slaughter, 1967). This would lead to the direct synthesis of 
methionine with OAHSS (a process not shown in figure 1.3). This reaction occurs 
much more slowly than that with H2S and its relevance in vivo is unknown. Both of 
these enzymes are PLP (Pyridoxal 5'-Phosphate)-dependent and the use of this 
cofactor begins a common theme in sulphur amino acid metabolism. 
1.7.2.2 Transsulphuration 
The two step conversion between cysteine and homocysteine, in either direction, 
is referred to as the transsulphuration or reverse transsulphuration pathway, 
respectively. All four enzymes associated with this are closely related PLP- 
dependent enzymes. 
In the formation of homocysteine, cysteine acts much like H2S in that it provides 
the sulphur moiety. It is condensed with homoserine by the action of 
cystathionine y-synthase (CGS) to form cystathionine. The molecule then 
undergoes cleavage by cystathionine ß-lyase (CBL) to release homocysteine, 
pyruvate and ammonia. The reverse transsulphuration pathway utilises two very 
similar but distinct enzymes to those used in the opposite direction. Here 
homocysteine acts as the sulphur donor in the conversion to cysteine. It is 
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condensed with serine, catalysed by cystathionine ß-synthase (CBS), to produce 
cystathionine prior to cleavage by cystathionine y-Iyase (CGL) to release cysteine, 
a-ketobutyrate and ammonia. CBS has been referred to as serine sulphydrase 
and has been shown to catalyse the production of cysteine from serine and H2S in 
vitro. This activity is low though and not thought to be relevant in vivo. 
The reactions catalysed by these enzymes are very similar and they each utilise 
PLP as a cofactor. Both pairs of enzymes (synthases and lyases) are sufficiently 
specific, however, that they are able to carry out reactions on opposite sides of 
the same atom without appreciably catalysing the other. Although in vitro it is 
possible to demonstrate these "side reactions", they are at very low rates and 
thought to be insignificant in vivo. By possessing this high degree of specificity a 
fruitless cycle of synthesis by the first enzyme and cleavage at the same point by 
the other is avoided. This is worth commenting on here both because of the 
elegance and specificity of the mechanism which will be discussed later, and also 
because of the large number of reactions that these enzymes are able to catalyse 
potentially in vivo. 
1.7.2.3 The Methionine Cycle 
Methionine is predominantly synthesised by the methylation of homocysteine by 
methionine synthase. As mentioned, OAHSS can utilise methanethiol as a 
sulphur donor in sulphydrylation to produce methionine directly but this is unlikely 
to be significant. The synthesis of methionine from homocysteine constitutes the 
first step in the methionine cycle. A critical role for methionine in biology is its part 
in the formation of SAM produced from methionine and ATP by SAM synthase. 
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Fulfilling one of its roles as a single carbon donor SAM donates its methyl group 
via a SAM dependent methyltransferase. The remaining molecule is S-adenosyl 
homocysteine (SAH). This is hydrolysed by SAH hydrolyase to adenosine and 
homocysteine, which completes the cycle. Homocysteine can then either be 
remethylated to again produce methionine or undergo reverse transsulphuration 
to produce cysteine. Thus homocysteine sits at a possible branch point regulating 
the levels of methionine and cysteine in the cell. 
Not shown in the figures above to avoid confusion is the action of MGL. This 
enzyme is able to catabolise methionine, homocysteine and cysteine to varying 
degrees. It is thus able to deplete the cellular pool of these amino acids. 
The presence or absence of any of these enzymes and processes in any 
parasites has not been addressed fully yet, nor are there specific details on the 
enzymes themselves except for the use of PLP by some. In the following sections 
their distribution will be considered followed by a detailed examination of 
published data on cysteine synthase and MGL. 
1.7.3 Sulphur Amino Acids in Bacteria 
Many bacteria have the ability to synthesise both cysteine and homocysteine 
through sulphydrylation and can assimilate inorganic sulphate to produce 
sulphide. The two reduction steps used to convert sulphate to sulphide utilise 
thioredoxin and NADPH (Siegel et a!., 1973; Tsang, 1983). However it has been 
shown for E. coli that other sulphur containing compounds such as sulphite, 
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thiosulphate, taurine and glutathione can act as the sole sulphur source (Kredich, 
1996). 
The synthesis of cysteine via suiphydrylation by cysteine synthase is well 
characterised in bacteria. The enzyme is PLP-dependent and uses OAS as the 
carbon backbone, synthesised from serine and acetylCoA by serine 
acetyltransferase (SAT). There are frequently two isoforms of cysteine synthase 
present and one in particular is found to copurify with SAT, a complex sometimes 
referred to as cysteine synthetase (Kredich et al., 1969). The structure of an 
uncomplexed cysteine synthase from S. typhimurium has been published 
(Burkhard et al., 1998). Synthesis of homocysteine by sulphydrylation occurs only 
in non-enteric bacteria. The identity of the acyl group associated with the 
homoserine carbon backbone varies. It is a succinate group in P. aeruginosa 
(Foglino et al., 1995) and an acetate in Brevibacterium (Brush and Paulus, 1973), 
Bacillus (Brush and Paulus, 1971), Pseudomonas syringae (Andersen et al., 
1998). There is evidence that homocysteine synthase can utilise thiols other than 
hydrogen sulphide to produce other Cy-SS-R compounds. For example 
methanethiol (CH3SH), which leads to the production of methionine directly 
(Flavin and Slaughter, 1967). This direct sulphydrylation is slow and the 
relevance of this in vivo is unknown at this time. 
The sequence databases contain many examples of the four enzymes of 
transsulphuration and there are numerous examples of purification and 
characterisation of the enzymes. Also the structures of the enzymes responsible 
for transsulphuration in E. coli have been solved (Clausen et al., 1996, Clausen et 
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al., 1998). They have been proposed as possible drug targets because the 
bacteria lack the reverse transsulphuration pathway and the enzymes are not 
present in mammals. This lack of the reverse pathway occurs in all enteric 
bacteria but others such as P. aeruginosa possesses both the forward and 
reverse pathway and thus can grow equally well on either cysteine or methionine 
as the sole source of sulphur (Foglino et al., 1995). The closely related bacteria 
P. putida lacks the key enzymes of reverse transsulphuration and 
transsulphuration is not very active. Perhaps to compensate for this apparently 
poor ability to interconvert cysteine and homocysteine, the organism is able to 
synthesise both of these through sulphydrylation (Vermeij and Kertesz, 1999). 
Interestingly the bacteria is one of the few organisms identified so far to possess 
MGL. It has been proposed that it may provide an alternative to reverse 
transsulphuration with methanethiol converted to a suiphonate and then sulphate 
before being reduced in he normal manner to provide sulphide (Vermeij and 
Kertesz, 1999). 
The differences between species of bacteria alone highlights the variations that 
exist in sulphur amino acid metabolism and the difficulties in making generalised 
statements. 
1.7.4 Plant Sulphur Amino'Acid Metabolism 
Plants are also able to assimilate inorganic sulphur for incorporation into amino 
acids in much the same way as bacteria (for a recent review see Ravanel et al., 
1998). The ability of plants to accomplish this is of undoubted importance to all 
mammals, with the possible exception of ruminants, as this provides the essential 
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source of dietary sulphur required in the form of methionine. One difference in 
this mechanism between plants and bacteria is the utilisation of glutathione for 
sulphate reduction by plants (Tsang and Schiff, 1976a) and thioredoxin in bacteria 
(Tsang and Schiff, 1976b). 
In plants, as in bacteria, the synthesis of L-cysteine is achieved by condensation 
of sulphide and OAS by OASS. This enzyme has been studied thoroughly in 
plants and found to be similar to the enzyme in bacteria. However, whether there 
exists a bienzyme complex of SAT and OASS in all plants is less clear. The 
published evidence seems contrary in some cases. For example, purification of 
cysteine synthase from rape leaves (Masada et al., 1975) and spinach leaves 
(Warrilow and Hawkesford; 1998) make no mention of co-purification with SAT. 
Others have shown the purification of both enzymes in a tight complex, for 
example in spinach chioroplasts (Droux et al., 1992), Allium tuberosum 
(Nakamura and Tamura, 1990) and water melon (Saito et al., 1995). Analysis 
using the yeast two-hybrid system has proposed association of the enzymes from 
Arabidopsis thaliana in vivo (Bogdanova and Hell, 1997) but later work using A. 
thaliana proteins expressed recombinantly in E. coli have claimed this is not the 
case (Droux et al., 1998). In common with bacterial cysteine synthase, multiple 
isoforms are found in plants. These can be classified into distinct isoforms which 
are intercellularly localised into plastids, mitochondria and cytosol (Lunn et al., 
1990; Rolland et al., 1992; Yamaguchi of al., 1998). Four species have been 
cloned from rice (Nakamura et al., 1999) and at least three from A. thaliana (Hell 
et aL, 1994; Barroso et al., 1995; Hesse and Altmann, 1995; Nakamura et al., 
1997). Although there are obvious organelle distributions for the enzymes (i. e. 
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chloroplast, ) in plants there are also multiple isoforms present in a single cellular 
location. 
In plants cystathionine is produced by the condensation of cysteine with 0- 
phosphohomoserine rather than an acetate or succinate substituted molecule 
(Datko, et aL, 1974). ' Homocysteine is generated in an identical fashion to 
bacteria with the a, ß elimination of cystathionine by CBL (also producing pyruvate 
and ammonia). The production of homocysteine by direct suiphydrylation in vivo 
is unlikely in plants. CGS has been shown in vitro to be able to utilise sodium 
sulphide as the sulphur donor to produce homocysteine (Ravanel et al., 1995). 
However it has been calculated that this would be only able to provide 3% of the 
homocysteine requirements (MacNicol et al., 1981). There is thought to be no 
reverse transsulphuration pathway in plants as no CBS or CGL genes or proteins 
have been identified. 
Plants are also unusual in the high concentration of uncommonly occurring 
sulphur amino acids present. These substituted cysteine and methionine 
compounds such as S-methylcysteine, homomethionine and various suiphoxide 
derivatives have largely unknown functions. 
1.7.5 Yeast and Fungi Sulphur Amino Acid Metabolism 
It had been thought for some time that S. cerevisiae was able to synthesise 
cysteine by two distinct pathways. Either via reverse transsulphuration from 
homocysteine and also by a dual action 0-acetylserine sulphydrylase/0- 
acetylhomoserine sulphydrylase (Yamagata et al., 1974). This latter mechanism 
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is now thought not to occur for the production of cysteine in vivo (Ono et al., 
1999). Instead only the sulphydrylation of O-acetyl-L-homoserine is of 
physiological significance. The OAHSS responsible for this has also been 
characterised in S. lipolytica (Morzycka and Paszewski, 1979), Aspergillus 
nidulans (Paszewski and Grabski, 1974) and Neurosporra crassa (Piotrowska et 
a1., 1980; Jacobson and Metzenburg, 1977). Thus it would appear that cysteine 
synthesis does not occur through direct suiphydrylation but from reverse 
transsulphuration only. OAHSS has also been shown in vitro to produce 
methionine and ethionine when sulphide was substituted for the appropriate thiols 
(Yamagata, 1971). However the relevance of the abilities of this enzyme in vivo is 
unknown at this time. 
The enzymes required for reverse transsulphuration have been found in these 
organisms. CBS from S. cerevisiae has been purified (Ono et al., 1994) and CGL 
cloned and expressed recombinantly in E. coli (Yamagata et al., 1993). This 
would allow for the production of cysteine from homocysteine. Conversion of 
cysteine back to homocysteine is also possible as CBL and CGS have also been 
identified. There is no evidence of MGL in yeast or fungi. For a comprehensive 
review on sulphur amino acid metabolism in S. cerevisiae the reader is directed to 
Thomas and Surdin-Kerjan (1997). 
1.7.6 Sulphur Amino Acids in Mammals 
The most obvious and key difference in the metabolism of sulphur containing 
amino acids in mammals to lower organisms is the absence of sulphydrylation. 
Methionine but not cysteine is commonly referred to as an essential amino acid in 
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mammalian nutrition. This is due to the lack of transsulphuration (conversion of 
cysteine to homocysteine) but the presence of the reverse transsulphuration 
pathway. Thus mammals can produce sufficient cysteine for requirements 
provided the dietary source of methionine is adequate. This is synthesised in the 
same manner as described for bacteria utilising CBS and CGL. For a summary 
see Griffith, 1987. 
1.7.7 Parasite Sulphur Amino Acid Metabolism 
As with many other aspects of their biology, the knowledge of the processes of 
sulphur amino acid metabolism in parasites is much scarcer than for other 
organisms. For a review see Walker and Barrett, 1997. The details of sulphur 
amino acid metabolism in parasites other than T. vaginalis will be considered in 
this section. 
There is evidence for direct sulphydrylation in Entamoeba. Two cysteine 
synthase genes have been cloned and partially characterised from both E. 
histolytica (Nozaki et al., 1998) and E. dispar (Nozaki et al., 1999). There are no 
other published accounts of the purification or cloning of enzymes capable of 
sulphydrylation in parasites although data on activities attributed to CBS have 
been published. This activity termed "activated serine sulphydrase" has been 
recorded in E. histolytica and Leishmania spp. (Thong and Coombs, 1985b) and 
also species of nematodes (Walker and Barrett, 1991). The enzyme responsible 
for the "activated serine sulphydrase" activity has also been partially 
characterised from a free-living nematode source. Described as a novel CBS 
enzyme it is able to catalyse the production of cystathionine from homocysteine 
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and serine or cysteine (Walker et al., 1992; Papadopolous et al., 1996). There is 
also evidence of an additional CBS in nematodes. Cystathionine synthesis and 
catabolism activity has also been detected in Hymenolepis diminuta (Gomez- 
Bautista and Barrett, 1988) and Fasciola hepatica (Bankov et al., 1996). The 
treatment of African trypanosomes with metabolic inhibitors and incubation with 
excess L-methionine have both shown increased intracellular levels of reverse 
transsulphuration products (cystathionine and cysteine) (Bacchi, et al., 1995; 
Goldberg et al., 2000). There does therefore exist part of the transsulphuration 
pathway in some parasites but the complete pathway has not been described. 
The role of SAM in one carbon donor reactions is likely to exist in a number of 
parasites. Several enzymes involved in the metabolism of SAM have been 
characterised. This includes SAM decarboxylase from Onchocerca volvulus 
(Da'Darra et al., 1996), Trypanosoma cruzi (Persson eta!., 1998) and a 
bifunctional SAM decarboxylase/ornithine decarboxylase from P. falciparum 
(Rathaur and Walter, 1987; Müller et al., 2000). Also SAH hydrolyase has been 
identified in both Leishmania donovani (Henderson et al., 1992) and Plasmodium 
falciparum (Creedon et al., 1994). In addition to this part of the methionine cycle, 
methionine y-lyase has also been shown in whole parasite lysates of E. histolytica 
(Lockwood and Coombs, 1991b). 
1.7.8 Sulphur Amino Acid Metabolism in T. vaginalis 
The synthesis and fate of sulphur amino acids in T. vaginalis is the central area of 
investigation of this project. Several processes and enzymes had been 
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characterised from the parasite prior to this study and these will be discussed 
here in detail. 
As with other, organisms methionine is required for the synthesis of SAM by the 
parasite. Radiolabelled methionine has been shown to be incorporated into living 
trichomonads (Thong, 1985) The radiolabelled carbon was detected in SAM and 
also nucleic acids and lipids presumably denoting its role as one carbon donor. 
The parasite has been shown to possess methionine adenosyl transferase 
(Yarlett, 1988) and SAM methyltransferases (Thong et al., 1987). S-Adenosyl 
homocysteine hydrolyase activity has also been detected (Thong et al., 1985) 
and the gene cloned and expressed (Bagnara et al., 1996; Minotto et al., 1998). 
Although the presence of methionine synthase has not been confirmed it would 
complete the cycle of production of methionine from homocysteine and eventual 
conversion back to homocysteine. 
No method of direct sulphydrylation has yet been published for T. vaginalis either 
for the production of cysteine or homocysteine. The presence of an "activated" 
serine suiphydrylase in species of trichomonads has been shown in crude lysates 
(Thong and Coombs, 1985b) but not characterised. The production of hydrogen 
sulphide from this enzyme is stimulated by the presence of p-mercaptoethanol, a 
situation also found in nematodes (Walker and Barrett, 1991). In T. vaginalis this 
activity has been shown to be attributable to several isoforms (Thong and 
Coombs, 1987). 
27 
CGL activity has been reported in T. vaginalis lysates (Thong, 1985). This was at 
very low levels however in a crude cell preparation and has since not been 
investigated. Methionine y-lyase has been purified and cloned from the parasite 
and as this is a major focus of this study it will be covered in detail in the next 
chapter. 
1.8 Pyridoxal 5'-Phosphate (PLP) Dependent Enzymes 
PLP-dependent enzymes are heavily involved in amino acid metabolism in 
general and that of sulphur amino acids in particular. The following sections of 
this introduction give a brief overview of these enzymes followed by a summary of 
those involved in this study. 
Pyridoxal 5'-phosphate, a derivative of pyridoxal or vitamin B6, acts as a cofactor 
in a very large number of enzymes. These PLP-dependent enzymes are 
ubiquitous in eukaryotes and prokaryotes and often play central roles in amino 
acid metabolism. The unique chemistry of the cofactor, which enables it to act as 
an electron "sink", conveys its versatility. The most commonly utilised substrates 
are amino acids and when conjugated to PLP by their amine group the a-carbon 
is labilised. That is, there is the potential to break any of the four bonds around 
the Ca. For this reason PLP-dependent enzymes are able to catalyse 
transamination, decarboxylation, racemisation, elimination and replacement 
reactions. Not only can changes take place at the Ca but also along the amino 
acid side chain as well at the ß and y positions. The specific architecture of the 
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enzymes active site dictates the catalytic event promoting the occurrence of the 
desired reaction, whilst excluding almost entirely all others. 
There are a very large number of sequences available for PLP-dependent 
enzymes in the databases, a situation increased dramatically by the recent 
genome sequencing projects. This has only recently been complemented with 
structural information on these enzymes. Classification has been difficult up until 
this time because of the low sequence homology even between related enzymes. 
A simple and largely accurate classification has been suggested in which these 
enzymes can be broadly subdivided into three classes, a, ß and y (Alexander et 
al, 1994). This was based upon the chemical characteristics of the reaction, 
corresponding to the position at which they act upon their amino acid substrates 
side chain, and correlated with sequence data. From sequence analysis it was 
predicted that the a and y families were more closely related to each other than 
the 0 family. Some PLP-dependent enzymes though do not fit this classification 
and it is thus not comprehensive as it stands. A classification based upon 
structural data has also been proposed (Grishin et al., 1995). At this point five 
different folds were observed and through sequence analysis it was predicted that 
further unknown folds existed. A recent review of PLP-dependent enzymes 
presents the most current attempt to summarise the available data and classify 
the enzymes (Jansonius, 1998). 
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1.8.1 Three Dimensional Structures of PLP-Dependent Enzymes 
The first structure of a PLP-dependent enzyme to be solved was that of aspartate 
aminotransferase (AAT) in 1980 (Ford et al., 1980). This enzyme has since been 
used as a model system and is the most extensively studied of all such enzymes. 
Currently, a search of the structural database reveals a total of 36 sets of atomic 
coordinates for AAT. These include enzyme-complexes with various compounds, 
enzymes from different organisms and numerous mutants. The total number of 
sets of coordinates for all PLP-dependent enzymes, complexes, mutants, etc. now 
exceeds 120. This is an even more remarkable number when one considers that 
the second enzyme structure to be solved, that of tryptophan synthase (TRPS), 
was not published until 1988 (Hyde et al., 1988). Since then a rapidly 
accelerating number of new structures have been solved (following the general 
trend of numbers of structures being solved) and with this the opportunity to 
assign each to an evolutionary family. Many PLP-dependent enzymes are 
multimers and normally active as dimers of at least 80 kDa. The large size of 
these molecules have undoubtedly caused many problems in the past in solving 
structures. Table 1.1 lists the different enzymes for which the three-dimensional 
structures have been solved. 
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Enzyme Source Reference 
Aspartate aminotransferase Chicken mitochondria Ford eta!., 1980 
Chicken cytosol Malashkevich et a!., 1995 
Pig cytosol Malashkevich at a/., 1995 
E. coli Okamoto et a!., 1994 
S. cerevisiae Jeffrey at al., 1998 
Thermus thennophilus Nakai, eta!., 1999 
Tryptophan synthase Salmonella typhimurium Hyde at al., 1988 
co-Amino acid: pyruvate 
aminotransferase 
Pseudomonas sp. Watanabe et al., 1989 
Glycogen phosphorylase Rabbit cytosol Martin et a/., 1990 
Dialkylglycine decarboxylase Pseudomonas capacia Toney at al., 1993 
Tyrosine phenol-lyase Citrobacter freundii Antson et al., 1993 
Erwinia herbicola Pletnev et al., 1997 
D-Amino acid aminotransferase Bacillus sp. Sugio et al., 1995 
Omithine decarboxylase Lactobacillus 30a Momany et al., 1995 
Trypanasoma brucei Grishin at al., 1999 
Mouse Kern eta!., 1999 
Cystathionine p-Iyase E. coli Clausen et al., 1996 
Alanine racemase Bacillus stearothermophilus Shaw at a/., 1997 
Glutamate-1-semialdehyde 
aminomutase 
Synechoccus Hennig at al., 1997 
O-Acetylserine suiphydrylase S. typhimurium Burkhard et al., 1998 
8-Amino-7-oxononanoate 
synthase 
E. coli AJexeev at al., 1998 
Aromatic amino acid Paracoccus denitrificans Okamoto et aL, 1998 
aminotransferase Trypanasoma cruzi Blankenfeldt et al., 1999 
E. coli 3TAT 
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Cystathionine 7-synthase E. coli Clausen et a!., 1998 
Nicotiana tabacum Steegbom et a/., 1999 
Omithine aminotransferase Homo sapiens Shen of a/., 1998 
Senne hydroxymethyltransferase Homo sapiens Renwick of a!., 1998 
Rabbit cytosol Scarsdale eta!., 1999 
E. coli Scarsdale et al., 2000 
Threonine deaminase E. coli Gallagher eta!., 1998 
Tryptophan indole-lyase Proteus vulgaris Isupov et al., 1998 
AHBA synthase Amycolatopsis mediterrane! Eads et al., 1999 
1-Aminocyclopropane-1- 
carboxylate synthase 
Apple Capitani et al., 1999 
Anthranilate synthase Su! folobus so! fataricus Knochel et a!., 1999 
Diaminopelargonic acid synthase E. coli Kack of a!., 1999 
Phosphosenne aminotransferase E. coli Hester et a!., 1999 
Bacillus sp. 1 BT4 
CsdB (SCL) E. coli Fujii et al., 2000 
Cystalysin Treponema denticola Krupka of a!., 2000 
Cystine lyase (C-DES) Synechocystis Clausen et al., 2000a 
MaIY E. co!! Clausen of al., 2000b 
NifS Thermotoga maritima Kaiser et al., 2000 
Table 1.1: List of structures published with PLP cofactor. Only the first example of any structure 
reported is referenced. Where there is no publication available on a deposited set of coordinates the 
PDB accession code is given. 
At the beginning of this study very few of those listed above were in the database 
(though not necessarily available). CBL was the only representative of the 
proposed y-family and since that time only two other examples have been 
published, those of CGS (Clausen et al., 1998; Steegborn et al., 1999). CBL was 
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also the only example of a PLP-dependent enzyme acting upon a sulphur 
containing amino acid. Since that time though four structures have been 
published that act upon cysteine (or cystine), CsdB (Fuji et a!., 2000), cystalysin 
(Krupka et al., 2000), C-DES (Clausen et al., 2000) and NifS (Kaiser et al., 2000), 
in addition to CGS. 
1.8.2 Methionine y-Lyase (MGL) 
In T. vaginalis the breakdown of L-methionine into ammonia, a-ketobutyrate and 
methanethiol has been shown to be catalysed by the PLP-dependent enzyme 
methionine y-Iyase (MGL) (Thong and Coombs, 1987, Lockwood and Coombs, 
1991 b): The same enzyme is also responsible for the even more rapid 
breakdown of L-homocysteine to ammonia, a-ketobutyrate and hydrogen 
sulphide, formerly described as homocysteine desuiphurase (Thong and Coombs, 
1985). The enzyme has been purified from the parasite (Lockwood and Coombs, 
1991 b) and two genes cloned and expressed in a prokaryotic system (McKie et 
al., 1998). As mentioned previously the enzyme is also present in P. putida and 
has been purified from the bacteria (Esaki and Soda, 1987) and two genes cloned 
in an analogous fashion to T. vaginalis (Inoue et al., 1995; Hod et al., 1996). 
Other sources from which the enzyme has been purified include Aeromonas sp. 
(Nakayama et al., 1984), Brevibacterium linens (Dias and Weimer, 1998) and 
Clostridium sporogenes (Kreis and Hession, 1973). A further report of purification 
of MGL from T. vaginalis has incorrectly claimed isolation of a further enzyme to 
the two already published (Han et al., 1998). The differences in this are very 
minor (two amino acid changes) and presumably strain specific or PCR based 
mutations. Activities for MGL have also been reported in a number of soil 
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bacteria, E. histolytica and rumen ciliates (Lockwood and Coombs, 1991 b). There 
is no mammalian homologue of the enzyme and it is apparently absent from yeast 
and other eukaryotes as well. Trace levels of homocysteine desuiphurase activity 
in mammals have been attributed to the action of cystathionine y-lyase and 
thought to be of little significance (Cooper, 1983). 
Characterisation of the enzyme has revealed it to be active as a multimer. 
Individual subunits have an Mr of 40-44 000 and the active enzyme has an 
estimated M, of >150 000. This suggests a tetrameric enzyme and the activity of 
recombinant enzyme from P. putida and T. vaginalis suggests that this is likely to 
be a homotetramer. Whether this is the case in vivo has not been shown. PLP is 
present at a ratio of 1 mole per mole of enzyme subunit in each case. Relative 
levels of activity differ between sources but the enzyme is able to catalyse a, y- 
elimination reactions on a range of CY-S8 containing amino acids such as 
methionine, ethionine and homocysteine. To a lesser extent, similar activities 
have been recorded against'CO-Sr substrates such as cysteine too. 
The in vivo role of the enzyme is unknown at present although there is evidence 
that the a-keto acids produced may be utilised as an alternate energy source 
(Lockwood and Coombs, 1991 b). This has also been suggested in P. putida 
because of its gene arrangement within an operon coding for part of an a-keto 
acid dehydrogenase (Inoue et al., 1997). The specific role of the large amounts of 
low molecular weight thiols produced is unknown but is at least partly responsible 
for the characteristic odour produced by T. vaginalis when grown in vitro. 
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1.8.3 Cysteine Synthase 
As already mentioned cysteine synthase or OASS is present in many bacterial 
species, plants and also recently discovered in Entamoeba. It catalyses the 
condensation of 0-acetyl-L-serine and sulphide to produce L-cysteine and 
acetate (for a recent review see Tai and Cook, 2000). The enzyme has been 
purified from a large number of species and also cloned and expressed 
recombinantly. It is active as a homodimer and the structure of the enzyme from 
S. typhimurium has been solved (Burkhard et al., 1998). As with MGL and the 
various cysteine desulphurase enzymes, it is a PLP-dependent enzyme. Unlike 
these others, though, it belongs to the ß-family of PLP-dependent enzymes with a 
fold similar to tryptophan synthase (Hyde et al., 1988). 
For both plant and bacterial enzymes there is evidence for cysteine synthase 
existing as a complex with serine acetyl transferase (SAT), the previous enzyme 
in the cysteine biosynthetic pathway. The evidence available seems to suggest 
that in appropriate circumstances certain isoforms of the enzyme associate with 
SAT to form the "cysteine synthetase" complex. In vivo the association of the 
plant enzyme is dependent on the concentration of both OAS and sulphide (Droux 
et a/., 1998) and SAT forms high molecular weight complexes in the absence of 
cysteine synthase. 
1.8.4 Cysteine Desulphurase 
Cysteine desuiphurase is a PLP-dependent enzyme that catalyses the removal of 
sulphur from cysteine to leave alanine. It is also able to utilise selenocysteine as 
substrate (Lacourciere and Stadtman, 1998). Note that this is a different reaction 
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from that of MGL which further reduces the carbon backbone to pyruvate and 
ammonia in the lysis of cysteine. The enzyme is alternatively referred to as NifS 
in reference to the gene product from Azotobacter vinelandii (Zheng et al., 1993). 
Homologues have been identified in E. coli (Mihara et al., 1997), S. cerevisiae 
(Kolman and Söll, 1993), Caenorhabditis elegans (Wilson et al., 1994) and mice 
(Nakai et al., 1998) amongst others. There does also exist an analogue first 
identified in pigs highly specific for selenocysteine termed selenocysteine lyase 
(SCL)(Esaki et a!., 1982). A homologue for this enzyme has been identified in E. 
coli termed CsdB (Mihara eta!., 1999). NifS has been shown to catalyse the 
formation of FeS clusters in nitrogenase to create a functional enzyme (Zheng et 
A, 1993). It does this by forming an internal persulphide complex between the 
released substrate sulphur and a conserved cysteine residue within the enzyme 
(Zheng et al., 1994). It is then believed that this would then be passed onto an 
unknown carrier molecule prior to use in FeS cluster formation or repair. There is, 
in addition, a different enzyme that can direct FeS cluster assembly. This enzyme 
isolated from Synechocystis has been named C-DES and has a different substrate 
profile and proposed mode of action to NifS proteins. Instead of forming an 
internal enzyme persuiphide complex, C-DES preferentially utilises cystine 
(dimerised cysteine) and releases pyruvate, ammonia and cysteine persulphide 
(Lang and Kessler, 1999). This cysteine persulphide is then presumed to be 
released and act as a sulphur atom donor in an analogous fashion to the enzyme 
bound persulphide of NifS enzymes. Recently the structures of several of these 
enzymes have been solved and published: a NifS-like protein from Thermotoga 
maritima (Kaiser et al., 2000), CsdB (a selenocysteine Iyase) from E. coli (Fujii et 
aL, 2000) and C-DES from Synechocystis (Clausen et al., 2000). All three 
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enzymes are members of the aminotransferase family, structurally similar to 
aspartate aminotransferase. 
Another different cysteine lyase enzyme from Treponema denticola has also been 
characterised (Chu et al., 1997). This enzyme is more similar to MGL in that it 
also catalyses an a, p-elimination reaction catabolising cysteine to pyruvate, 
ammonia and H2S. Another interesting observation is that it is proposed to be at 
least partly responsible for the haemolytic properties of the organism. A feature 
also found in T. vaginalis pathology. Recently the structure of this enzyme has 
been reported (Krupka et aL, 2000) and confirmed its structural similarity to other 
PLP-dependent aminotransferases. The active site is more structurally similar to 
CBL and CGS reflecting the reaction similarity. 
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1.9 Aims of The Project 
The overall aim of this study was to further understand sulphur amino acid 
metabolism in T. vaginalis. In particular the roles of MGL and cysteine synthase. 
To do this three practical goals were set: 
1. Crystallise and solve the structure of MGL 
2. By site-directed mutagenesis analyse the mechanism of MGL and relate this to 
potential roles in vivo 
3. Produce and purify recombinant cysteine synthase cloned from T. vaginalis 
and investigate its role in vivo 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Crystallisation and Structure Solution Materials and Methods 
2.1.1 MGL Purification 
Enzyme for use in crystallisation was purified as published (McKie et al., 1998) 
with minor revisions as indicated in section 3.2.1. 
2.1.2 Enzyme Sample Preparation 
Freshly prepared MGL1 and 2 for crystallisation was concentrated using a 10 kDa 
cut-off MicrosepTm centrifugal concentrator (Flowgen) and simultaneously washed 
to remove glycerol and replace the buffers. Firstly the enzyme sample was 
concentrated to a volume of approximately 0.25 ml. 3 ml of 100 mM HEPES pH 
7.5,250 µM PLP, 1 mM DTT was added and the sample concentrated by 
centrifugation until the volume of the retained sample was approximately 0.25 MI. 
This process was repeated three times to ensure removal of glycerol, salts, etc. 
After concentration of the sample to a suitable volume, protein concentration was 
determined and the sample resuspended in the same buffer to 6 mg/ml. 
2.1.3 Crystallisation Solutions 
Sparse matrix screens were prepared in house from published recipes, e. g. Magic 
50 (Jancarik and Kim, 1991). All solutions were filtered through a 0.22 µm syringe 
filter to reduce microbial contamination. 
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2.1.4 Sitting Drop Crystallisation 
24 well sifting drop plates were used for crystallisations (NBS biologicals, UK). 1 
ml of the appropriate crystallisation solution was added to the reservoir. For each 
condition, 1.5 µI enzyme solution was added to 1.5 µl reservoir solution and mixed 
by pipetting. Wells were sealed using transparent adhesive tape. 
2.1.5 Dynamic Light Scattering 
Monodispersity of the concentrated enzyme solution was examined by dynamic 
light scattering using a Dynapro-801 (Protein Solutions, UK). Enzyme was 
concentrated to >10 mg/ml in 25 mM HEPES pH 7.5 in an identical fashion to that 
described in section 2.1.2. Enzyme was then resuspended at a concentration of 1 
mg/ml in the desired solution. Samples of 200 µl were loaded into the instrument 
by syringe through a 0.1 µm filter. 
2.1.6 Data Processing and Scaling 
All data were processed with DENZO and scaled using SCALEPACK (Otwinowski 
and Minor, 1997). 
2.1.7 Molecular Replacement 
Molecular replacement was performed using the programme AMoRe 
(Navaza, 1994) with data from 10 to 4.5 A and the structure of CBL (Clausen et al., 
1996) used as a search model. 
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2.1.8 Refinement 
Refinement of all MGL1 structures in this study was carried out using REFMAC 
(Murshdov et al., 1997) using the Free R-factor (Branger, 1992) to monitor 
progress. 5% of randomly assigned reflections were selected for the Free R set 
and excluded from all stages of refinement. A bulk-solvent correction (Kostrewa, 
1999) was used in later stages of refinement. Geometric restraints were 
calculated using PROTIN, new entries for PLP and the PLP-propargylglycine 
complex were produced using MAKEDIC. Maps were calculated from the output 
of REFMAC using the CCP4 programme FFT. Waters were assigned initially 
using the programme ARP (Lamzin and Wilson, 1993). 
2.1.9 Model Building 
All model building was done using the programme QUANTA (Molecular 
Simulations Inc., UK). Early rounds of model building fitted only one monomer 
and advantage was taken of the 2-fold NCS in the asymmetric unit. The maps 
produced by refinement were then averaged over a single monomer using the 
CCP4 programme MAPROT and the process repeated. This was performed until 
density was visible for all main chain atoms and subsequently monomers were 
checked individually. 
2.2 Molecular Biology Materials and Methods 
2.2.1 Bacterial Maintenance, Cultivation and Harvesting 
Escherichia coli strains used in this study were XL1-Blue (Stratagene) and JM109 
(Promega) for cloning and M15pREP4 (Qiagen) and BL21 DE3 (Novagen) for 
expression of recombinant protein. Stocks of bacterial strains were maintained by 
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combining an overnight culture 1: 1 with a 40% glycerol and 2% peptone solution 
and stored at -70 °C. Overnight bacterial cultures were always produced by 
picking a single discrete colony and using this to inoculate an aliquot of LB. 
Colonies were produced by streaking out a sample of bacterial stock onto a solid 
LB-agar plate with appropriate antibiotics. Bacteria were harvested by 
centrifugation for 5 minutes at 13 000 rpm in a benchtop microfuge or, for large 
scale cultures, 15 minutes at 4000 g. Antibiotics were used at the following 
concentrations: ampicillin 100 µg/ml, kanamycin 25 gg/mI. 
2.2.2 Plasmid Purification 
Plasmid DNA was routinely isolated from a3 ml overnight culture using either 
WizardTM mini prep kits (Promega) or Qiaspin columns (Qiagen). For automated 
sequencing, Qiaspin columns were used and plasmid resuspended in double 
distilled deionised water (dddH2O). 
2.2.3 Polymerase Chain Reaction (PCR) Amplification 
PCR amplifications of DNA fragments which engineered restriction sites onto the 
ends each contained 5 ng template DNA, oligonucleotide primers at 1 mM, 0.1 
mM dNTPs, 0.75 mM MgCI2, reaction buffer as supplied by the manufacturer and 
5U of DNA polymerase. VentTm DNA polymerase (New England Biolabs) was 
used because of its proof-reading ability to minimise mutations inserted during 
amplification. Taq DNA polymerase (Promega) was used for routine 
amplifications. Pfu polymerase (Stratagene) was used for site-directed 
mutagenesis experiments. Individual protocols including thermal cycling 
parameters will be referred to in the text as required. All PCR was carried out on 
a Perkin Elmer GeneAmp PCR System 2400. 
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2.2.4 Isolation of T. vaginalis Genomic DNA 
Genomic DNA (gDNA) was purified from T. vaginalis using a phenol/chloroform 
extraction. Parasites in log phase were harvested by centrifugation at 4000 g for 
15 minutes at 4 °C and washed twice in pre-chilled 1x PBS. The resulting cell 
pellet was resuspended in extraction buffer (50 mM TRIS-HCI pH 8.0,50 mM 
EDTA, 100 mM NaCI) with the addition of 1% SDS and 4 mg proteinase K in a 
final volume of 2 ml. This was then incubated at 37 °C for 2 hours under gentle 
agitation. The lysate was combined 1: 1 with phenol and mixed gently for 5 
minutes before centrifugation at 1500 g for 15 minutes. The upper, DNA 
containing aqueous phase, was carefully removed using a wide bore pipette and 
the remaining organic solvent discarded. The aqueous phase was then mixed 
gently with a phenol/chloroform solution (1: 1 v/v) and centrifuged and separated 
as before. Finally the aqueous phase was combined 1: 1 with chloroform and 
mixed gently before centrifugation as before. High molecular weight genomic 
DNA was then precipitated by adding 0.1 volumes of 3M sodium acetate pH 5.2 
and 2.5 volumes of 100% ethanol. The visible gDNA was spooled using a pipette 
tip to obtain the largest possible fragments and avoid co-purification of RNA. The 
precipitated gDNA was resuspended in TE buffer and incubated at 37 °C 
overnight with 1 mg/ml proteinase K before repeating the phenol/chloroform 
extraction procedure and ethanol precipitation. High levels of EDTA and 
proteinase K were deliberately used in the extraction buffer to minimise nuclease 
degradation of gDNA. The second proteinase K treatment removed 
contaminating proteins to aid in the complete enzymatic digest of the DNA for 
Southern analysis. 
43 
2.2.5 Restriction Endonuclease Digest of DNA 
Plasmid DNA digests were routinely done using an excess of enzyme to ensure a 
rapid complete digest. Generally up to 200 ng of plasmid DNA was digested in a 
total volume of 10 µl using 5 to 10 units of restriction enzyme for 1 to 2 hours at 
37 °C. Restriction enzymes were obtained from various commercial companies 
and used with compatible buffers as supplied. T. vaginalis gDNA was digested in 
a total volume of 40 µl with 40 units of restriction enzyme. 30 units were added 
initially and incubated for 3 hours at 37 °C before the addition of a further 10 units 
and continued incubation for another hour. 
2.2.6. DNA Ligations 
Ligation of PCR products into pGEM-T vector (Promega) were performed 
according to the manufacturers instructions with ligase and buffer as supplied. 
PCR products were purified after separation on I% agarose gel and DNA 
concentration estimated from known DNA standards. Sub-cloning of DNA 
fragments into restriction digested plasmid was performed using commercially 
obtained T4 DNA ligase (New England Biolabs or Promega) and buffer as 
supplied. Ligations were performed in a minimal volume, generally 10 µI, with 
varying ratios of insert to vector at either 16 °C or 4 °C overnight. 
2.2.7 Competent Cells 
Chemical competent cells were commercially supplied XL-1 Blue (Stratagene) or 
JM109 (Promega), efficiencies were 1 x109 and 1x 107 respectively. 
Electrocompetent cells M15p(Rep4) (Qiagen) and BL21 DE3 (Novagen) were 
produced by the method of Tung and Chow (1995). 
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2.2.8 Transformation of Competent E. coil with Plasmid DNA 
The protocol for transformation of chemical competent cells was identical for 
either type of cells with one small exception. For both, a sample of the ligation 
mix (usually 1 or 2 µi from a 10 µl sample) was added to the competent cells in a 
prechilled eppendorf tube and left on ice for 30 minutes. The tubes were then 
transferred rapidly to a water bath at 42 °C for exactly 45 seconds before 
replacing on ice for a further 2 minutes. 1 ml of LB, pre-warmed to 37 °C, was 
then added and incubated at 37 °C for 1 hour with shaking at 200 rpm. 100 µl of 
this was then spread onto an LB-agar plate containing the appropriate antibiotic. 
XL1-Blue cells followed exactly the same protocol with the addition of ß- 
mercaptoethanol with the ligation mix as outlined in the supplied protocol. Where 
colour selection of positive clones was required, the plates were also 
supplemented with 60 µi of 100 mM IPTG and 40 µl of 20 mg/mi X-gal 
immediately prior to adding the cells. For routine transformation of intact circular 
plasmid, high efficiency competent cells were not used. Instead, 1 ml of an 
overnight culture of XL1-Blue cells was added to 9 ml LB and incubated at 37 °C 
for 1 hour with shaking at 200 rpm. A1 ml aliquot was removed, the cells 
harvested by centrifugation in a bench top microfuge at 6000 rpm for 5 minutes 
and washed 2 times in 1x PBS. The pellet was then resuspended in 100 µl ice 
cold 20 mM CaCI2.100 ng of plasmid was added to this and left on ice for 30 
minutes before heat shocking at 42 °C. To this 400 µI LB, pre-warmed to 37 °C, 
was added and 100 µl immediately spread onto LB-agar plates with the 
appropriate antibiotic. 
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2.2.9 Agarose Gels 
For routine analysis of DNA, agarose gels were prepared by melting 1% 
powdered agarose (w/v) in 0.5 x TBE. The solution would be allowed to cool to 
hand hot temperature before pouring. If the DNA was to be excised and purified 
from the gel then an identical procedure was carried out but 1x TAE replaced the 
TBE buffer. Samples were loaded onto the gels in the presence of gel loading 
buffer containing glycerol and bromophenol blue dye. To visualise DNA after 
running the gels, they were stained in a solution of the relevant buffer and 0.5 
µg/ml ethidium bromide. Stained gels were viewed under ultraviolet illumination 
and the image recorded using an Appligene Imager (Appligene Oncor). Long 
wave UV was used if the DNA was to be excised or used subsequently for transfer 
to a membrane to minimise damage to the DNA. 
2.2.10 DNA Extraction from Agarose Gels. 
DNA fragments were excised from TAE/agarose gels with a clean scalpel blade 
and isolated using a Qiaquick gel extraction kit (Qiagen) or GenElute column 
(Sigma). Despite manufacturer's claims, total DNA recovery was variable and it 
was essential that subsequent to the removal of contaminating agarose the exact 
concentration of DNA was confirmed by running a sample on a gel with a DNA 
marker of known quantities. 
2.2.11 Automated DNA Sequencing 
Purified plasmid for sequencing was resuspended and sent to one of the following 
commercial laboratories for analysis: PNACL (Leicester, UK), MWG (Milton 
Keynes, UK), MBSU (Glasgow, UK). 
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2.2.12 Oligonucleotide Primers for Cloning and Site Directed Mutagenesis 
Gene specific primers were obtained from commercial suppliers. All were 
supplied desalted but not subject to further purification. The sequence of the 
primers used in this study are indicated in Table 2.1. 
Oligonucleotide Name Oligonucleotide Sequence 
OL281 5 -AGATCTGAGGACTAAGTCGAGAGCCT-3' 
O L282 5'-CCATGGGTGGCCACGCTATCGACCCAACACATA-3' 
R58 Kf 5'-CCGGCTACATCTACACAAAGCTCGGCAACCCAACAG-3' 
R58 Kr 5'-CTGTTGGGTTGCCGAGCTTTGTGTAGATGTAGCCGG-3' 
R58Mf 5'-CCGGCTACATCTACACAATGCTCGGCAACCCAACAG-3' 
R58Mr 5'-CTGTTGGGTTGCCGAGCATTGTGTAGATGTAGCCGG-3' 
L59 Ff 5'-GGCTACATCTACACACGTTTCGGCAACCCAACAG-3' 
L59Fr 5'-CTGTTGGGTTGCCGAAACGTGTGTAGATGTAGCC-3' 
Y111 Ff 5'-CCGATGAGTGCCT7TTT GGCTGCACACATGC-3' 
Y111 Fr 5'-GCATGTGTGCAGCCAAAAAGGCACTCATCGG-3' 
C113Pf 5'-CCGATGAGTGCCTTTATGGCCCCACACATGCTCTC-3' 







OASS 1 5'-CATATGATCTACGACAACATCCTCGAGAC-3' 
OASS 2 5'-GAAGAAATCTGGGCCCAG-3' 
OASS 3 5'-GGTTCTTGCCAACACCCC-3' 
OASS 4 5'-CCGTGTCTACCGCGGTAGGCATTCC-3' 
OASS 5 5'-CTCACTCCCGCAAAGTTAGCTTGCGGC-3' 
OASS 7 5'-GCAGTGTCGACTTCTGTGTCGAAGAGCTTTG-3' 
Table 2.1 Oligonucleotides used for sequencing and mutagenesis 
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2.2.13 Radioactive Labelling of Nucleotide Probes 
DNA probes for Southern blot hybridisations were radiolabelled using the Prime 
ItTM' kit (Stratagene) following the supplied protocol. Briefly, 25 ng of template 
DNA was incubated in the presence of radioactively labelled dATP (32P-3000 
mCi/mmol, NEN Dupont). Random hexamer primers and Exo(-)Klenow DNA 
polymerase were used to incorporate the radioactive nucleotides into the probe. 
Probes were denatured by boiling for 10 minutes prior to incubation with the 
membrane. 
2.2.14 Southern Blotting 
T. vaginalis gDNA was digested with an appropriate restriction enzyme as detailed 
in section 2.2.5 and resolved on a 0.7% agarose gel. The gel was stained with 
ethidium bromide to confirm adequate digestion of the DNA and then 
photographed before further treatment prior to transfer to Hybond N membrane 
(Amersham Pharmacia). The gel underwent depurination in 0.25 M HCI for 10 
minutes before rinsing briefly in dddH2O. This was followed by denaturation (1.5 
M NaCl, 0.5 M NaOH) and neutralisation (1.5 M NaCl, 0.5 M TRIS-HCI pH 7.5) for 
30 minutes each. The gel was rinsed briefly in dddH2O after both steps before 
transfer by capillary action as described in Sambrook et al., 1989. After overnight 
transfer in 20 x SSC the gel was restained with ethidium bromide to confirm 
complete transfer of DNA. The transferred DNA was cross-linked using a 
SpectrolinkerTM XL-1000 crosslinker (Stratagene) before the filters were used for 
hybridisation with radioactively labelled probes. The membranes were 
prehybridised for 4 hours in rotating glass tubes with sealed ends at 65 °C with 10 
ml hybridisation solution (0.5 M sodium phosphate pH 7.2,7% SDS, 1 mg 
denatured and sheared herring sperm DNA). Denatured radioactively labelled 
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probe was then added directly to this solution and incubated at 65 °C overnight 
with continuous rotation. The hybridisation solution was then decanted and the 
membrane washed. Increased stringency washes were performed at 65 °C with 
rotation for 30 minutes. Firstly in 2x SSC, 0.1% SDS, then 1x SSC, 0.1% SDS 
and finally 0.1 x SSC, 0.1 % SDS. The blot was then wrapped in saran wrap and 
exposed to autoradiographic film (Fuji RX) at -70 °C for as long as necessary 
(typically 12-36 hours). Film was developed automatically using a Kodak Xomat 
film processor or manually using Kodak reagents. 
2.2.15 Site Directed Mutagenesis of MGL1 
Mutagenesis of specific residues was performed using mismatched 
oligonucleotide primers following the Quickchange (Stratagene) protocol. Briefly, 
plasmid g114 which contains the mgll ORF in expression vector pQE60 (Qiagen) 
was used as a template and complementary oligonucleotides were used to mutate 
appropriate nucleotides changing the amino acid sequence. The remaining 
plasmid sequence was then synthesised using the thermostable DNA polymerase 
pfu, which possesses an exonuclease activity and has a reduced likelihood of 
incorporating errors into the DNA strand. After 25 cycles of DNA synthesis the 
original plasmid template was removed from the mutated DNA by digestion with 
Dpn I. This restriction enzyme is a methylated DNA specific endonuclease and as 
such only digested the template plasmid. The remaining nicked circular mutated 
plasmid was then transformed into competent E. coli and selected on LB agar 
plates containing ampicillin. Verification of the mutant was by automated DNA 
sequencing and restriction digest analysis where appropriate. 
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2.2.16 Production of New mg12 Construct 
Plasmid gl15 encoding mgi2 was used as a template to add restriction sites to the 
5' and 3' ends by PCR using primers OL281 and OL282 (Table2.1) as detailed in 
section 2.2.3. This added an Ncol site to the 5' end of the ORF whilst replacing 
the missing residues and a BgfI site at the 3' end. This fragment was then 
excised from the plasmid and ligated into precut pQE60 as described for mg/I 
(McKie, 1997). To produce mutant MGL2(c"6G), a SalUSphl 350 bp fragment was 
removed from the original construct and ligated into the new one. This 
circumvented the need to repeat the site-directed mutagenesis previously 
required. 
2.2.17 Cysteine Synthase 5'-RACE 
Isolation of the 5' untranslated region (5'-UTR) of T. vaginalis cysteine synthase 
was attempted using a 5'-RACE system kit (Life Technologies). Total RNA 
isolated from the parasite was used as the template for the reaction. Experiments 
were carried out according to the manufacturers instructions. Briefly, cDNA was 
transcribed from mRNA using reverse transcriptase and an oligo dT primer. A 
poly-dC tail was added to the isolated cDNA and this used as a template for PCR 
with a supplied anchor primer (complementary to the dC tail) and a cysteine 
synthase gene specific primer (OASS 4). Amplification of the product from this 
reaction was attempted with another gene specific primer (OASS 5) and a 
supplied anchor primer. 
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2.3 Biochemical Materials and Methods 
2.3.1 Protein Concentration Estimation 
Protein concentration was routinely determined with the Pierce BCA system using 
the supplied microtitre plate protocol. Bovine Serum Albumin or y-globulin were 
used as protein standards over a range of 0.1 to 2.0 mg/ml. 
2.3.2 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS- 
PAGE) 
Protein analysis and molecular weight estimation was done using discontinuous 
SDS-PAGE as described by Laemmli, 1971. Acrylamide resolving gels of 
between 7.5 and 12.5% (w/v), 0.75 mm thick were cast and run using a Bio-Rad 
Mini Protean II dual slab cell as per manufacturer's instructions. Molecular weight 
markers (10 kDa protein ladder, Gibco) were run routinely to estimate the 
apparent molecular weight of sample proteins. 
Proteins were revealed by staining with Coomassie blue dye. Gels were 
immersed for 30 minutes or more in staining solution (40%(v/v) methanol, 7%(v/v) 
acetic acid, 0.1% (w/v) Coomassie Blue R250) and then destained with 40%(v/v) 
methanol, 7% (v/v) acetic acid until background staining was at a minimum. Gels 
were either photographed or stored by drying. To dry, gels were soaked 
overnight in a 4% glycerol (v/v) destain solution and then dried overnight between 
2 cellulose sheets pre-soaked in dddH2O. 
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2.3.3 Native Gel Electrophoresis 
Native gels were cast and used exactly as for SDS-PAGE but with the omission of 
SDS from gel and buffers. Reducing agents such as DTT or p-mercaptoethanol 
were also omitted from loading buffer. 
2.3.4 Western Blotting 
Transfer of proteins to Hybond-ECL membrane (Amersham Pharmacia) from 
acrylamide gels was achieved as described by Towbin eta!., 1979. A Bio-Rad 
mini transblot cell was used following the manufacturer's instructions. 
2.3.4.1 Membrane Staining 
To verify successful transfer of proteins to the membrane they were stained with a 
Ponceau S solution. This also enabled the membrane to be cut accurately if 
required between protein lanes and molecular weight marker positions could be 
marked on the membrane. The membranes were immersed in the Ponceau stain 
for a few minutes and rinsed with dddH2O to remove background staining. 
2.3.4.2 Prehybridisation of Membranes - Blocking 
Blocking of non-specific binding is essential in Western blotting to obtain a clear 
result with minimal background. The blocking procedure prevents binding of 
immunoglobulins (both primary and secondary) to non-specific areas of low 
affinity on the membrane, leaving only the high affinity binding sites which would 
be preferentially bound. Before adding the primary antibody the membrane was 
immersed for 4 hours at room temperature with gentle agitation in blocking 
solution (5% (w/v) skimmed milk powder, 0.2% TWEEN 20,1 x TRIS buffered 
saline (TBS) (20 mM TRIS-HCI, 150 mM NaCl, pH 7.6). 
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2.3.4.3 Primary Antibody Binding 
After prehybridisation, the solution was removed and replaced by hybridisation 
solution (1 % (w/v) skimmed milk powder, 0.1 % TWEEN 20,1 x TBS) and primary 
antibody or pre-immune serum added. This was then incubated overnight at 4 °C 
with gentle agitation. Subsequent to incubation with the primary antibody, 
membranes were washed 3 times for 30 minutes with 1x TBS plus 1% (w/v) 
skimmed milk powder at room temperature. 
2.3.4.4 Secondary Antibody Binding 
The secondary antibody used for detection of anti-cysteine synthase primary 
antibody was a horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG 
(Scottish Antibody Production Unit, SAPU). After washing the antibody was 
hybridised to the membrane in 1x TBS plus 1% (w/v) skimmed milk powder at 
room temperature for 2 hours. After incubation the membrane was washed 3 
times for 30 minutes in 1x TBS plus 1% (w/v) skimmed milk powder at room 
temperature and finally in 1x TBS for 10 minutes. 
2.3.4.5 Western Blot Developing 
Detection of HRP activity was by enhanced chemiluminescence (ECL) using the 
ECL kit (Amersham Pharmacia) as supplied. Essentially the two solutions 
provided are combined 1: 1 in an appropriate volume and incubated with the 
membrane with agitation for 2 minutes. The luminol solution in the kit is cleaved 
by the action of HRP and photons of light are emitted. This should only occur at 
sites of secondary antibody binding to the primary antibody and thus specific for 
the presence of the protein antigen desired. Film was developed automatically 
using a Kodak Xomat film processor or manually using Kodak reagents. 
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2.3.5 MGL Purification 
Recombinant MGL for biochemical analysis was purified as previously published 
(McKie eta!., 1998). 
2.3.6 Homocysteine Desulphurase Assays 
The a' elimination of homocysteine and subsequent detection of 1-12S production 
was by the published method of Thong and Coombs (1985a). This assay was 
routinely used for the measurement of enzyme activity as it was the most reliable, 
simple and sensitive of those available. 
Other MGL assays investigated during this study are indicated in the relevant 
chapters. 
2.3.7 Lysis of Small Samples of E. coli 
When performing test expressions in E. coli, samples removed to monitor over- 
expression of recombinant proteins were too small to be conveniently lysed by 
sonication: Cells were instead lysed by enzyme and detergent action. 15 ml 
samples of cultured bacteria were removed as appropriate and harvested by 
centrifugation at 3200 g for 15 minutes at 4 °C. Pellets were washed in PBS and 
placed at -20 °C until required. Lysis was performed by resuspending the pellets 
in 0.5 ml of 2 mg/ml lysozyme, 0.1% Triton X-100,25 mM TRIS pH 8.5 and 
incubating overnight at 37 °C with agitation. The lysate was then spun at 13 000 
rpm in a benchtop microfuge for 25 mins to remove intact cells and insoluble 
debris. 40 µl of the supernatant was then used for analysis by SDS-PAGE. 
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2.3.8 Purification of Recombinant Cysteine Synthase 
The purification of cysteine synthase is accomplished in a very similar manner to 
that used for MGL. The development of the method used for expression and 
purification is discussed in detail in section 5.2.3. 
2.3.9 Cysteine Synthase Assays 
Cysteine synthase activity was assayed under the following conditions. Buffer 
and dddH2O were deoxygenated by bubbling with N2 gas for 15 minutes prior to 
use. In a total volume of 0.5 ml, enzyme was added to 100 mM sodium phosphate 
buffer pH 7.3,3 mM sodium sulphide, 10 mM O-acetyl-L-serine, 1 mM DTT to 
initiate the reaction. This was mixed briefly and incubated at 37 °C for 5 minutes 
in a water bath. The reaction was terminated by adding 150 µl of the assay mix to 
350 µl of acidic ninhydrin solution (1.3% (w/v) ninhydrin in 1: 4 concentrated 
hydrochloric acid: glacial acetic acid) (Gaitonde, 1967) in screw capped eppendorf 
tubes and mixed thoroughly. To complete the colourimetric reaction eppendorf 
tubes were boiled for 10 minutes in a boiling water bath before cooling on ice for 
30 minutes. The samples were then diluted by adding 0.7 ml 100% ethanol and 
the absorbance measured at 560 nm. The quantification of the amount of 
cysteine produced was by calibrating against a standard curve of known 
concentrations of L-cysteine. " 
2.3.10 "Activated Serine Sulphydrase" Assays 
These assays were carried out essentially as described previously (Thong and 
Coombs, 1985b). Enzyme was added to a total volume of 1 ml 100 mM sodium 
phosphate pH 7.3,330 µM lead acetate, 3.3 mM p-mercaptoethanol and L- 
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cysteine to initiate the reaction. The production of lead sulphide from the reaction 
of H2S with lead acetate was followed at 360 nm. 
2.4 General Materials and Methods 
2.4.1 Parasite Line 
A single line of T. vaginalis was used in this study throughout. Clone G3 is a 
metronidazole sensitive line used for many years in this laboratory and also used 
for the random cDNA library sequencing project carried out by collaborators. 
2.4.2 Cultivation of T. vaginalis in vitro 
The parasite was cultured axenically in Modified Diamonds Medium (MDM) 
(Diamond, 1957), supplemented with 10% (v/v) heat inactivated horse serum (Life 
Technologies)(Complete MDM), at 37 °C. MDM is comprised predominantly of 
peptone (1 % (w/v)), yeast extract (0.5% (w/v)) and maltose (0.5% (w/v)) buffered 
with potassium salts and supplemented with ascorbic acid and iron sulphate. 
Cultures were checked by microscopical examination for contamination before 
use. 
To produce parasites for DNA purification, they were inoculated into fresh 
complete MDM and grown under anaerobic conditions until they reached late log 
growth phase, producing cells at a density of 1-2x106 cells/ml. 
Parasites cultured under different environmental pressures were grown in 
complete MDM supplemented with the relevant compound. 25 ml cultures were 
prepared in tightly capped universals, except for those exposed to aerobic growth 
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conditions which were grown in 500 ml tissue culture flasks in a normally 
aspirated incubator. For growth without ascorbate, complete MDM was prepared 
identically with the exception of the omission of ascorbic acid. All cultures were 
initiated with 1x105 parasites per ml and grown for 18 hours before dividing into 5 
ml aliquots and harvesting. 
2.4.3 Cell Counts 
Parasites were fixed with 4% paraformaldehyde and counted under phase 
contrast microscopy using an improved Neubauer hemocytometer. 
2.4.4 Harvesting Parasites 
T. vaginalis were harvested by centrifugation at 2300 g for 15 minutes at 4 °C and 
washed twice with ice cold 0.25 M sucrose. Cells for RNA analysis were 
resuspended immediately in I ml Trizol (Life Technologies) and stored at -70 °C 
until required. Others were stored as pellets at -70 °C until required. 
2.4.5 Parasite Lysis 
Crude lysates of parasites were obtained in one of two ways. For small numbers 
of cells (less than 5x107) the washed cell pellet was resuspended in 0.25 M 
sucrose plus 0.25 % (v/v) Triton X-100. Cell debris was removed by 
centrifugation at 13 000 rpm in a benchtop microfuge for 5 minutes. For larger 
numbers of cells typically resulting from a 500 ml culture, the cells were lysed 
using a tissue homogeniser. Parasites were resuspended at approximately 2x108 
cells/ml in 1x PBS or 0.25 M sucrose. Lysis of cells was checked by 
microscopical examination. Cell debris was removed by centrifugation at 13 000 
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g for 30 minutes. To reduce proteolytic degradation 10 µM leupeptin and 10 µM 
E64, both cysteine proteinase inhibitors, were added to the lysates. 
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CHAPTER 3. MGL1 STRUCTURE - HOLOENZYME AND 
INHIBITOR COMPLEX 
3.1 INTRODUCTION 
This chapter deals with the result of completing the primary aim of this study, 
obtaining the 3-dimensional crystallographic structure of MGL. Results of the 
processes carried out to achieve this and a discussion of these findings are given. 
The first step to accomplish in the structural determination of MGL was the growth 
of suitably diffracting crystals. This is often a limiting factor in the structural 
studies of proteins. The situation can be made more difficult if the protein is post- 
translationally modified or must be purified from a native source if not available 
recombinantly. This was not the case for MGL and the production of large 
amounts of active, highly pure recombinant enzyme meant that it was possible to 
make many attempts to produce crystals. Preliminary trials were conducted at the 
beginning of the project to ascertain the likelihood of succeeding in this and the 
results are detailed in section 3.2.4 (this work was carried out by Dr. AJ 
Lapthom). 
It was envisaged that the large number of PLP-dependent enzyme structures 
solved and published would aid in solving the structure of MGL using the 
technique of molecular replacement. Failing this, heavy atom derivatives would 
allow for isomorphous replacement. It was briefly considered at the beginning of 
the project to produce selenium derivatives of the enzyme for MAD (Multiple 
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Anomalous Diffraction) experiments using selenocysteine or selenomethionine but 
the activity of the enzyme towards both of these compounds prevented this 
approach. 
At the beginning of this project only a single structure with significant sequence 
homology and predicted to be in the same family as MGL (Alexander et al., 1994) 
had been published, that of cystathionine ß-lyase (CBL) (Clausen et al., 1996). 
The coordinates for this structure were unavailable at the time though and this 
prevented detailed analysis. More recently there have been two further structures 
published of the closely related enzyme cystathionine y-synthase (CGS) (Clausen 
et al., 1998; Steegborn et al., 1999). A mechanism of action has been proposed 
for CBL (Clausen et al., 1997) but this was thought likely to differ significantly from 
that of MGL because of the apparently important cysteine residue of MGL (McKie 
et al., 1998). Differences in substrate preference between the enzymes, MGL 
from'T. vaginalis is unable to act upon cystathionine, also suggested the active 
site would be dissimilar and thus possibly the mechanism. Solving the structure 
of MGL would enable us to propose a mechanism and assign roles to specific 
residues within the active site. 
The role of an active site cysteine in MGL was difficult to define without structural 
information as the enzymes from T. vaginalis and Pseudomonas. putida were not 
completely inactivated by either chemical modification or mutagenesis of this 
residue (Nakayama 1988a; McKie et al., 1998). The activity though was severely 
curtailed and this pointed to an important if not essential function. MGL is 
inactivated by the suicide inhibitor L-propargylglycine and this has been shown to 
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target either a cysteine or tyrosine in the active site (Johnston et al., 1979). This 
also implicated the cysteine as playing a role in catalysis. The crystal structure 
would hopefully elucidate the role of this residue and confirm the inhibition by 
propargyiglycine. 
3.2 RESULTS 
3.2.1 MGL purification 
MGL1 and MGL2 were purified as published (McKie et al., 1998) with some 
revisions. As enzyme was to be used for crystallisation, it was considered critical 
to obtain as close to a 100% homogenous enzyme preparation as possible. 
Elution by a linear gradient of 0-500 mM imidazole produced predominantly 
homogenous enzyme, but some contaminating E. coli proteins still co-eluted. A 
sample of each of the fractions collected was ran on 7.5% SDS-PAGE and 
coomassie blue stained. This generally revealed low level but detectable 
contamination of MGL with proteins of higher and lower molecular weights. 
In an attempt to avoid this contamination and produce a purer preparation, up to 
50 mM imidazole was included in the sonication and wash buffers to prevent E. 
coli proteins with low affinity from binding to the column. This was less successful 
than had been expected, giving no obvious improvements and causing the 
premature elution of enzyme. It is possible that this was due to low levels of 
imidazole competing for Ni-NTA binding with the hexahistidine tag of MGL. 
Although these concentrations are not high enough to elute the tagged protein 
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directly, during the loading of the crude lysate onto the column a proportion of the 
recombinant enzyme is washed away as it is continually displaced and passes 
further down the column until it is eventually eluted with the flow through buffer. 
In support of this suggestion is the observation that subsequent elution of the 
recombinant enzyme occurs over a larger volume. Moreover the MGL bound to 
the column can usually be seen as a band at the top of the column in a standard 
purification (its yellow colour visible due to the PLP cofactor). Adding 50 mM 
imidazole to the buffers results in the yellow band of enzyme becoming more 
diffuse than the normal tight band. 
Therefore in a different attempt to remove the last remaining E. coli protein 
contaminants effectively; 75 mM imidazole was applied to the column prior to 
elution by the linear imidazole gradient. This caused the elution of a number of 
proteins while having a negligible effect upon the bound MGL and proved a highly 
successful method for removing trace contaminants and obtaining a high yield of 
very pure enzyme. Figures 3.1 and 3.2 show the FPLC purification profile of the 









Figure 3.1: FPLC profile of MGL purification. The blue line represents the eluted sample 
absorbance at a wavelength of 280 nm. The upper limit of detection is 2.0 AU. Fractions collected 
are indicated on the figure by vertical downward strokes of the blue line. Red line represents the 
percentage of 500 mM imidazole containing buffer applied to the column. 
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Figure 3.2: SDS-PAGE of a typical MGL1 purification. 10% Polyacrylamide gel stained with 
Coomassie blue. Lanes: A- 10 kDa protein ladder; B- Crude lysate; C- Column loading/flow 
through; D- First wash; E- 75 mM Imidazole wash; F to I- Fractions eluted by linear 155 to 185 
mM imidazole gradient. 
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MGL1 can be clearly identified in lane B as a band at 43 kDa. The absence of 
this in lanes C, D and E indicated it was still bound to the Ni-NTA matrix. The 
efficacy of the 75 mM imidazole wash is clearly seen by the large number of 
bands visible in lane E and the sharp rise in absorbance at 280 nm. 1 ml fractions 
corresponding to an increase in imidazole concentration of 10 mM were collected 
across the linear gradient. Examples of those containing MGL1 are shown above. 
Displacement of the enzyme occured at imidazole concentrations of 
approximately 160 mM and higher although this was partially obscured by the 
strong absorbance of imidazole at 280 nm. The gradient was not halted though 
when this occured and purified enzyme was collected in a number of fractions. 
Routinely, the MGL1 containing fractions from the column were identified by their 
yellow colour in solution and checked using SDS-PAGE. The purest fractions 
were pooled and either concentrated ready for crystallisation, or dialysed into 
sodium phosphate buffer and stored as published (McKie et aL, 1998). The 
enzyme suffered only minor losses in activity when stored at -20 °C over a period 
of several weeks in either condition. Enzyme for crystallisation was, in most 
cases, prepared fresh with 2 or 3 days required in total for purification, 
concentration and preparing the crystallisation experiments. 
3.2.1.1 Identification of Two Species of Recombinant MGLI 
Initially purification of MGL1 was monitored by analysing samples using 7.5% 
polyacrylamide SDS-PAGE. In order to detect contaminants more easily a 
significant amount of highly pure MGL1 (> 5 µgs) was loaded on each occasion. 
This ran as a large 43 kDa band with only a single species visible. However, 
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running the same samples on a 10% gel showed two very close but distinct bands 






Figure 3.3: Coomassie blue-stained 10% SDS-PAGE of purified MGL1. Lanes: A- protein 
molecular weight markers; B to D- Increasing amounts of purified MGL1. 
This was not noticed for some time and was suspected of causing the failure of 
some of the crystallisation trials. As can be seen in figure 3.3, both bands stained 
to a very similar degree and were estimated to be present in an approximately 1: 1 
ratio. The figure shows clearly the difficulty in identifying two bands in lane D 
compared with lane B. The large amount of protein loaded in lane D, though, 
does confirm the very high purity of the sample. It was assumed that both bands 
were recombinant MGL1 for various reasons including the appearance of two 
bands in a native substrate-PAGE gel (not shown). In an attempt to avoid the 
production of 2 distinct proteins, the levels of IPTG used to induce MGL1 
expression were reduced from the very high concentration used of 2 mM to 0.1 
mM. This had a positive effect, greatly reducing but not totally eliminating the 
smaller of the two bands (the second MGL1 band is not visible in figure 3.2 lanes 
F to I). The modification did, however, coincide with successful crystallisation of 
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the enzyme. Thus no further attempts were made to eliminate the second protein 
from the preparation. The cause of this second band and the effect of reducing 
IPTG levels will be considered in the discussion section of this chapter. 
3.2.2 Protein Preparation 
MGL was prepared for crystallisation as described in section 2.1.2. No problems 
were encountered for the concentration of MGL1 samples but it was apparent that 
there was some protein losses when concentrating MGL2 and this was attributed 
to binding to the MicrosepTM membrane. Concentrators were soaked in 10% 
glycerol overnight at 4 °C before use in order to try and alleviate this problem as 
much as possible. Although not quantified the recovery of MGL2 after this was 
significantly better. 
3.2.3 Analysis of MGL Monodispersity by Dynamic Light Scattering (DLS) 
It has been proposed that that the monodispersity of a crystallisation sample can 
be correlated to the likelihood that crystals will form (Malkin et al., 1994; Veesler 
et ai., 1994). Polydispersity can indicate the presence of impurities, isoforms or 
multiple aggregation states in the protein sample. A sample which is composed of 
a single species is theoretically more likely to produce crystals. 
Monodispersity of MGL was measured as detailed in section 2.1.5. Several 
factors may effect the monodispersity of a solution, the most straightforward to 
examine being the pH or the presence of salts. The effect of pH was examined by 
diluting the enzyme sample to 1 mg/ml in 100 mM of relevant buffer. Buffers were 
selected to cover a wide range from pH 4.6 to pH 10.0. The results were 
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equivalent for both enzymes showing that it was possible to obtain a 
monodisperse solution by altering the pH to below 6.5 or above 8.0. Both 
enzymes aggregated heavily at pH 7.5 as was immediately evident from the 
difficulty in injecting the sample through a 0.1 µm filter. That part of the solution 
which did pass through the filter showed species of estimated molecular weights 
of greater than 1000 kDa confirming a large aggregate of protein. This was the 
case for both MGL1 and MGL2. 
In combination with pH, the effect of DTT and additional PLP were also examined. 
However these had no apparent effect on the solution regardless of the buffer and 
pH. 
3.2.4 Crystallisation of MGLI 
Initial attempts to crystallise MGL1 preceded the DLS investigation and utilised a 
number of "sparse-matrix" screens (Jancarik and Kim, 1991). Here the enzyme 
had been stored at -20 °C in 100 mM HEPES pH 7.5,40 µM PLP, 30 µM DTT, 
40% glycerol and used at 6 mg/ml in the same conditions minus the glycerol. The 
positive results are summarised in the table below: 
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Precipitant Buffer (0.1 M) Salt Result 
30% PEG 4k TRIS pH 8.5 0.2 M Li2SO4 Many thin rods 
30% PEG 4k TRIS pH 8.5 0.2 M NaCl Many tiny rods 
3M AmmSO4 Citrate pH 5.6 0.2 M Li2SO4 Thin plate like crystals 
20% PEG 8k HEPES pH 7.5 0.2 M Li2SO4 Irregular shapes 
20% PEG 8k TRIS pH 8.5 0.2 M NaKPO4 Very fine granular 
20% PEG 8k TRIS pH 8.5 0.2 M NaCl Very fine granular 
30% Me2k PEG Citrate pH 5.6 Small granular crystals 
10% PEG 4k Citrate, pH 5.6 0.1 M Li2SO4 Feathered needles 
20% PEG 4k Citrate pH 5.6 0.2 M AmmSO4 Long needles 
30% Me2k PEG MOPS pH 6.5 Irregular needles 
25% PEG 4k HEPES pH 7.5 Small rectangular 
30% PEG 4k TRIS pH 8.5 Many tiny rods 
30% PEG 4k TRIS pH 8.5 0.2 M CaC12 Few tiny rods 
25% PEG 4k PIPES pH 6.8 Small rods 
Table 3.1: Results of initial crystallisation trials of MGL1. N. B. This work was done by Dr. AJ 
Lapthom. 
Thus PEG was seemingly the precipitant of choice with a range of suitable buffers 
at varying pH and with different salts. The first comprehensive attempts at 
crystallising MGL1 encompassed these conditions. After a number of trials it was 
evident that a combination of PEG 4k, 0.1 M citrate pH 5.0 - 6.0 and various salts 
gave the most consistent and promising results. The crystals resulting from these 
conditions varied from small cubic shaped (approx. 0.05 mm x 0.05 mm) and small 
rods (0.1 mm) to long fine needles (up to 0.5 mm). However none of these were 
suitable for structural analysis. 
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At this time the data on the monodispersity of the solution were obtained from the 
DLS analysis and the buffer was changed to 50 mM imidazole pH 6.5. 
Additionally, because of reports that the PLP cofactor can be unstable in some 
enzymes giving rise to a population of apoenzyme over time, the concentration of 
the cofactor was increased to 250 µM and the DTT concentration raised to 1 mM 
which is more commonly used than the previous 30 µM. These new conditions 
considerably changed the morphology of the resulting crystals. In the same 
conditions as had previously been tried, the crystals produced were much larger 
(0.15 mm x 0.075 mm) but were hollow. This suggested that their growth rate was 
too rapid and so the same conditions were repeated at 4 °C and with 4% glycerol 
in the solution to retard growth. Neither of these alternatives succeeded in 
producing large crystals without a hollow centre. 
In parallel to the DLS analysis, duplicate sparse-matrix screens had been set up 
with the enzyme inactivated by the inhibitor DL-propargylglycine (5 mM). L- 
propargylglycine is a covalent, suicide inhibitor of several PLP-dependent 
enzymes, including MGL (Johnston et al., 1979). It was hoped that the inclusion 
of this would produce a more rigid structure leading to larger crystals. 
Crystallisations were set up identically as previously described but with the 
addition of 5 mM DL-propargylglycine to the enzyme solution. The screen gave 
similar results as previously but with the addition of large, bipyramidal crystals 
(0.3 x 0.2 mm) in conditions of 3.0 M AmmSO4, OA M citrate buffer pH 5.6,0.2 M 
Li2SO4. The enzyme at this time was concentrated in HEPES buffer indicating the 
monodispersity of the enzyme was not critical in allowing large crystal formation. 
After optimisation via linear screens the exact concentration of ammonium 
69 
sulphate required was found to be 2.3 M. The process of optimisation also 
highlighted an additional point, freezing of MGL1 reduced its ability to form 
crystals. This appears to be a relatively common problem with protein 
crystallisation and the most successful trials were consistently those using freshly 
purified enzyme no more than 2 or 3 days old and stored at 4 °C prior to use. The 
native enzyme also crystallised in exactly the same conditions as the inhibitor 
complex, once all of the important factors had been identified. 
Thus in summary: crystals were grown at 20 °C by combining 1.5 . tl of 6 mg/ml 
MGL1 in 0.1 M HEPES pH 7.5,250 µM PLP, 1 mM DTT with 1.5 µl of precipitant 
comprising 2.3 M AmmSO4,0.2 M Li2SO4 and 0.1 M citrate buffer pH 5.6. Single 
crystals formed over 6 weeks and achieved approximate dimensions of 0.6 mm x 
0.4 mm x 0.4 mm (See figure 3.4). The gross morphology of both types was 
identical and both diffracted anisotropically to 1.6 A. 
Figure 3.4: Single orthorhombic crystal of MGL1 in complex with L-propargylglycine grown as 
detailed above. Crystal shown had dimensions of approximately 0.6 x 0.4 x 0.4 mm. 
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Smaller crystals were obtained with ammonium sulphate concentrations of 2.4 to 
2.5 M but these had rounded edges between faces rather than the sharp edges 
(as shown in figure 3.4 above). Note also the yellow colour of the crystals caused 
by the cofactor. 
3.2.5 Crystallisation of MGL2 
The first attempts at crystallising MGL2 were performed identically to those for 
MGLI. The protein was concentrated to 6 mg/ml and resuspended in 0.1 M 
HEPES pH 7.5,40 µM PLP, 30 IN DTT but the results from the screens gave no 
promising leads. After DLS analysis the buffer was changed to 20 mM imidazole 
buffer pH 6.5,250 µM PLP, 1 mM DTT. Using this new buffer produced some 
small crystals, the best results are listed below: 
Precipitant Buffer (0.1 M) Salt (0.2 M) Result 
15% PEG 8k MOPS pH 6.5 NaKPO4 Heavy crystalline precipitate 
20% PEG 8k TRIS pH 8.5 NaCl Clusters of very small needles 
15% Melk PEG MOPS pH 6.5 MgCl2 Few small rods 
15% Me2k PEG HEPES pH 7.5 MgCl2 Few feathered rods 
20% PEG 4k HEPES pH 7.5 AmmSO4 Heavy crystalline precipitate 
30% PEG 400 HEPES pH 7.5 MgCl2 Very small cubic crystals 
8% PEG 8k TRIS pH 8.5 Few clusters of needles 
15% PEG 4k TRIS pH 8.5 MgCl2 Few small rods 
Table 32: irrst successtui results of attempts to crystallise MGLZ 
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It was not possible to improve upon these results further and so a new expression 
construct of MGL2 was produced in an attempt to improve the prospects for 
producing crystals. The previous expression construct had the hexahistidine tag 
at the N-terminus and also 5 residues missing from the original sequence which 
were replaced by 8 residues from the cloning vector (McKie, 1997). It was 
considered possible that the incorrect residues and N-terminal tag were 
preventing crystallisation in some manner and it was hoped that replacing these 
would lead to the production of useful crystals. Therefore the new construct was 
designed to remove the incorrect residues and replace with the correct sequence 
(see section 2.2.16 for method). The expression vector was also changed to 
position the hexahistidine tag at the C-terminus rather than the N-terminus as 
already used for MGL1. 
This new MGL2 was examined for the retention of activity in various buffers at 
both 4 °C and 20 °C. It was decided to avoid using sodium phosphate buffer in 
crystal I isations because of the likelihood of producing phosphate crystals. Thus a 
suitable alternative buffer had to be chosen. The previous enzyme had been 
shown to be most stable in sodium phosphate buffer at pH 7.5 and this pH was 
used as a starting point for the selection of others (McKie, 1997). The buffers 
chosen to be examined were: BIS TRIS pH 6.5, BTP pH 7.5, HEPES pH 7.5, 
PIPES pH 7.0 and TES pH 7.5. All were used at 0.1 M with 80 µM PLP and 60 
µM DTT added. Enzyme was expressed and purified as already published. 
Pooled enzyme was then dialysed overnight at 4 °C into the relevant buffer and 
stored at a concentration of 1 mg/ml at either 4 °C or 20 °C. The enzyme was 
then assayed with DL-homocysteine as detailed (section 2.3.6) over two weeks. 
72 













0 ----_ - -a 






Figure 3.5: ay-elimination activities of MGL2 toward DL-homocysteine after storage in different 

























Figure 3.6: ay-elimination activities of MGL2 toward DL-homocysteine after storage in different 
buffers at 4 °C 
The results clearly showed that there is no measurable activity after 2 weeks when 
the enzyme is kept at 20 °C. The results also showed that the enzyme lost 
considerable activity when stored in BTP and BIS-TRIS buffers regardless of the 
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temperature. Much better retention of activity was exhibited in PIPES, HEPES 
and TES. The highest values recorded were in PIPES and so this buffer was 
selected for use in crystallisation. However, despite these changes, and attempts 
at co-crystallisation with propargylglycine, it was not possible to produce suitably 
diffracting crystals of MGL2 during the course of this study. However the attempts 
made were not exhaustive and further experimentation may yield good quality 
crystals. 
3.2.6 Structure Solution 
This section of the chapter describes the results of the structure solution process 
for native and inhibitor complex MGL1. As stated in the aims of this project the 
intention was to solve the structure of MGL and from this learn something of its 
function in vivo. It was envisaged that if suitable crystals were grown then the 
technique of molecular replacement would be used to facilitate the process rapidly 
and easily. This assumption was due to the number of PLP-dependent enzyme 
structures already deposited in the PDB (albeit of the a-and p-families) and the 
anticipation of the release of the coordinates of CBL (Clausen et al., 1996), a 
member of the y-family. 
3.2.6.1 Data Collection and Processing 
Complete 2.18 A datasets were collected from cryocooled single crystals of both 
the holoenzyme and the enzyme-inhibitor complex at station 9.5 at the SRS, 
CLRC Daresbury Laboratory at a wavelength of 1.1 A on a 30 cm MAR image 
plate. A summary of the statistics for each is presented below: 
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Structure Holoenzyme Inhibitor Complex 
Resolution Range (A) 25.0-2.18 25.0-2.18 
Oscillation Range (°) 0.5 0.5 
Temperature (K) 100 100 
Unique Reflections 49696 48724 
Completeness Overall (25.0 - 2.18) 





Redundancy 2.3 3.6 
Rmeme 4.5 6.7 
Table 3.3: Data collection and processing statistics for MGL1 holoenzyme and inhibitor complex 
As mentioned previously these crystals exhibited diffraction to 1.6 A but with 
differing levels of anisotropism. This was seen subsequent to collecting complete 
2.18 A datasets. It was not possible to collect higher resolution data because of a 
lack of time. Decreasing the wavelength of the X-ray beam away from its optimum 
of 1.1 A would have resulted in a much lower intensity beam and therefore a 
significant increase in the time required for each frame. 
Both holoenzyme and inhibitor complex crystals contain a dimer in the asymmetric 
unit and belong to the same spacegroup and possessed identical dimensions, that 
is: 
Spacegroup a b c a p 7 
P3,12 88.26 A 88.26 A 217.85 A 90° 90° 1200 
table 3.4: Unit cell parameters for crystals of holoenzyme and inhibitor complex MGL1. 
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Attempts were also made at this time to soak crystals in solutions containing 
heavy metal atoms. The lack of time and small number of crystals available 
allowed only a few attempts. 1 mM mercury acetate and 1 mM mercury chloride 
were used and crystals were soaked for between I and 30 minutes. The 
diffraction exhibited by these crystals after exposure to both compounds was 
significantly poorer than that shown for untreated crystals. It was decided not to 
collect data from these crystals and whilst waiting for the growth of larger crystals 
a molecular replacement solution was sought. 
3.2.6.2 Structure Solution by Molecular Replacement 
It was envisaged that it would be possible to find a Molecular Replacement (MR) 
solution for MGL1 using one of the numerous PLP-dependent enzyme structures 
available. No y-family enzyme structure was initially accessible from the database 
and so attempts were made using members of the a and 0 families. These all 
proved unsuccessful whether using the whole polypeptide chain or selected 
fragments. After the eventual release of the coordinates for CBL from E. coli it 
was possible to use a search model with a much higher degree of sequence 
similarity and presumed structural homology. Comparing the sequence of MGL1 
with those used to find a MR solution shows that the a- and y-families of PLP- 







Cystathionine ß-Iyase (Clausen et al., 1996) 28.8% 36.9% 
Tryptophanase (Isupov et al., 1998) 15.2% 41.4% 
Tyrosine phenol Iyase (Antson et al., 1993) 14.6% 36.9% 
Aspartate aminotransferase (Okamoto et al., 1994) 11.4% 37.6% 
Ornithine aminotransferase (Shen et al., 1998) 15.2% 32.3% 
D-amino acid transferase (Sugio et al., 1995) 9.4% 16.8% 
Table 3.5: Sequence comparison of enzymes used to find a MR solution with MGL1. 
The first attempts at MR with AMoRe (Navaza, 1994) using inhibitor data from 25 
to 2.2 A and the entire CBL molecule as a search model gave no clear solution. 
Subsequently the CBL model was truncated to more closely resemble MGL1. 
Insertions in the primary sequence alignment were removed and where individual 
residues differed they were changed to either alanine or glycine. See figure 3.7 
for an alignment of the two sequences. This again gave no single solution but by 
using data to only 4.5 A and the truncated CBL model a best solution with an R- 
factor and correlation coefficient of 47.3% and 36.0%, respectively was obtained. 
The packing was verified visually using Setor (Evans, 1993). This provided a 
usable map with which to start modelling the structure of the inhibitor complex. 
The solution for the holoenzyme structure was solved rapidly by using the phases 
from the inhibitor complex model directly without the need to use molecular 
replacement. This does result in greater model bias to be carried over from the 
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inhibitor from the active site in early stages of refinement. The Free R-factor set 
of reflections set aside for monitoring the progress of refinement were identical for 
both datasets. 
1 10 20 30 40 50 60 70 80 
T. vaginalis_MGL1 MSHERMTPRTRCIHRNPQKDQFGHRIPPIYQTSTFVIUNCUQGGNRFRGQESGYI-YTRLGNPIVSNIIGKIRFItKTER 
E. coli_CBL MRDKKLDTQLVNRGRSKKYTLGRVNSVIQRRSSLVFDSVIRKKHRTRNRRNGELFYGRRGTLIHFSIIJQRMCEIIGGRG 
Consensus 
... # .............. K... GR.... I... S.. VFD.. tt........... G... Y. R. tl.. I...! U..... 
It .... 
81 90 100 110 120 130 140 150 160 
1--------+---------+---------+---------+---------+---------+---------+---------I 
T. vaginalis_MGLI ('VHTSSI; MGII I HRTVI TILKRGI)HLISDI CLYGCTHRLFEHRI TKFI [QVDFINTR I Pill '. 'KKHt1KPN IKI VYFI 11 BHP 
E. coli_CBL L': LFPCI; RHFI ; 'FINS II RFIEQI, IIIIVLMTNTRYEPSQDFCSKII SKLI VTTSUFUPL 1601) I VKHI QPNT KI VI LESPGSI 
Consensus UV .... (;.. H! H..! I..... GI1H.... a.. Y.......... I. K. (;!..... a.. l.. tt!, KHf. 
FNIKIV%. F"P... 
161 170 180 190 200 210 220 230 240 
I --------+---------+---------+---------+---------+---------+---------+---------I 
T. vaginalis_MGL1 IL KIIDMERVCKDRHSQ-EGVLVIRDNIFCSPMITNPVDFGVDVVVHSRIKYINGHTLIVVRGLICGKIIDLLIIUIRMVGIK 
E. coli_CBL IMEVHDVPRIVRRVRSVVPDRIIMIDNIURRGVLFKRLDFGIDVSTQRHTKYLVGHSDRMII; TRVCNIIRCHIULRENRY- 
Consensus TE.!. D......... 5...... !.. DNI.......... DFG! DV.!.. R1KY.. GH. II... 11..... I1... *U. R..... 
241 250 260 270 280 290 300 310 320 
I--------+---------+---------+---------+---------+---------+---------+---------I 
T. vaginalis_MGL1 DITGSVISPHDfNILITRGLSTLNIRtIKAESENRMKVRFYLKSHPRVEKVYYPGFEDHEGHDIRKKUMRMI; GSNITFItKS 
E. coli_CBL -LMGQMVDRDTRYITSRGLRTLGVRLRQHHESSLKVHENLREHPQVRRVNHPRLPGSK(; HEFNKRIFFTGSSGLFSFVIKK 
Consensus 
... 
G..!.... R.... RGL. TL.! RI.... F.. IKVHE. I.. HP. V.. V.. P...... GH#.. K. tt... S.. f.. I! IK. 
321 330 340 350 360 370 380 390 400 
I --------+---------+---------+---------+---------+---------+----------------- I 
T. vaginalis_MGL1 GF--I GRKKLIIINLKLITLHVSLGGCIStIQHPRSMTHRVVPKEERERRGITDGIIIRISVGIEDRDELIHIIFKQGLDRLL 
E. coli_CBL KLNNIELRNYIDHFSI. FSMRYSMGGYLSLIL--HNQPEHIRRIRPQGEIDFSGTIIRLHIGLEDVDDIIHULORGFRRIV 
Consensus .... i..... LDN.. l.. tR. S. GG. ESLI... fl .....! .............. IIRL.! 
G. ED. 0#11HIl... G..... 
Figure IT Sequence alignment of T. vaginalis MGL1 and CBL from E. coli. Conserved residues 
and similarities are highlighted in red. The consensus sequence is given in the third line. 
3.2.6.3 Refinement of MGL1 
Refinement of MGL1 was performed as outlined in section 2.1.8. Table 3.6 and 
3.7 lists the improvements in the R and Rfree factors for the native and inhibitor 
complex structures after successive rounds of refinement using all data from 40 to 
2.18 A. 
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Round of Refinement R-factor Rt. 
1. After AMoRe 54.9 53.5 
2. Main chain 14% incomplete 36.5 40.6 
3. Main chain complete, 352 waters added 29.7 34.4 
4. Bulk solvent correction added 20.8 25.5 
5. Poor waters removed, NCS restraints relaxed 18.9 24.3 
6.2 glycerols identified 16.3 20.2 
7. Final round 14.7 19.0 
Table 3.6: MGL1 inhibitor complex refinement progression. 
Round of Refinement R-factor Rt. 
1. Using phases direct from inhibitor complex 22.0 27.0 
2. Removed poor atoms 20.1 26.3 
3.456 waters, cofactor and bulk solvent 
correction added 
16.3 21.2 
4. Final round 16.2 21.2 
Table 3.7: MGL1 holoenzyme refinement progression. 
3.2.6.4 MGLI Model Building 
The structure of CBL itself was used to guide placement of residues using the 
molecular replacement map calculated from the MGL1 inhibitor complex data. 
Areas of large divergence between the two structures lead to poor electron 
density and there were several breaks in the main chain where it was impossible 
to assign Ca positions as well as numerous incomplete side chains. In particular 
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the following regions were not visible 13-22,41-55,227-241,294-296,316-325 
and 348-370 (MGL1 numbering). Advantage was taken of the 2-fold NCS in the 
asymmetric unit, allowing a single monomer to be constructed and then 
transformed into a dimer to complete the asymmetric unit. The assumption was 
that during early stages of refinement, differences between the two monomers 
would be insignificant compared to any errors and poor quality of the electron 
density map. Thus the maps produced by refinement were averaged over a 
single monomer and the modelling process repeated. Until density was visible for 
the entire main chain and waters added this was repeated and then subsequently 
each atomic position checked individually. 
3.2.7 MGLI Structure 
The following part of this chapter describes the crystal structure of MGL1 and the 
inhibitor complex with L-propargylglycine. The large size of the structure prevents 
a detailed description of all residues and their apparent roles, instead those with 
key roles and/or positions will be mentioned as appropriate. In the multimeric 
structure of the enzyme, residues from an adjacent monomer involved in an 
interaction will be marked by an asterisk (*). 
3.2.7.1 MGL1 Monomer 
The MGL1 monomer can be divided into three domains: 1) An extended loop N- 
terminal domain; 2) a PLP-binding domain; and 3) a C-terminal domain (Figure 
3.8). The enzyme shares the same overall fold as the other published y-family 
members and is closely related to the a-family. Both families possess the PLP- 
dependent transferase fold, the y-family have in addition an N-terminal domain. 
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Figure 3.8: Ribbon diagram of the MGL1 monomer. a-helices are coloured green, ß-strands are 
coloured blue and numbered individually. The PLP cofactor is represented as a ball and stick 
model and coloured by atom type. Figure produced using the programmes RIBBONS (Carson, 
1997) and THE GIMP (http: //www. gimp. org). 
The N-terminal domain of MGL1 (residues 4-60), comprises helices al and a2 
and a fairly open loop structure. Comparing other y-family members reveals that 
this is the most varied domain, in both sequence and length. CBL differs having a 
short a-helix and ß-strand between the two helices (Clausen et al., 1996) and 
CGS has no defined secondary structure elements and a more open conformation 
(Clausen et a!., 1998; Schoenbrook et a!., 1999). Helix al of MGL1 packs against 
helices a9 and a3 of the PLP-binding domain. Residues 22-35 interact to form 
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part of the tetramer interface, while helix a2 forms part of the opening to the active 
site and is critical in mediating monomer-monomer interactions. 
The PLP-binding domain (residues 61-258) is the largest domain with a core 
seven stranded, mainly parallel, ß-sheet surrounded by seven a-helices. The 
strands are arranged in the order A, G, F, E, D, B, C, with G in an antiparallel 
direction. The cofactor is bound at the edge of the monomer, between strands ß 
E, ßF and helices a4, a5, where it would be accessible to solvent. However, the 
interactions of the C-terminal domain and the N-terminal domain of the adjacent 
monomer in the catalytic dimer bury the cofactor and form the active site. Figure 
3.8 shows quite clearly the distorted helix. a5. The regular geometry is distorted 
by His120 and A1a121, which are close to Lys238* and Asp239*. These residues 
are implicated in the enzyme mechanism and shall be discussed further below. 
The C-terminal domain (residues 259-396) is composed of a five strand ß-sheet 
with five a-helices. The strands are in a mainly anti-parallel arrangement in the 
order H, I, L; K, J. The domain is dominated by helix a10. This has a large kink 
induced by Thr259 which connects to helix a9 of the PLP-binding domain. 
Together helices a9 and al0 extend for almost the entire length of the monomer. 
Helix al0 is situated on the outer edge of the domain, between helix a14 and the 
loops at the ß-sheet of the C-terminal domain. The loop between strand ßK and 
helix a13 (residues 348-357) is critical in sculpting the entrance and restricting 
access to the active site. 
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3.2.7.2 Disulphide Bridges in MGLI 
There are no intact disulphide bridges visible within the structure of MGL1. The 
enzyme has not been indicated as being located extracellularly so this is perhaps 
as expected. The crystallisation solution also contained high concentrations of 
DII (1 mM) and thus may also be expected to reduce any bonds. Examination of 
the structure reveals two cysteine residues with the potential to form a disulphide 
under appropriate conditions. Cys80 and Cys223 have their Sy 4.1 A apart in 
both structures but would be able to move closer by rotation around the Cß. 
Figure 3.9 shows the relative positions to each other and the position of Cys80 on 
strand ßA and Cys223 on ßG. The strands are positioned in an antiparallel 
direction. It can be seen from an alignment of MGL sequences (Figure 3.10) that 
none of the residues shown in figure 3.9 are conserved including the cysteines 
except for MGL1 and 2 from T. vaginalis. Neither residue is involved in 
intersubunit interactions or catalysis in anyway and it is difficult to see how the 
formation of a disulphide bridge would change this. One possibility is that 
disulphide formation may shift helix a4 enough to disrupt either tetramer binding 
or cofactor binding via GIy86 and Met87. 
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Figure 3.9: Arrangement of Cys80 and Cys223 in MGL1. Residues are coloured according to atom 
type and labelled. The distance between Sy atoms is 4.1 A in both holoenzyme and inhibitor 
complex structures and identical between monomers. 
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Figure 3.10: Alignment of MGL sequences from T. vaginalis and P. putida. 100% conserved 
residues are in red and 75% conserved in blue. Secondary structure elements in MGL1 as denoted 
by DSSP (Kabsch and Sander, 1983) are indicated above the sequences. Residues involved in 
subunit contacts are underlined in colour, blue for monomer-monomer interactions, green for 
dimer-dimer and red if involved in both. The alignment was carried out using Multalin (Corpet, 1988) 
3.2.7.3 cis-Prolines in MGLI 
There are two cis-prolines in the structure of MGL1, Pro156 and Pro159. Both are 
rigidly conserved in MGL sequences identified so far and also CGS but only 
Pro156 is conserved in CBL. Neither residue is involved in intersubunit contacts 
but they have an indirect role in cofactor binding. Both residues are positioned in 
type IV ß-turns (residues 154-157 and 158-161) between strand ßD and helix a7. 
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This positions Asn158 in the optimal site for making hydrogen bonds with 03' of 
the cofactor and Arg373. The role of 03' is important in the catalytic mechanism 
proposed here and Arg373 is conserved in all PLP-dependent enzymes that 
utilise amino acids as substrates. There are two conserved cis-prolines in AAT 
although not in the same arrangement as MGL1. The two residues are numbered 
138 and 195 for the E. coli enzyme but are positioned within van der Waals 
contact with each other. Pro195 is analogous to Pro159 of MGL1, coordinating 
the adjacent asparagine residue (Asn194 in AAT). However mutagenesis studies 
have revealed that neither of these residues are critical for structure or activity 
(Birolo et al., 1999). They have been postulated to play a subtle role in optimising 
catalysis but are substitutable for alanine with very little deleterious effect. 
3.2.7.4 Intersubunit Interactions 
There are extensive contacts made between adjacent monomers in the catalytic 
dimer with residues from the adjacent subunit being essential for activity, 
throughout the text residues from the neighbouring subunit involved in 
interactions are marked with an asterisk (*). The MGL1 homotetramer is 
constructed by symmetric association of two catalytic dimers. Analysis of the 
subunit interactions was performed using the protein-protein interaction server 
(Jones and Thornton, 1995). Residues involved in intersubunit interactions are 
indicated in figure 3.10 in an alignment with other MGL sequences. Those 
residues at the monomer-monomer interface are underlined in blue, those in the 
tetramer interface green and those involved in both are underlined in red. The 
most significant are mentioned individually below. 
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3.2.7.4.1 Monomer-Monomer in the Catalytic Dimer 
The association of the two monomers in the asymmetric unit buries approximately 
2600 A2 of solvent accessible surface in an area of approximately 67 A by 39 A in 
both structures. The interface formed is predominantly non-polar but does include 
36 intersubunit hydrogen bonds. The symmetry between the two dimers can be 
clearly seen in figure 3.11. The dimer is formed predominantly by close 
association of the PLP-binding domains, which comprises 51 % of the interface. 
The "clamp" of the N-terminal domain contributes 31 % of the interface surface 
area, interacting with both the PLP-binding and C-terminal domains of the 
adjacent monomer. 
Figure 3.11: MGL1 dimer. The three domains are highlighted in colour: green = N-terminal; gold = 
PLP-binding; purple = C-terminal. The PLP cofactor is represented as a spacefilling model. The 
figure was produced using RIBBONS. 
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There are a number of residues playing a significant role in dimer formation; 
Gln31 forms a hydrogen bond between its amide nitrogen and the carbonyl 
oxygen of Thr215* and in addition also hydrogen bonds via waters 55,84 and 31 
to the amide nitrogen and side chain hydroxyl of Thr215*. In this region, also 
close to the dimer surface involved in tetramer formation, these three waters 
mediate interactions between Ser33 and residues Thr208*, Thr215`, Ser338* and 
Leu339. Phe37 in concert with Phe47, I1e55, Leu59, Va1337* and Met352* forms 
a hydrophobic patch along the active site channel leading to the cofactor. Phe37, 
Phe47, Va1337 and Met352 are all highly conserved in MGL enzymes with I1e55 
and Leu59 being substituted only for hydrophobic residues. Another hydrophobic 
patch formed by the two monomer interactions involves residues Leu 117, Leu122, 
Leu95, IIe240 and Leu95* and IIe240* and a stacking interaction between Phe125 
from both subunits. 
3.2.7.4.2 Tetramer formation 
The MGL1 tetramer is constructed by symmetric association of two catalytic 
dimers, as shown in figure 3.12. The approximate dimensions of the interface 
between the two dimers is 64 A by 46 A and buries around 4100 A2 of solvent- 
accessible surface, which is comparable to other y-family enzymes. The tetramer 
is formed predominantly by hydrophobic interactions which comprise 70% of the 
total buried surface area but also includes 33 intersubunit hydrogen bonds. The 
N-terminal region, despite being the smallest domain of the enzyme, is 
responsible for 55% of the interface. This highlights its key role in all intersubunit 
interactions as well as active site formation. The PLP-binding and C-terminal 
domains play less central roles and form 20% and 25% of the interface, 
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respectively. Residues 25-33 form one ß-strand (not identified by DSSP) in a two 
strand antiparallel ß-sheet at the tetramer interface. The second strand is 
comprised of the same residues from the diagonally opposite subunit. 
Figure 3.12: Ribbon diagram of MGL1 tetramer. Monomers are coloured individually in red, gold, 
blue and green. The cofactor is shown as a spacefilling model coloured according to atom type. 
The figure was produced using RIBBONS. 
For the most part residues involved in tetramer formation are not conserved 
between MGL, CBL and CGS. There are equivalent regions involved but few of 
these are identical at the primary structure level. 
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A crucial interaction that is conserved is the intersubunit salt bridge made by 
Arg255 which lies antiparallel to its symmetry partner in the adjacent dimer and is 
coordinated by Asp216* (Figure 3.13). Alongside this is His214 which is also 
conserved and with His214* coordinates a water molecule. Trp251 on the other 
side of the salt bridge is not conserved. The sum of these interactions account for 
approximately 17% of the interface. 
T 
Figure 3.13: Salt bridge interaction between catalytic dimers. Atoms are coloured according to 
type, distances between key interactions are marked in Angstroms and denoted by dashed lines. 
Residues from adjacent dimer are indicated by ". Figure produced using Setor. 
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A large hydrophobic patch of residues from the N-terminal domain is also key in 
MGL1 and although these residues are not conserved in CBL and CGS there are 
analogous interactions. In MGL1, Phe22 is angled roughly perpendicular to the 
plane of Tyr30, Phe35, Tyr54 and Pro62 in an area which makes up 
approximately 12.5% of the total interface area. Tyr30 is also involved in an 
interaction on its opposite side with Pro28 and I1e29 to form another hydrophobic 
patch. I1e29 is conserved between CBL, CGS and MGL and is positioned 
adjacent to its symmetry partner in the opposite dimer. 
3.2.8 Comparison of Holoenzyme and Inhibitor Complex Structures 
There are no major conformational differences between monomers in the catalytic 
dimer of either model nor between the structures of the holoenzyme and inhibitor 
complex. Superimposing monomers onto each other gives an RMS deviation of 
0.360 A and 0.326 A for main chain atoms in the holoenzyme and inhibitor 
complex respectively. Superimposing the dimers of the two structures gives an 
RMS deviation for main chain atoms of 0.251 Ä. 
However, a comparison of main chain atom B-factors between the holoenzyme 
and inhibitor complex models does reveal higher values for the holoenzyme 
(Figure 3.14). After allowing for a systematic variation, the most significant 
variation occurs for the residues 38-50 and 350-370. Both of these regions are in 
the entrance to the active site. Flexibility for this part of the structure is likely to 
be important to enable the active site to accommodate bulky substrates such as 
S-adenosyl methionine (Lockwood and Coombs, 1991b). 
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Figure 3.14: Comparison of atomic B-factors for holoenzyme and inhibitor complex. The native 
model values are indicated by the bold solid line, the inhibitor complex values by the dashed line. 
3.2.9 Active Site Structure and Implications for the Catalytic Mechanism 
The following description of the structure details the architecture in the active site 
around the cofactor and the residues implicated in the enzyme mechanism. The 
presence of a suicide inhibitor covalently bound allows a good estimate of the 
likely position of a bound substrate especially when studied in conjunction with a 
native enzyme structure. 
3.2.9.1 Cofactor Binding 
The active site is located at the subunit interface in the catalytic dimer with the 
cofactor held in place by a network of hydrogen bonds characteristic of PLP- 
dependent enzymes. All of the close contacts between the protein and cofactor 
are shown schematically in figure 3.15, including those involving the inhibitor L- 
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propargylglycine. Differences between the two structures are minimal as 
previously stated. In addition, Van der Waals contacts between the pyridine ring, 
Tyrl 11 and Ser206 also exist, restricting any vertical movement and holding the 
ring approximately parallel to the plane of Tyrl 11. As described for aspartate 
aminotransferase (Hayashi et a!., 1990), the positioning of the aromatic side chain 
should increase the electron sink character of the cofactor. From the second 
monomer, Arg58* forms a salt bridge to the phosphate group of the cofactor whilst 
also being close (3.1 A) to the OH group of Tyrl 11. In addition Tyr56* hydrogen 
bonds to the PLP phosphate and Lys209 when the enzyme is in the external 
aldimine form, as seen in the inhibitor complex. In the holoenzyme Lys209 is 
covalently attached to the cofactor via a Schiff base. Also in the holoenzyme 
structure there is a sulphate ion positioned in the active site adjacent to Arg373 
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Figure 3.15: Schematic representation of the L-propargylglycine inactivated MGL1 active site. 
Cofactor atoms are coloured red, the covalently attached inhibitor molecule is shown in blue and 
protein atoms and water molecules are labelled in black. Non-covalently attached atoms are 
indicated by dotted lines and distances are shown in Angstroms. 
3.2.9.2 Substrate Binding 
Substrate binding site in the active site is primarily through the Schiff base link to 
the cofactor and also the coordination of the carboxylate group by Arg373. This 
residue is conserved in all PLP-dependent enzymes that have amino acids as 
substrate. 
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3.2.9.3 Substrate Access 
Entrance to the active site is via a channel approximately 15 A long from the 
position of the substrate Ca to the solvent, running along the dimer interface. 
Consequently residues from both monomers are involved. The cofactor is angled 
at -90 ° to the channel and the inhibitor is positioned with the side chain pointing 
outwards as shown in figure 3.16. It can be seen that Phe47* and Leu59*, 
although not playing an active part in catalysis, are in this channel to the active 
site and form a hydrophobic patch along with Va1337 and I1e55* (not shown). Also 
crucial are Cys113 and Lys238* which are positioned on the opposite side relative 
to His354*. These two residues and Asp239* appear to be functionally important 
but are not directly involved in the catalytic mechanism proposed. 
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Figure 3.16: Diagram of the channel leading to the active site in the MGL1-inhibitor complex The 
solvent accessible area is shown by pink lines. Water molecules in the inhibitor complex are 
indicated by red crosses. Key residues involved in the channel formation are indicated, with residues 
involved in catalysis also marked. Solvent accessible surface was calculated by the programme 
SURFNET using the inhibitor structure model without cofactor and inhibitor atoms. The figure was 
produced using QUANTA. 
3.2.9.4 Covalent Attachment of L-Propargylglycine 
The attachment of this suicide inhibitor of several PLP-dependent enzymes is 
unambiguous in the electron density. The earliest maps in the inhibitor complex 
model showed continuous density between the hydroxyl group of Tyrl 11 and the 
cofactor consistent with the binding of a substrate/inhibitor to the cofactor and 
enzyme. Fitting a putative propargylglycine molecule was simple following the 
predicted mechanism from (Washtien and Abeles, 1977). The active site 
nucleophile was thought to be either a cysteine or tyrosine residue, and although 
activity data from mutagenesis and chemical modifications implicated a cysteine, 
the model showed clearly a covalent link to Tyr 111. Thus propargylglycine is 
held in place by covalent attachment to Tyrl 11 and also via aldimine linkage to 
the cofactor. The distance from the Tyrl 11 side chain oxygen atom to the 
inhibitor Cß in the final model is 1.8 A. Arg373 plays its usual role in coordinating 
the carboxylate group of the substrate and in this case the inhibitor. 
3.2.9.5 Comparison of the Holoenzyme and Inhibitor Complex Active Site 
As has been previously stated there are no gross structural changes between the 
two crystal structures and this allows us to make certain assumptions concerning 
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binding of the substrate and residues involved in catalysis. However the active 
sites differ subtly and this provides more information on the likely mechanism. 
A sulphate ion is substituted for the carboxylate group of the inhibitor in the 
holoenzyme structure and the Schiff base attachment of Lys209 to the cofactor 
replaces the attachment of the inhibitor amine group. Superimposing the two 
structures shows essentially no movement of the cofactor nor changes in the 
pucker of the ring. The position of Tyrl 11 shows minimal movement, the most 
significant factor is the poor electron density for this residue (Figure 3.17). As 
mentioned there is a systematic increase in B-factors for all of the holoenzyme, 
however the electron density for the cofactors in each model is similarly clear. 
The poor density exhibited by this residue adjacent to the cofactor can be taken to 
be because of mobility, a situation prevented in the inhibitor complex because of a 
covalent bond. 
Figure 3.17: Comparison of active site electron density. In the native (A) and inhibitor complex 
(B) structures. 2 FO - Fc electron density maps contoured at 1 and 2a are shown in orange and 
pink respectively. Inhibitor molecule atoms have been omitted from B for clarity. The continuous 
electron density for the covalent bond between Tyrl 11 and propargylglycine is clearly visible. The 
figure was produced using QUANTA and the GIMP. 
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3.2.9.6 The Role of Cys113 
It has been shown previously that Cysl 13 is very important for MGL activity. The 
mutant MGL1(c"3G) was shown to have a greatly reduced activity towards all 
substrates, though still exhibiting measurable activity (McKie et al., 1998). 
Chemical modification studies on MGL from P. putida have also indicated the 
importance of an unidentified cysteine residue in catalysis, but confirmed that it is 
not essential (Nakayama et al., 1988a). 
In the inhibitor-complex Cysl 13 has an obvious dual conformation with an angle 
between the two Sy of 33.4 °. This places the Sy 3.5 A from the C8 atom of L- 
propargylglycine and 3.15 A from -OH of Tyrl 11 in one conformation and 2.8 A 
from the Ne of Lys238* which is 2.8 A from the 08 of Asp239* in the other. The 
same residue in the holoenzyme model does not appear to be in such a geometric 
arrangement and has only a single conformation despite appearing similar in the 
figure above. Continually through refinement any attempts at arranging Cys113 
as a dual conformation were rejected because of negative density in the 
difference maps. It is probable that a limited range of movement of Cys113 exists 
in the native structure but it is certainly more pronounced in the inhibitor complex. 
Perhaps most interestingly in the holoenzyme are the differences in the active 
sites in which the distances between atoms are not equal. The distance between 
Cys113 Sy and Tyrl 11 -OH is 3.66 A and 4.17 A, Sy to Lys238* NE is 3.71 A and 
4.13 A and Lys238* Ne to Asp239* 08 2.65 A and 2.98 A. Thus one active site 
has a more relaxed arrangement with the distances between all atoms larger than 
the other. 
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The distances between the Sy of Cys113 and the CS of propargylglycine and S8 of 
homocysteine are likely to be very similar. The 3.55 A distance seen in the 
inhibitor complex structure suggests that this is too great for a direct interaction 
between Cys113 and the substrate in catalysis unless a considerable 
conformational change occurs. The sequence information on MGL sequences 
(Figure 3.10) indicates that both Asp239 and Lys238 are conserved. The 
distances in the inhibitor complex suggest that a charge relay between the three 
residues would result in the Cysl 13 Sy being ionised. The influence of this 
charge upon other atoms in the active site and therefore activity may be two-fold. 
The distance between the Sy and Tyr111 OH is close enough to influence the 
charge upon this and with the added effect of Arg58* could conceivably produce a 
phenolate ion. This will be discussed further in the proposed catalytic 
mechanism. The other effect of the Sy may well be directly upon the substrate. 
The action of MGL is a predominantly Cy-S and to a lesser extent Cp-S lyase. 
Homocysteine is the preferred substrate for the enzyme with a published activity 
almost 40 times more than that for methionine (McKie et al., 1998). The structure 
of homocysteine is identical to methionine but lacks the terminal methyl group of 
the amino acid side chain. The much higher activity towards homocysteine 
relative to methionine may be due to the "shielding" effect this methyl group has 
upon Cys113 Sy. The much lower activity towards cysteine can be postulated to 
reflect the greater distance between Cysl 13 Sy and the substrate Sy. That is, the 
nucleophilic attack by Tyrl 11 is not aided by the action of Cys113 Sy to anywhere 
near the same degree. This idea is further supported by the substrate 
preferences of the MGL1 C 3G mutant. It shows a greater relative loss of activity 
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for ay-elimination reactions, i. e. 9.3% remaining activity toward homocysteine and 
39% activity toward cysteine compared to wild type enzyme (McKie et al., 1998). 
Another possible role for the residue is suggested by the action of a related 
enzyme: There is a cysteine analogous to Cysl 13 in the active site of cysteine 
desuiphurase, the enzyme encoded by the nifS gene of A. vinelandii (Zheng et al., 
1993), and its homologues. As mentioned in section 1.8.4 these enzymes belong 
to the a-family of PLP-dependent enzymes and catalyse the removal of sulphur 
from cysteine'by mechanisms different from that proposed here. However the 
analogous cysteine residue has been shown to form an internal enzyme bound 
persulphide complex after cleavage of the substrate SH group (Zheng et al., 
1993). The sulphur produced is then ideally placed to be donated for Fe-S cluster 
formation in the case of NifS. It is the generation of a persulphide group that is 
key here and the controlled delivery of sulphur. A comparison of MGL1 with the 
structures of cysteine desulphurase enzymes and homologues follows in this 
chapter. 
3.2.10 Predicted Catalytic Mechanism for MGL 
Although MGL is classified in the same family of enzymes as CBL and CGS and 
possesses a same overall fold, it has considerably different substrate 
preferences., It catalyses the breakdown of homocysteine and methionine at a 
much more rapid rate than CBL or CGL but has no activity towards cystathionine. 
This is surprising given its published activity toward S-adenosyl L-methionine 
(Lockwood and Coombs, 1991 b), a much larger substrate, suggesting that this is 
not entirely due to steric restrictions on substrate binding. It is the proposal of this 
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study that MGL has a different catalytic mechanism (Figure 3.18) from that 
proposed for CBL and CGS (Clausen et al., 1996,1997,1998; Steegborn et al., 
1999). 
In PLP-dependent enzymes, a lysine residue (Lys209 in MGL1) is "essential" for 
activity. However, it has been observed that mutated PLP-dependent enzymes 
lacking the analogous lysine do retain trace levels of activity (Watabe et al., 
1999). This residual activity is at very low levels though and for most PLP- 
dependent enzymes removal of this residue produces an inactive enzyme. In 
agreement with the published mechanisms for CBL and CGS it is proposed that in 
MGL1 Lys209 catalyses deprotonation of the substrate Ca and generation of the 
quinonoid intermediate. The second part of the mechanism involves nucleophilic 
attack at the ß or y atom of the substrate but in MGL1 Lys209 does not appear to 
be optimally positioned to perform this function. There are few other residues in 
the active site as suitable alternatives except for Tyrl 11. The phenol side chain 
of this residue seems to be in precisely the correct orientation for interaction with 
the substrate at this point. 
Tyr111 has been suggested to exist as a phenolate ion in CGS (Clausen et al., 
1998) and to have a role in transaldimination (Steegborn et al., 1999), i. e. the 
conversion between enzyme-cofactor and substrate-cofactor complexes. The 
residue is indeed likely to be in a deprotonated form under the influence of 
Cys113 and the combined action of Arg58* and the phosphate group of the 
cofactor. If this is accepted as the case upon binding of the substrate then the 
side chain must be protonated prior to cleavage of the substrate y-S bond. This is 
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because the enamine complex generated is highly reactive and would covalently 
bond to the Tyrl 11 in an analogous fashion to the action of L-propargylglycine. 
Acting as the active site nucleophile upon the substrate removes this problem and 
the hydroxyl group seems optimally positioned for this. Addressing the proposal 
that this residue is instead involved in transaldimination, this function could be 
carried out instead by the cofactor itself. It is likely that the 03' of the cofactor is 
deprotonated and this could mediate a proton transfer between the amine group 
of the incoming substrate and the Ns of Lys209 and generation of the external 
aldimine (substrate-cofactor) complex. 
Thus we are able to postulate an enzyme mechanism based upon the structure of 
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Figure 3.18: Postulated mechanism for the ay-elimination reaction catalysed by MGL. (I) 
Deprotonation of the substrate Ca by Lys 209 and formation of the quinonoid intermediate. (II) 
Nucleophilic attack at the substrate Cß by the phenolic Tyr111. (III) Elimination at the Cy of SH 
influenced by the ionised Sy of Cys113. (N) Reprotonation at the Cy by Tyrl 11 to form the enamine 
intermediate. (V) Deprotonation of Lys209 by the cofactor 03. (VI-VIII) Regeneration of the internal 
aldimine and displacement of the enamine which via hydrolysis generates a-ketobutyrate and 
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ammonia. This production of an a-keto acid is not catalysed by the enzyme and is presumed to 
occur in free solution away from the active site. 
3.2.11 Comparison of other PLP-dependent enzyme structures 
It is beyond the scope of this study to perform a comprehensive comparison of 
MGL with published structures of PLP-dependent enzymes. However where 
specific points on the structure of MGL1 have been raised and other structures 
show analogous situations these are mentioned here. 
The structure of CBL from E. coil is similar enough that it provides a molecular 
replacement solution and this reflects the overall secondary structure 
arrangement. CGS is also similar and yet all three catalyse different reactions 
reflecting their different active site arrangements. It is apparent as well that the 
opening to the active site is different to MGL for both of these enzymes. The size 
of cystathionine as a substrate or product suggests this but the ability of MGL to 
catabolise SAM does not fit perfectly with this argument. 
Despite the close similarity in substrate for MGL and the various "cysteine 
desulphurase" structures published there is little homology seemingly beyond that 
normally seen for these types of PLP-dependent enzymes. As previously 
mentioned there are now three published structures of enzymes able to catalyse 
the removal of sulphur from L-cysteine and a related enzyme whose preferred 
substrate is L-cystine. 
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The structure of C-DES from Synechocystis is perhaps unsurprisingly the least 
informative (Clausen et al., 2000). It does not possess the active site cysteine so 
strongly implicated in the action of cysteine desulphurase and has a binding site 
specific for cystine, a situation more analogous to CBL. 
The published structure of a NifS-like protein from T. maritima (NifS) is similar in 
structure to MGL, being a member of the a-family of PLP-dependent enzymes 
(Kaiser et al., 2000). It shows more similarity overall to the structure of 
phosphoserine aminotransferase (Hester et al., 1999) than CBL. However, the 
active site appears to be more analogous to the situation found in CBL. Thus 
His99 in NifS is in an analogous position to Tyrl 11 in MGL. The predicted active 
site cysteine residue in NifS (Cys324) is not visible in the structure, being located 
on a presumably mobile loop. It is impossible therefore to compare the positions 
of this and Cys113 in MGL. The mechanism predicted for NifS gives Cys324 a 
direct role in a nucleophilic attack upon the substrate. This is plainly not the case 
in MGL as already mentioned with the distance being too great. Further evidence 
in support of this mechanism in NifS is provided by an inhibitor complex structure 
utilising allylglycine (AG). The inhibition of NifS by AG is thought to be by 
alkylation of the active site cysteine and in the inhibitor complex neither Cys324 
nor AG are visible. This implies that AG is bound to Cys324 and therefore that 
Cys324 must move close to the substrate at some point. Allylglycine is not an 
irreversible inhibitor of MGL though, again suggesting a different mechanism of 
action. It must also be remembered that unlike MGL the products of the reaction 
with NifS are alanine and sulphide, the formation of a-keto acid and ammonia do 
not occur. 
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The structure of CsdB from E. coli (Fujii et al., 2000) is similar to NifS from T. 
maritima and therefore to a degree also to MGL. The active site arrangement is 
much more like that already mentioned for NifS. In CsdB, His123 mimics Tyr111 
in MGL in much the same way as His99 in NifS from T. maritima. However the 
putative active site cysteine (Cys364) is visible in CsdB. The lower resolution of 
the structure (2.8 A) prevents accurate measurements of interatomic distances but 
the Cys364 Sy to hypothetical substrate Sey is around 5 A, clearly too far to make 
a direct interaction. However the authors still speculate on the ability of some 
residues to deprotonate Cys364 enabling it to perform a nucleophilic attack upon 
the substrate. Consideration though is given to an alternative method of action in 
which the cysteine is not directly involved in catalysis. This involves a 
deprotonation of the selenohydryl group and subsequent elimination in a fashion 
similar to that proposed here for MGL. The residue predicted though is not 
His123 (analogous to Tyrl11 in MGL1) but His55. Additionally there has been 
site-directed mutagenesis performed upon Cys364 (mutating it to an alanine) 
which has confirmed a role for the residue in cysteine but not selenocysteine 
degradation (Fujii et al., 2000). Although no activity data has been shown this 
seems to agree with the loss of activity toward homocysteine shown in MGL 
(McKie et a1., 1998). 
The crystal structure of cystalysin from T. denticola (Krupka et al., 2000) is 
perhaps the most promising in terms of hoping to learn something that may help in 
the analysis of the mechanism in MGL. It catalyses an a, ß-elimination reaction, 
has a similar overall structure and an analogous residue to Tyrl 11 in MGL 
(Tyr123 in cystalysin). Comparing the active sites though reveals no analogous 
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residue to Cys113 nor Arg58, both of which are implicated in the action of MGL. 
A very similar mechanism to that of CBL and MaIY is predicted in which Lys238 
(analogous to Lys209 in MGL) first deprotonates the Ca and then protonates the 
Sy of the substrate to cause y-elimination. 
3.3 DISCUSSION 
The results of initial crystallisation screens of MGLI were promising and indicated 
that it was likely that suitable crystals for structure determination could be grown. 
Ultimately however these results proved to be unhelpful in the search for optimal 
growth conditions. The results of DLS although indicating a polydisperse solution 
of enzyme in the selected buffer also proved to be misleading in finally growing 
large crystals. The most significant factors involved in growing strongly 
diffracting, large crystals was the preparation of enzyme and concentration of 
AmmSO4 used as precipitate. The use of freshly purified, unfrozen, recombinant 
enzyme produced crystals but this ability was lost if the enzyme sample was 
combined with glycerol and stored at -20 °C. Although no apparent loss of activity 
is detectable there is undoubtedly a detrimental change, a feature also of purified 
glutathione S-transferases in this laboratory (R Thom, personal communication). 
By varying the AmmS04 concentration by 100 mM also abolished crystal 
formation, 2.4 M produced an abundance of much smaller crystals and 2.2 M 
failed to produce any crystals at all. The use of alternative salts to Li2SO4 in 
crystallisation was not investigated. 
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After apparent optimisation of the purification to prevent even the minor 
contamination that previously existed it was highly surprising to discover a second 
apparent MGLI species. A native polyacrylamide gel stained for homocysteine 
desulphurase activity showed two bands which indicated that there were indeed 
two MGLs. The fact that both proteins co-eluted from the column with imidazole 
also implied that they were both histidine tagged MGL. Contamination of the 
expression culture was ruled out by picking a single colony from an agar plate for 
use in each expression and purification. Proteolysis was unlikely because of the 
presence of only two species at apparently equal concentrations and C-terminal 
degradation could be ruled out because of both proteins ability to still bind 
strongly to the Ni-NTA column. What seemed most likely was the production of 
two forms during expression. This seemed entirely plausible with the presence of 
a methionine residue at position 6. Why lowering the concentration of IPTG 
added to the cultures should reduce the amount of this truncated MGL1 is not 
clear. It may be that a consequence of expressing this eukaryotic gene in E. coli 
is the recognition of the 2nd methionine as a transcriptional start codon as readily 
as the first: - The cells used for expression of MGL1 contain an additional plasmid, 
pREP4, which encodes additional copies of the lac repressor protein. It may be 
that high concentrations of IPTG are enough to fully dissociate all repressor 
proteins., -- Whereas lower concentrations may result in only partial derepression 
and, for an unknown reason, produce predominantly the full length transcript. 
Although small crystals were grown of MGL2 and linear screens performed 
around these conditions, with and without the use of propargyiglycine, no 
substantial improvements could be made. The production of an alternative 
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expression construct was also unsuccessful in improving upon these results. At 
this point the success of growing large well diffracting crystals of MGL1 and the 
work involved in solving the structure lead to the abandonment of any further 
attempts to crystallise MGL2. 
The failure to crystallise MGL2 was mediated by the success with MGL1 but a 
good deal of useful information could have been gained by comparing the two 
structures: Specifically, in examining the fine detail of the active site and 
correlating this with the small but measurable differences in activity. Given more 
time (and less success in crystallising MGL1) further attempts could have been 
made. The process of crystallisation is poorly understood at least in terms of 
being able to predict the correct conditions required or the reasons for success 
with any in particular. Searching for the appropriate recipe in a largely empirical 
manner therefore allows for an almost inexhaustible number of variations. For 
MGL2 the next logical progression could have been temperature variations, a 
different set of sparse-matrix screens (there are always more to try) and variations 
in protein concentration and drop size. However, using the small crystals already 
obtained to seed other drops would probably be the first course to follow. The 
conclusion is clear though, although it is impossible to predicted how to, or even 
whether a protein will crystallise, there remains many more options to try if 
required. 
The results of refinement confirm the observation that the crystals of inhibitor 
complex MGL1 diffracted better than the native enzyme. It was apparent from 
comparing the diffraction patterns of both datasets that the native enzyme crystals 
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were more anisotropic with the familiar "rugby ball" pattern of reflections much 
more obvious. The maps for the native enzyme were always inferior, a reflection 
of the lower redundancy in the data despite being apparently more complete in 
the highest resolution shell. It is possible that the better data for the inhibitor 
complex is a result of the enzyme being held in a fixed conformation. The 
variation in B-factors for the two structures gives further support to this theory. 
The structure of MGL confirms its relationship to CBL and CGS in the postulated y 
-family of PLP-dependent enzymes (Alexander et al., 1994). The secondary 
structure elements in the two largest domains are very similar and the N-terminal 
domain in the three enzymes plays a comparable role in subunit interactions. 
Despite this, although residues Tyr56 and Arg58 are conserved in these enzymes 
the short N-terminal region shows considerable sequence variability. 
The attraction of finding a change in the structure resulting from disulphide 
formation is the generation of a negative feedback scenario. It is possible to 
imagine a situation in which the lack of products from the enzyme mechanism 
leads to inactive enzyme (via the disulphide bridge). This is because a possible 
role for MGL in vivo may be in the production of sulphide for cysteine formation by 
direct sulphydration or as an alternative to the reverse transulphuration pathway 
in converting methionine and homocysteine to cysteine. Thus inactivation of MGL 
leads to lower cellular cysteine levels because of insufficient sulphide which in 
turn leads to increased transcription and translation of the mgl genes. The 
possible roles that MGL may play in vivo will be discussed in the final chapter of 
this thesis. 
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It has been reported that there is an asymmetry of the B-factors in residues in the 
entrance to the active sites of CGS (Clausen et al., 1998). This is said to show 
evidence of non-equivalency in the active sites and supports the evidence from 
other studies on mechanism-based inactivators (Abeles and Walsh, 1973; 
Silverman and Abeles, 1977; Johnston et al., 1979). The structure of MGLI does 
not exhibit this variation in B-factors but there are subtle differences between 
monomers in the catalytic dimer. Although small the differences in arrangements 
of Tyrl 11, Cys113, Lys238 and Asp239 in the holoenzyme structure point to the 
possible existence of non-equivalent active sites. 
The covalent bond between Tyrl 11 and propargyiglycine confirms the previous 
biochemical evidence, that inhibition was caused by binding to an active site 
cysteine or tyrosine (Johnston et al., 1979). It may have been thought however 
that Cys113 was the probable target in MGL1 based on the mutagenesis 
evidence. Even without the inhibitor complex structure it would be easily seen 
now that this cannot be the case and the positioning of Cys113 precludes any 
direct interaction with either mechanism-based inhibitor or substrate. 
The main disagreement between the mechanism postulated for MGL and that for 
CBL, CGS and cystalysin is the action of Lys209. In MGL1 we believe that the 
residue is positioned poorly for interaction at the substrate ß or y position and that 
Tyrl 11 is more likely to fulfill this role. Cys113 has been confirmed as playing no 
direct role in catalysis. Both Tyrl 11 and Lys209 are conserved in MGL, CBL and 
CGS sequences and are likely to have essential roles. The next chapter in this 
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thesis details the investigation into the catalytic mechanism of MGL and attempts 
to define key residues and their roles. 
..., . 
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CHAPTER 4. SITE-DIRECTED MUTAGENESIS OF MGLI 
AND SEQUENCE ANALYSIS OF MGL ENZYMES 
4.1 INTRODUCTION 
The structure of MGLI presented in chapter 3 allows us to postulate roles for 
individual residues both in the physical structure of the enzyme and also in 
catalysis. Taking into account this, in conjunction with published data on PLP- 
dependent enzymes in general and MGL specifically, facilitated the proposal of a 
catalytic mechanism for MGL. In this, we have putatively identified residues 
responsible for the substrate specificity of the enzyme and involved directly in 
catalysis. To test these hypotheses, site-directed mutagenesis (SDM) was carried 
out to obtain modified proteins for analysis. The results are presented in this 
chapter. In addition, the primary amino acid sequences of MGLs were compared 
to provide more information on apparent key residues and aid in the identification 
of the enzyme in various organisms. 
Site-directed mutagenesis had been used previously on T. vaginalis MGL to 
identify a role in catalysis for Cysl 13 (Cyst 16 in MGL2) (McKie et al., 1998). This 
showed that the residue was important for activity, but not essential. Chemical 
modification, and random mutagenesis of the gene were techniques that could 
have been used to extend this study, but it was decided that a targeted approach 
was more appropriate. Mutagenesis is a powerful tool for determining the role of 
functional groups in proteins and has been extensively used in a variety of PLP- 
dependent enzymes. For example, it has been used to show the essential role of 
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the active site lysine residue, which forms the Schiff base with the cofactor and 
has a role in catalysis (Rege et aL, 1996; Hunter and Ferreira, 1999). There are 
also a large number of mutants for which the structures have been solved and are 
now deposited in the protein structure database. The structures have highlighted 
a consideration when mutating residues within a protein, what effect may the 
change have upon the overall structure? It would therefore be ideal to 
accompany enzymatic data on mutant enzymes with structural data. Attempts to 
obtain the structures of mutants produced in this study are also detailed here. 
4.1.1 Site-Directed Mutagenesis of MGLI 
The decision on which residues to perform mutagenesis upon was based 
predominantly on the structure of MGL1 presented in chapter 3. It had been 
envisaged that if the structural studies had been delayed that these decisions 
would have been based upon sequence analysis and comparisons with other 
related enzymes. This would have been less desirable not only because of the 
difficulty in identifying key targets but also because of the difficulty in interpreting 
results based solely upon in vitro assay data. The proposed roles of the residues 
selected were discussed in chapter 3, but mutations planned are listed and 
explained here as they form a central part of this chapter. 
4.1.2 Residues Selected for Mutagenesis 
The residues selected for mutagenesis and the changes introduced are listed in 
Table 4.1: 
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Original Residue Proposed Role Mutant 
Arg58 Cofactor binding and catalysis Met & Lys 
Leu59 Substrate access Phe 
Tyrl 11 Cofactor binding and catalysis Phe 
Cysl13 Indirectly in catalysis Pro & Ser 
Lys209 Cofactor binding and catalysis Ser 
Lys238 Catalysis Ala 
Table 4.1 Residues selected for site-directed mutagenesis and their predicted roles. 
4.1.2.1 Arginine 58 
A primary function of Arg58 appears to be the coordination of the PLP cofactor in 
the active site. Together with Tyr56 it belongs to the opposite chain of the 
catalytic dimer when compared with the other residues that directly interact with 
the cofactor. As can be seen in figure 3.15 in the previous chapter, Arg58 is 
within hydrogen bond distance of 0P2 and 0P3 of the cofactor and also 3.1 A 
from the side chain hydroxyl of Tyr111 in the holoenzyme and inhibitor complex. 
With the proposed role in catalysis of Tyrl 11 reliant upon its deprotonation, Arg 58 
seemed well positioned to modify the pKa of Tyrl 11 together with a role in 
positioning the cofactor. It was envisaged that substituting methionine would 
retain the architecture of the active site because of its similar size, but would 
remove the charge interactions. Lysine was also selected as a means of partially 
removing the positive charge. It was hoped that this would bind the cofactor 
adequately but be less effective in deprotonating the Tyrl 11 hydroxyl group. 
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4.1.2.2 Leucine 59 
This residue is not implicated in the catalytic mechanism at all but it is in the 
entrance to the active site. It was envisaged that the substrate preference of the 
enzyme could be altered by manipulating the size of this entrance. By 
substituting a bulkier residue, the enzyme activity toward larger compounds such 
as S-adenosyl-L-methionine, which had previously been reported as substrate 
(Lockwood and Coombs, 1991 b), may be reduced. The decision was taken to 
mutate this residue to a phenylalanine, a substitution that would place the large 
phenyl ring of the side chain directly into the "channel". The prediction was that 
the smaller molecules, e. g. L-cysteine, would be the best substrates. 
4.1.2.3 Tyrosine 111- 
The catalytic mechanism for MGL'proposed in this study predicts a critical role for 
this residue. After a proton abstraction by Lys209 at the substrate Ca, the ß or y- 
elimination is catalysed by the nucleophilic attack from Tyrl 11. The phenol ring 
of Tyrl 11 also coordinates the pyridine ring of the cofactor, holding it 
approximately parallel by van der Waals interactions. This interaction by an 
aromatic group, alternatively substituted for by phenylalanine or histidine in other 
PLP-dependent enzymes, increases the electron sink character of the cofactor 
(Hayashi et al., 1990). The inhibitor complex structure also shows that the 
hydroxyl group of this residue is unequivocally targeted by propargylglycine in its 
action as a suicide inhibitor. Changing this residue to any other would be 
expected to greatly curtail catalytic activity, or remove it completely, and also 
prevent covalent attachment of propargylglycine and its action as a suicide 
inhibitor. The most reasonable change would be to histidine or phenylalanine, 
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thereby removing the active hydroxyl group but retaining the aromatic ring. 
Another possible change would be to alanine and then subsequently attempting to 
rescue any lost activity with phenol. Phenylalanine was selected for this study as 
the residue most likely to retain the structure of the enzyme whilst removing the 
active group and so allowing the testing of our hypothesis. 
4.1.2.4 Cysteine 113 
The possible role of Cys113 in the enzyme mechanism is one of the most 
interesting features. Previous mutagenesis and chemical modifications have 
shown that the thiol group is important and its loss has a detrimental affect upon 
the catalytic activity (Nakayama et al., 1988a; McKie et al., 1998). It was 
something of a surprise therefore to find in the MGL1 structure that the residue 
was too distant from the presumed position of the substrate to be directly involved 
in catalysis. Neither does the cysteine appear to coordinate the cofactor. There 
are several possible reasons for the drop in activity seen upon modification of this 
residue: 
1/ Chemical modification may partially block access to the catalytic centre of the 
active site; 
2/ A cysteine to glycine change would allow Tyrl 11 (only two residues away) to 
move a significant distance from the optimal position for its proposed role in a 
nucleophilic attack upon the substrate; 
3/ A non-catalytic interaction between the thiol group of Cysl 13 and the substrate 
is lost. 
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Through mutagenesis it was intended to substitute a serine which would maintain 
all steric conditions (with the exception of the Sy being larger than the 
corresponding Oy) but remove the thiol group. It was also chosen to mutate 
Cys113 to a proline. This was selected to mimic the active site structure of CBL. 
4.1.2.5 Lysine 209 
An essential lysine residue analogous to Lys209 in MGL is present in all PLP- 
dependent enzymes studied so far. It is via the side chain amine group that the 
Schiff base linkage is formed between cofactor and enzyme (the so called 
"internal aldimine" (Christen and Metzler, 1985)). The binding of substrate, 
release of products and regeneration of the starting complex is catalysed by this 
residue. Where substrates are amino acids, it catalyses a deprotonation at the 
Ca. " It was envisaged that a mutant MGLI lacking this residue would be inactive 
and this would confirm its essential role in catalysis. More importantly, perhaps it 
would then allow enzyme substrate-complexes to be produced and their 
structures determined. This would allow examination of the binding of different 
substrates and identify reasons for differences in specific activities. The 
substitution chosen was serine, although it could have equally been another non- 
charged, non-aromatic residue such as alanine or methionine. 
4.1.2.6 Lysine 238 
The reason for mutating this amino acid was related to the desire to discover the 
role of Cys113 in the enzyme mechanism. The method of catalysis postulated 
from the crystal structures implies that the Sy of Cys113 is ionised and Lys238* in 
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combination with Asp239* may be required to produce this. Thus the hope was 
that mutating Lys238 may prevent this ionisation and so the activity would fall to a 
level reflecting the contribution of the cysteine alone. This possibly being similar 
to that measured in the MGL1(c"3G) mutant. Lys238 is also located in the channel 
leading to the cofactor, but makes no direct interactions with the adjacent 
monomer. Thus any change would not be predicted to interfere with subunit 
association as water would fill any spaces left by the missing side chain. To fulfill 
the aims for this mutation, alanine was chosen as the alternative residue. It is 
small, non-polar and would allow water to enter into any empty space and so be 
unlikely to distort the structure. 
4.2 RESULTS 
4.2.1 Site-Directed Mutagenesis of MGLI 
This section of this study details the results of construction, production and 
analysis of mutant recombinant MGL1 enzymes. 
SDM was carried out using the QuickchangeTm kit (Stratagene) as detailed in 
section 2.2.15. An overview of the technique is shown in figure 4.1. The design 
of complementary mismatched oligonucleotide primers followed the guidelines in 






Figure 4.1: Overview of site-directed mutagenesis. I- Isolate plasmid with gene target for 
mutagenesis; II - Denature plasmid and anneal complementary oligonucleotide primers containing 
the desired mutation; III - Extend both DNA strands using thermostable proof-reading DNA 
polymerase, incorporating mutagenic oligonucleotide primer. Repeat steps II and III for 20-25 
cycles. IV - Incubate amplification products with Dpnl restriction enzyme to cleave parental 
methylated DNA template. Leaves only mutated, circular nicked plasmid; V- Transform mutated 
plasmid into E. coli where cellular machinery repairs nicks and produces intact circular plasmid. 
Transformation of competent E. coli with the products from the mutagenesis 
reactions gave a varied number of colonies, from less than ten to more than 
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several hundred. In the first instance three colonies from each plate were picked 
and grown up overnight for mini-prep plasmid purification. Successful production 
of mutants L59F, R58K and R58M was selected for by restriction digest and then 
confirmed by DNA sequencing. For all other mutants, DNA sequencing alone was 
used to identify positive mutations. These three mutants however, resulted in the 
same change to the restriction map of the plasmid by destroying a BsmAI 
recognition site. The changes are listed in Table 4.2. 
Mutant Sequence 












Table 4.2: Sites of mutagenesis of MGL1 R58K, R58M and L59F mutants. The BsmAl restriction 
site is marked in bold text in the parental plasmid template sequence. Changes made to nucleotide 
and amino acid sequences are highlighted in red in the mutants. 
Several mutations were successfully isolated and identified rapidly but, 
surprisingly, sequencing showed a number of unexpected non-positive mutation 
results. These were in addition to the expected levels of negative clone 
background which results from template plasmid being uncut by Dpnl and 
transformed. There were also a number of clones which were mutated but did not 
encode the specific mutations designed into the oligonucleotide primers. The 
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strategy used to produce the mutants ensures that the site of mutagenesis and 
the upstream and downstream flanking sequence is defined by the oligonucleotide 
primers. Thus it was very surprising to have a number of mutants which encoded 
changes within these areas not designed into the primers. This problem was most 
evident in the designed Tyrl 11 to Phe and Cys113 to Ser mutations. A positive 
MGL1 O'"'F) mutant was isolated only after sequencing twelve transformants. 
MGL1(c"3s) was difficult to synthesise for an unknown reason and resulted in the 
lowest number of transformants. After repeating the mutagenesis and 
transformation step and obtaining no positive clones, this mutant was abandoned 
as there had by then been success in producing seven other mutants. 
4.2.2 Expression and Purification of Mutants 
Confirmed mutants were transformed into E. co/i strain M15 pREP4, for 
expression in an identical fashion to the parental plasmid. Successful 
transformants were selected by growing on LB, f,, agar plates. Single colonies 
were used to prepare an overnight starter culture and expression and purification 
were performed identically to that already detailed for unmutated MGL1. All 
mutants were produced as soluble enzyme and the recombinant proteins were 
isolated to a similar purity as the parent MGL1. 
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4.2.3 Enzyme Assays 
This section of the thesis describes the data obtained from the enzymatic analysis 
of the site-directed mutants produced of MGL1. There are three previously used 
and published assays for MGL: 
1/ a stopped assay to detect a-keto acid production, 
2/ a continuous, coupled assay measuring the production of a-keto acid, 
3/ a continuous assay measuring the production of hydrogen sulphide. 
The results and problems from each of these will be dealt with in turn. 
4.2.3.1 Results of Stopped Assay Using Methylbenzoylthiolhydrazone 
(MBTH) to Determine a-Keto Acid Production 
This detection of a-keto acid products is from a published method (Soda, 1968). 
It relies upon the reaction of MBTH specifically with the a-keto acids to produce 
an azine which has a measurable absorbance at a wavelength of 320 nm. The in 
vitro assay is thus incubation of enzyme with substrate followed by termination of 
the reaction and finally reaction of the products with MBTH. Calibration is by a 
standard curve produced using commercially available a-ketobutyrate. 
The previously used conditions were a total reaction volume of I ml, 100 mM 
buffer with varying levels of substrate and enzyme maintained at 37 °C for 5 
minutes. The assay was stopped by the addition of 125 µl of 12.5% (w/v) 
trichloroacetic acid (TCA) and the sample centrifuged to remove precipitates. 1 ml 
of this was then added to 1 ml of 1M acetate buffer pH 5.0 and 0.4 ml 0.1 % 
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MBTH and heated at 65 °C for 30 minutes before measuring the absorbance at 
320 nm. The high concentrations of acetate buffer were used to neutralise the 
effects of the TCA used in stopping the assay and maintaining an optimum pH for 
the reaction of MBTH with a-keto acids. 
It was observed initially that the results from the assays were quite variable 
between replicates and also on any given date. These observations also included 
the apparent detection of activity towards compounds not shown previously to be 
substrates of MGL1. This was thought to be highly significant at first, until it 
became apparent that the results were not repeatable and then the accuracy of 
the assay came under question. These apparent errors and uncertainties were 
compounded by the low catalytic activities exhibited by the MGL1 mutants. 
To obtain more reliable data, the components of the assay were investigated 
further. The most surprising finding was that the MBTH reagent reacted strongly 
with the acetate buffer giving high absorbance readings around 305-325 nm. This 
caused obvious concerns as the reaction was thought to be specific for a-keto 
acids. Evidently acetate (CH3COOH) was able to cross react strongly and there 
was concern that the TCA used to halt the assay and even the carboxylate group 
of the substrate could also react. Investigations with a number of different acids 
showed varying degrees of reactivity and whilst the absorbance peaks were not 
precisely at 320 nm there was a high level of absorbance at this wavelength. 
The decision was therefore taken at this point to not use this assay system further 
but to utilise one of the other assays available to us. 
124 
4.2.3.2 Continuous Coupled Assays Detecting a-Keto Acids 
An alternative assay system previously used to study MGL has used lactate 
dehydrogenase (LDH) as a coupling enzyme to monitor the production of pyruvate 
from L-cysteine and 0-acetyl-L-serine (McKie, 1997). The conversion of NADH to 
NAD+ by the enzyme as pyruvate is catabolised is measured continuously at 340 
nm. Several isoforms of LDH are expressed in cells with differing substrate 
specificities. The enzymes are not totally specific for pyruvate but also act upon 
larger a-keto acids including a-ketobutyrate. It was hoped that this could then be 
used to detect ay- in addition to aß-elimination reactions by MGL. 
Assays were attempted in an identical manner to that already published for MGL. 
Unfortunately it was not possible to obtain reliable data for any of the mutants with 
this assay. In control reactions using pyruvate, the LDH enzyme was shown to be 
active. The activity of mutant MGL1 was also confirmed using the 1-12S trapping 
assay detailed in the next section of this chapter. However the activity of these 
enzymes could not be coupled to the action of LDH. Because both enzymes 
exhibited activity separately it is assumed that the lack of success was due to the 
very low levels of a-keto acids produced. 
The decision was then taken not to pursue the reasons for the failure of this 
assay but instead to use the H2S trapping assay. 
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4.2.3.3 Hydrogen Sulphide Trapping Assays 
These assays were performed as previously described for homocysteine 
desulphurase (Thong and Coombs, 1985b). This continuous assay utilises the 
reaction of hydrogen sulphide with lead acetate which forms lead sulphide. The 
lead sulphide forms a brown precipitate which in the timespan of the assay 
remains in suspension and can be measured at a wavelength of 360 nm. 
Hydrogen sulphide is one of the products of the ay-elimination of homocysteine 
and ap-elimination of cysteine. Thus this assay was used for measuring activity 
of MGL1 mutants on these substrates. It is also used in detecting activity in 
native PAGE (Thong and Coombs, 1987). Enzyme resolved on a gel can then be 
visualised by incubating in a solution containing cysteine or homocysteine and 
lead acetate. The action of the enzyme causes the lead sulphide precipitate to 
accumulate in a band denoting the position of the enzyme in the gel. 
4.2.4 Analysis of Mutated MGLI Activities 
4.2.4.1 MGLI Arg58 Mutants 
The results of mutating Arg58 to lysine or methionine could not be predicted with 
confidence. The residue is strictly conserved in other y-family PLP-dependent 
enzymes but a role in catalysis, although proposed from the structure of MGLI, 
was not definitely established. 
Both mutants (R58K and R58M) were overexpressed successfully in E. coli 
although neither were yellow in solution as seen for MGL1. This presented no 
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problems in purification though and highly homogenous preparations were 
produced. 
Neither mutant exhibited normal Michaelis-Menten behaviour and, in fact, it was 
difficult initially to detect any activity at all for either enzyme. Activity was finally 
only seen at or below certain concentrations of substrate. These values were 
dependent upon the amount of enzyme being used and indicated likely substrate 
inhibition. When detectable, both enzymes exhibited high levels of activity at very 
low levels of substrate. By increasing the substrate concentration whilst 
maintaining the same amounts of enzyme, the linear rate observed would 
increase until a substrate concentration was reached when no activity was 
detectable. With normal substrate inhibition the activity would be expected to 
decrease more gradually. What was observed however, was an intermediate 
concentration where a lag phase of several minutes lasted until rapid linear 
activity was measured until the substrate was exhausted. An example of the 



















Figure 42: Spectrophotometer traces of MGL1 (RmK) assays. I- DL-homocysteine concentration of 
2.5 mM; II - DL-homocysteine concentration of 5 mM. X-A, ds denotes time of reaction in minutes. Y- 
Ads denotes change in absorbance measured at 360 nm from approximately 0 to 1.0 absorbance 
units. Both assays gave approximately equal upper limits of absorbance, no scaling has been 
applied to the outputs. 
The narrow "window" of substrate concentrations required for activity made it 
difficult to make estimates for Km and Vmax values. This was also compounded 
by the difficulty to accurately measure an initial rate because of the rapid 
depletion of substrate. Neither enzyme appeared to be exhibiting Michaelis- 
Menten kinetics and so attempts to define Km and Vmax values were not 
attempted. 
Compounding problems in assaying MGL1 « was the change in pH profile and 
buffer preferences of the mutant enzyme. Activity was measurable between pH 
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4.3 and 5.6 with acetate buffer and similar ones such as formate and succinate. 
However no activity was seen with buffers such as citrate, pthalate or imidazole at 
these pHs. The concentration of acetate buffers also had a critical effect on 
activity. At concentrations of 50 mM there was no lag in absorbance increase but 
at higher concentrations of buffer and the same concentrations of substrate and 
enzyme there was a distinct lag. This lag lengthened as the buffer concentration 
increased until no activity was detected at all at concentrations greater than 200 
mM. The rates measured after these lags were also lower than those with no lag. 
It therefore seemed possible that acetate was acting as an activator at low 
concentrations and an inhibitor at high concentrations. This idea had to be 
discarded when it was found that equally high activity with no lag phase was 
measured using the sulphonic acid buffer MES. Although MGL1(R58M) showed a 
similar substrate inhibition profile as MGL1(R58"), it did not exhibit this strange 
buffer activation/inhibition and was highly active at pH 6.5 in 100 mM imidazole. 
Due to the difficulties in interpreting data from these mutants further investigations 
into the pH profile was not conducted. 
Estimations of specific activity for both mutants with DL-homocysteine were made. 
The assay conditions are probably sub-optimal though and the true values may be 
higher. 
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Mutant Specific Activity 
(µmol/min/mg protein) 
R58K 308 ± 28 (9) 
R58M 187 ± 22 (5) 
Table 4.3: Estimated specific activities for MGL1(RSp and (R") with DL-homocysteine. Activities 
given are means :tS. D. with the number of experiments given in parenthesis. 
4.2.4.2 MGLI L59F Mutant 
This mutant exhibited the typical expression and purification profile seen for 
parent MGL1. The recombinant enzyme was coloured yellow, clearly seen 
binding to the column and after elution, and similar quantities of enzyme were 
purified (' 10-15 mg of purified enzyme per litre of culture). 
Unlike MGL1 « and M), there was no immediate problem in performing 
assays for this mutant. Firstly the enzyme was assayed with a range of buffers at 
varying pH values to find optimal conditions for calculating activities. A broad 
screen of pH values showed higher activity for the enzyme at pH values above 
that optimal for MGL1. The enzyme was then assayed in a variety of buffers 
above pH 7.0, in 0.2 pH unit increments, using sodium phosphate, TRIS and 
HEPES (data not shown). The results showed an optimum activity in 100 mM 
sodium phosphate pH 8.0 and so this was used for all further assays with this 
mutant. This determination of pH and buffer optimums was carried out for all 
mutants prior to attempting to calculate rate constants and specific activities. 
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To examine the kinetic properties of the mutant enzyme, a fixed amount of 
enzyme was assayed with varying concentrations of DL-homocysteine. The 












Figure 4.3: MGL1(L59F) reaction rate with DL-homocysteine. Data points are mean values, error bars 
are S. D. with n=3. 
A plot such as this typically indicates substrate inhibition at high concentrations 
but can also be caused by other conditions such as the assay conditions being 
altered. The solution was checked to ensure the pH of the assay had not 
changed before or after the reaction. There was no evidence that this had 
occurred. Plotting the data obtained at substrate concentrations up to 25 mM 
shows a clear hyperbolic relationship between reaction rate and substrate 
concentration (figure 4.4). 
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Figure 4.4: Saturation curve of MGL1 (L59F) with DL-homocysteine up to 25 mM. Data points are 
mean values, error bars are S. D. with n=3. 
A Hanes plot was then constructed to calculate Km and Vmax. Unfortunately this 
leaves only a few data points but these are enough to produce what appears to be 
a good linear plot (figure 4.5). 
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Figure 4.5: Hanes plot of homocysteine catabolism by MGL1(L59F) 
This Hanes plot produces a plot of [s]/v against [s] which is linear with a slope of 
1Nmax and an x-axis intercept of -Km. Knowing these values we can then go on 
to calculate the specific activity of the enzyme with a good estimate of the Km: 
Specific Activity (Etmol/min/mg protein) 8.26 (± 1.18) 
Km (mM) 3.7 
Vmax (pmol/min/mg protein) 2.0 
kcat (S) 1.5 
kcat/Km (M S) 400 
Table 4.4: Kinetic data for MGL1(L59F) with DL-homocysteine as substrate. Numbers in parenthesis 
are S. D. with n=5. 
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An identical process was carried out with L-cysteine as that detailed above for DL- 
homocysteine, with the exception of determining a pH optimum. A fixed quantity 
of enzyme was assayed with varying concentrations of L-cysteine. A plot of the 











Figure 4.6: MGL1(L59F) reaction rate with L-cysteine. Data points are mean values, error bars are 
S. D. with n=3. 
Unlike the situation seen for DL-homocysteine, with this mutant there is no clear 
hyperbolic curve even at low substrate concentrations. It seems unlikely that a 
better curve could have been produced even had the range of concentrations 
been extended lower. Thus for some unknown reason the action of this enzyme 
upon L-cysteine in vitro does not seem to adhere to the Michaelis-Menten 
equation. The measured specific activity for the enzyme at a substrate 
concentration of 40 mM is given below. 
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[L-cysteine] (mM) 
Specific Activity (µmol/min/mg protein) 1.75 (± 0.34) 
Table 4.5: Kinetic data for MGL1(SF) with L-cysteine as substrate. Numbers in parenthesis are S. D. 
with n=7. 
4.2.4.3 MGLI Y111 F Mutant 
Over-expression of this mutant in E. coli produced a colourless recombinant 
enzyme, purified in an identical manner as parental MGL1. From the mechanism 
proposed for MGL it was not expected that this mutant would possess any activity, 
or at best only very low levels. This was apparent immediately because of the 
large amounts of enzyme required before any activity could be detected. Once it 
was confirmed that the enzyme was catalytically active, it was assayed to find the 
pH optimum and buffer preferences. Screening a range of buffers and pHs gave 
highest activity with 100 mM TRIS at pH B. B. This was then followed up by trying 
to calculate kinetic parameters for homocysteine and cysteine. 
Assays were carried out as before with varying substrate concentrations over a 
broad range whilst maintaining the same amount of enzyme. The result of this is 














Figure 4.7: MGL1(Y"1F) reaction rate with DL-homocysteine. Data points are mean values, error 
bars are S. D. with n=3. 
Saturating concentrations of substrate were reached and Michaelis-Menten 
conditions apply for this enzyme. The data points on the graph conform to the 
hyperbolic curve expected and there is no evidence of substrate inhibition at high 
concentrations. A Hanes plot was then constructed to obtain a linear relationship 
and define Km and Vmax values (Figure 4.8). 
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Figure 4.8: Hanes plot of DL-homocysteine catabolism by MGL1(Y111F) 
Again this plot shows the non-linearity of the data, largely distorted by the two 
lowest substrate points. This is only a distortion, however from the perceived ideal 
and rather than discard experimental data they were included in the calculation of 
kinetic parameters. If these values were omitted, the Km and Vmax would be 
lower than the values given below (Table 4.6). 
Specific Activity (µmol/min/mg protein) 0.99 (± 0.31) 
Km (mM) 15.7 
Vmax (pmol/min/mg protein) 1.0 
kcat (s) 0.8 
kit/Km (M s) 50 
Table 4.6: Kinetic data for MGL1(Y"1F) with DL-homocysteine as substrate. Numbers in 
parenthesis are S. D. with n=8. 
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DLfiomocysteine (mM) 
No activity could be measured using L-cysteine as a substrate with this mutant. It 
is likely that any trace activity remaining is below the limits of detection for this 
assay. 
Another reason for constructing this mutant was to confirm the action of L- 
propargylglycine. In the inhibitor-complex structure presented in the previous 
chapter there is continuous electron density between the hydroxyl group of the 
Tyrl 11 side chain and the Cy of the propargyiglycine. Removing the hydroxyl 
group was postulated to abolish activity for the enzyme and prevent suicide 
inhibition by the inhibitor. To test this, purified enzyme was incubated with 
inhibitor for 5 minutes at room temperature prior to assaying and also added to 
the assays immediately before the enzyme. Both these experiments gave 
identical results. The level of inhibition exhibited was dependent upon the 
concentration of DL-propargylglycine added. Enzyme preincubated with inhibitor 
had the same levels of activity as that with inhibitor added at the beginning of the 
assay. Assays were performed with increasing concentrations of inhibitor added 
immediately prior to enzyme. The table below shows the loss in activity. Each 
assay contained 20 mM DL-homocysteine with identical amounts of enzyme and 







0 3.73 (t 0.21) 0 
0.5 3.50 (t 0.52) 7% 
5.0 3.16 (t 0.27) 15% 
12.5 2.81 (t 0.26) 25% 
25.0 2.57 (t 0.14) 31% 
Table 4.7: Inhibition of MGL1(Y"'F) by DL-propargylglycine. Numbers in parenthesis are S. D. with 
n=3. 
As a control the same amount of non-mutated MGL1 was assayed and inhibition 
was 100% at all concentrations of propargyiglycine. The data show a non-suicide 
inhibition confirming the role of Tyr111. 
4.2.4.4 MGLI Cl 13P Mutant 
This mutant was overexpressed successfully in E. coli but exhibited no yellow 
colour in solution as seen for parental MGL1. This presented no problems in 
purification though and highly homogenous preparations were produced. 
After screening a range of buffers and pH, this mutant was found to have the 
highest detectable activity in 100 mM sodium phosphate, pH 7.0, although the 
activity was very low. All further assays of this enzyme were performed under 
these conditions. 
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The saturation curve with DL-homocysteine is similar to that seen for MGL1111F) . 
No substrate inhibition is seen even at the highest concentrations, but the data 
from the lowest substrate concentrations did not produce an ideal hyperbolic 















Figure 4.9: MGL1 (c"3p) reaction rate with DL-homocysteine. Data points are mean values, error 
bars are S. D. with n=3. 
The data for this mutant enzyme appeared to adhere well to standard Michaelis- 
Menten kinetics. This was confirmed by producing a Hanes plot (Figure 4.10) 
where the only points not accurately fitting a linear plot were those at low 
substrate concentrations. 
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Figure 4.10: Hanes plot of DL-homocysteine catabolism by MGL1(c1 13P) 
The plot above was used to calculate values for Km and Vmax values (Table 4.8). 
Using this information the specific activity of the enzyme was then measured and 
kc, at values calculated. 
Specific Activity (pmol/min/mg protein) 0.88 (± 0.24) 
Km (mM) 20.1 
Vmax (µmol/min/mg protein) 1.0 
ko (s) 0.7 
,, 
/Km (M s") k, 40 
Table 4.8: Kinetic data for MGL1(C 13P) with DL-homocysteine as substrate. Numbers in 
parenthesis are S. D. with n=4. 

















L-Cystei ne (mM) 
Figure 4.11: MGL1 «"3P) reaction rate with L-cysteine. Data points are mean values, error bars are 
S. D. with n=3. 
The kinetics exhibited by this mutant against L-cysteine are very similar to those 
seen with homocysteine. No evidence of substrate inhibition exists and 
Michaelis-Menten kinetics are apparently observed. As previously a Hanes plot 
was constructed to calculate estimates of Km and Vmax (Figure 4.12). 
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Figure 4.12: Hanes plot of L-cysteine catabolism by MGL1 (c"3P) 
40 
This plot was also very similar to that observed against homocysteine with least 
adherence to a linear relationship seen at low substrate concentrations. Values 
calculated from the plot are given below (table 4.9). 
Specific Activity (pmol/min/mg protein) 1.20 (± 0.17) 
Km (mM) 16.2 
Vmax (µmol/min/mg) 1.1 
kcat (s) 0.9 
k/Km (M s) 50 
Table 4.9: Kinetic data for MGL1(C13P) with L-cysteine as substrate. Numbers in parenthesis are 
S. D. with n=3. 
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4.2.4.5 MGLI K209S Mutant 
This mutant was overexpressed in E. coli and purified successfully as a colourless 
soluble protein. Despite using large amounts of enzyme with either homocysteine 
or cysteine as substrate, no catalytic activity could be measured. Although this 
was the expected outcome, it was checked thoroughly to ensure the inactivity of 
the enzyme before attempting to prepare enzyme-substrate complexes for 
crystallographic analysis. 
4.2.4.6 MGL1 K238A Mutant 
Expression and purification of MGL1() M) was carried out identically as for 
unmutated MGL1. It was noticeable that the E. coli lysate loaded onto the Ni-NTA 
column was distinctly orange rather than the yellow colour normally seen. This 
was attributable to the mutant enzyme which, after elution from the column, 
retained the same colour in solution. The preparation retained this colour in the 
presence or absence of exogenous PLP or DTT. 
The enzyme was assayed in an identical manner to all other mutants. It was 
determined first that activity was highest in 100 mM sodium phosphate, pH 8.0. 
Then a fixed amount of the enzyme was assayed with varying concentrations of 
substrate (DL-homocysteine and L-cysteine). 
Figure 4.13 clearly shows a relationship between activity and substrate 















Figure 4.13: MGL1( M) reaction rate with DL-homocysteine. Data points are mean values, error 
bars are S. D. with n=3. 
The curve shown in the figure above seems to correspond to Michaelis-Menten 
type kinetics well. It is immediately apparent that the rates at low substrate 
concentrations are very rapid and saturating levels of substrate are reached at 
10 mM, suggesting a low Km value. The data were expected to produce a good 
linear plot to calculate good estimates of Km and Vmax values (Figure 4.14). 
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Figure 4.14: Hanes plot of DL-homocysteine catabolism by MGL1("238 
As thought, the data from these experiments produced a clear linear relationship. 
The cluster of data points at the lowest substrate concentrations did not show the 
disagreement with the line of best fit as seen for MGL1(C13P) seen above. They 
did fix the y-axis intersection clearly and calculation of a Km did produce a very 
low figure as thought. The calculated figures for Km and Vmax from this graph 
and specific activity from other experiments are shown below (Table 4.10). 
Specific Activity (µmol/min/mg protein) 39.2 (± 2.7) 
Km (mM) 1.1 
Vmax (µmol/min/mg protein) 21.4 
kit (s) 16 
kcat/Km (M s) 15000 
Table 4.10: Kinetic data for MGL1(K238A) with DL-homocysteine as substrate. Numbers in 
parenthesis are S. D. with n=8. 
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The process was repeated with L-cysteine as substrate to find the highest activity 














Figure 4.15: MGL1( A) reaction rate with L-cysteine. Data points are mean values, error bars are 
S. D. with n=3. 
The data points suggested that there may have been some substrate inhibition at 
high concentrations. However this apparent non-adherence to a hyperbolic curve 
may also be explained by the errors observed in the rate measurements. Thus 
the data was truncated to produce a Hanes plot to calculate Km and Vmax values 
(Figure 4.16). 
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Figure 4.16: Hanes plot of L-cysteine catabolism by MGL1(123eA) 
The linear plot was distorted by the data obtained at substrate concentrations of 
25 mM and higher. The low number of data points used to plot a line of best fit 
though is more of a concern in terms of calculating Km and Vmax values from the 
graph. Despite this, the values calculated from the plot are given below (Table 
4.11). 
Specific Activity (µmol/min/mg) 3.27 (± 0.21) 
Km (mM) 1.1 
Vmax (µmol/min/mg) 2.9 
kcat (s) 2.2 
kcat/Km (M" s) 2000 
Table 4.11: Kinetic data for MGL1lr""°") With L-cysteine as substrate. Numbers in parenthesis are 
S. D. with n=6. 
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4.2.4.7 Summary of Assay Results for MGLI Mutants 
The following tables summarise the results from the previous sections of the 
chapter presenting the results of the enzyme assays of the mutant MGL1 s. 
Homocysteine 
Enzyme Specific Activity Km Vmax kcat kcaIKm 
MGL1 370 t 11 12.2 256 197 16100 
Cl 13G 34.5 t 3.2 (9.3) 15.2 42 32.3 2100 
R58K 308 ± 28 (83) nd nd nd nd 
R58M 187 ± 22 (51) nd nd nd nd 
L59F 8.26 t 1.2 (2.2) 3.7 2.0 1.5 400 
Y111 F 0.99 ± 0.31 (0.3) 15.7 1.0 0.8 50 
Cl 13P 0.88 ± 0.24 (0.2) 20.1 1.0 0.7 40 
K238A 39.2 ± 2.7 (11) 1.1 21.4 16.4 15000 
Cysteine 
Enzyme Specific Activity Km Vmax k k /Km 
MGL1 6.02 t 0.63 8.5 14.9 11.5 1350 
Cl 13G 2.33i 0.35 (39) 9.7 4.6 3.5 360 
L59F 1.75 ± 0.34 (29) nd nd nd nd 
Cl 13P 1.20 ± 0.17 (20) 16.2 1.1 0.9 50 
K238A 3.27 ± 0.21 (54) 1.1 2.9 2.2 2000 
Table 4.12: Summary of kinetic parameters for MGLI mutants. Units: specific activity = 
µmol/min/mg protein, Km = mM, Vmax = µmol/min/mg, kcat = s', k,, /Km = M' s'. The numbers in 
parenthesis are the percentage activities compared to unmutated MGL1 activity for the same 
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substrate. Data for MGL1 and mutant Cl 13G were taken from McKie et a1., 1998. nd = not 
determined for reasons explained in the text. 
Enzyme Buffer/pH Optimum 
MGL1 Imidazole pH 6.5 
Cl 13G Imidazole pH 6.5 
R58K Acetate or MES pH 5.0 to 5.5 
R58M Imidazole pH 6.5a 
L59F Sodium Phosphate pH 8.0 
Y111 F TRIS pH 8.8 
Cl13P Sodium Phosphate pH 7.0 
K238A Sodium Phosphate pH 8.0 
Table 4.13: Buffer and pH optimum of MGLI and mutants. a this enzyme was not examined 
thoroughly for pH optimum. 
4.2.5 Structural Investigations of MGL1 Mutants 
The effects of mutagenesis may be simply the removal of an active group, e. g. a 
thiol, from the catalytic centre of an enzyme or they may be more subtle, inferring 
a conformational change of some degree upon the enzyme. This effect is 
obviously more pronounced when substituting amino acids with very different 
properties, especially if these occur deep within the structure rather than on the 
surface. Perhaps the best way of interpreting any changes of activity in mutant 
enzymes is to have a high resolution structure to accompany enzymatic data. 
This is an ambitious and possibly unrealistic desire, but within the scope of this 
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project attempts were made to achieve this. The results are detailed in the 
following sections. 
4.2.5.1 Crystallisation of MGLI Mutants 
Mutant enzymes were purified and prepared as detailed for MGL1 in chapter 2 of 
this thesis. In all cases enzyme for crystallisation was concentrated to 6mg/ml in 
100 mM HEPES pH 7.5,250 µM PLP, 1 mM DTT. Sitting drop vapour diffusion 
crystal Iisations were set up under identical conditions as for MGL1, i. e. 2.3 M 
AmmSO4,0.1 M NaCitrate pH 5.6,0.2 M Li2SO4. The results of these experiments 
are summarised in the table below: 
Mutant Result 






Small bipyramidal crystals (0.15 mm x 0.05 mm x 0.05 mm). 
Also co-crystallised with 5 mM DL-allylglycine 
K209S Large colourless bipyramidal crystals 
(0.6 mm x 0.4 mm x 0.4 mm) 
K238A Large orange bipyramidal crystals (0.6 mm x 0.4 mm x 0.4 mm) 
Table 4.14: Results of crystallisations of MGL1 mutant enzymes 
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MGL1P"3c) previously produced in this laboratory was available at the beginning 
of the study. Attempting to find suitable crystallisation conditions it was screened 
in the same manner as MGL1 but yielded no promising results. Similar attempts 
were not performed with the mutants produced in this study due to time 
constraints. 
4.2.5.2 Data Collection and Processing 
Crystals of MGL1 X38'", MGL1 K20'S and MGL1 C1 13P (holoenzyme and co-crystallised 
with DL-allylglycine) were taken to the ESRF synchrotron facility Grenoble, 
France for data collection. A summary of the diffraction exhibited by the crystals 
is given below: 
Crystal Highest Resolution 
K238A 1.7 A 
K209S 1.6 A 
C1 13P - holoenzyme 5.0 A 
C1 13P - co-crystallised 5.0 A 
Table 4.15: Summary of the diffraction limits exhibited by mutant MGL1 crystals. 
No data was collected for MGL1(C13P) because of the low resolution diffraction 
exhibited. Indexing of the initial frames of both MGL1('209S) and MGL1(`2 ) 
indicated the same space group as unmutated enzyme, P 3112, and similar unit 
cell dimensions. A strategy was then computed to collect complete datasets for 
both crystals. 
152 
In an attempt to produce enzyme-substrate complexes, crystals of MGL1 ("2°9S) 
were soaked with homocysteine and cysteine. Unfortunately the results of these 
soaks was a total loss of diffraction by the crystals. The gross morphology of the 
crystals did not alter during the soaking and they remained intact for several 
minutes. The loss of diffraction was concluded to be due to a conformational 
change. No further attempts were made to produce complexes with these 
crystals. 
Only the data from MGL1( ) was processed and analysed further, a summary of 
the statistics is presented below. All data were processed with DENZO and 
scaled using SCALEPACK (Otwinowski and Minor, 1997). 
Resolution 35 - 1.8 A 
Temperature 100K 
Oscillation Range 0.5° 
Completeness Overall (40.0 - 1.82) 
Highest (1.91 - 1.82) 
98.6% 
84.7% 
Unique Reflections 90109 
Rmerge 5.6 
Table 4.16: Data collection and processing statistics for MGL1(Y'm) 
4.2.5.3 Structure Solution of MGL1 ý"M") 
The solution of this mutant was relatively straightforward due to the similarity 
between it and native MGL1. Phases were obtained directly from the refined 
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holoenzyme structure and the same subset of reflections used for Free R-factor 
determination extended to include the higher resolution data. 
4.2.5.4 Model Building and Refinement of MGL1I"238A) 
Model building of the mutant was carried out with QUANTA using the coordinates 
of MGLI holoenzyme to trace the first maps. These maps were of a very high 
quality due to the similarity of the mutant to the refined holoenzyme structure, 
from which the phase information was obtained. No breaks in the electron density 
for main chain atoms were evident and there was no need for averaging of the 
maps. In the first round of model building waters were included from the 
holoenzyme structure and individually checked. Poorly defined atoms were 
removed and extra waters added, the glycerol molecule and sulphates were 
clearly visible in the first maps. Refinement was subsequently performed with 
REFMAC using a bulk solvent correction and maps created using the programme 
FFT from the CCP4 suite. Geometric restraints were relaxed after the second 
round of refinement. A summary of the refinement process and statistics is given 
below (Table 4.17): 
Round of Refinement 
1. Phases taken from holoenzyme model 
2. Few changes necessary, extra waters added 
3. Poor waters removed, minor adjustments only 
4. Final round 
R-factor Rf 
22.1 1 26.6 
21.3 1 25.3 
20.2.1 23.4 
19.8 1 23.4 
Table 4.17: Summary of refinement of MGL1( &) structure. 
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4.2.5.5 MGL1l Structure 
The following section details the structure of the mutant MGL1 ('238'°') at 1.7 A. The 
crystallisation and indexing of data from the crystals implied that the structure was 
likely to be very similar to the native enzyme. Purification of the enzyme revealed 
that instead of the yellow colour associated with the parental enzyme, purified 
mutant enzyme was orange and this was clearly visible in the crystals. This 
phenomenon was not attributable to a change in pH of the solution as conditions 
were identical in each case, and as seen in the native structure, Lys238 does not 
make a direct interaction with the cofactor. 
4.2.5.5.1 Secondary Structure 
The secondary structure of the mutant enzyme is, as expected, identical to the 
native enzyme. The two monomers in the asymmetric unit do not differ 
appreciably as is seen in the holoenzyme and inhibitor complex structures. An 
RMS deviation of only 0.294 A for main chain atoms was seen when 
superimposing the two subunits. Similarly, superimposing the dimers of the 
mutant structure with the holoenzyme and inhibitor complex structures gave an 
RMS deviation of only 0.235 A and 0.262 A respectively. 
4.2.5.5.2 Active Site Areas 
The active site of the mutant is also largely similar to the holoenzyme structure. 
There is a clear difference seen at the site of the lysine to alanine change at 
residue 238. There is no electron density past the position of the Cß and the 
space vacated is not clearly occupied by any other atoms. Figure 4.17 shows the 
electron density in the region around A1a238. 
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Figure 4.17: 2F0 - Fc and electron density maps of the area around A1a238 in the MGL1(K238A) 
structure. The 2F0 - Fc map is contoured at one and two a in pink and orange, respectively. In the 
F0 - Fc map positive density is indicated in green, negative density in red. Only Arg58, Tyrl 11 *, 
C113`, AIa238 and Asp239 are shown in the figure for clarity. 
There is weak density nearby to the Cß of A1a238 which did not successfully refine 
as either water molecules or an alternative conformation for neighbouring Asp239. 
Both of these have been omitted from the final model, although it is possible that 
both may actually be present at low occupancy. The electron density for the side 
chain of Asp239 is significantly poorer than for neighbouring residues and is 
reflected in the high average B-factor of 38.2. This reinforces the idea that the 
side chain may possess a dual conformation. 
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Also evident in the mutant structure is the change in the electron density for 
Tyrl 11. There is a small amount of positive density above the plane of the phenol 
ring between the side chain and the cofactor pyridine ring. Although not clear in 
figure 4.17, this density is consistent with the ring rotating -900 to position itself 
parallel with the cofactor. Attempts were made to refine a dual conformation of 
Tyr111 but were unsuccessful. A change such as this would force a movement of 
the cofactor as it is within Van der Waals distance of the phenol side chain. 
The most intriguing observation in the active site though is the density around 
Cys113. At all stages of refinement, there was positive density adjacent to the Sy. 
Unlike the maps for the holoenzyme and inhibitor complex this was not 
attributable to a dual conformation. Instead the unaccounted for density in the 
mutant structure extends in the same direction from the Sy, resulting in an angle 
of -120° between Cß-Sy-X, where Xis the unknown atom. The distance appears 
to be approximately 1.7 A from Sy to X indicating a covalent bond between the two 
atoms. 
It was supposed that the orange colour exhibited by this mutant was due to a shift 
in the position of the cofactor relative to the residues coordinating it. To test this 
monomers of the mutant, holoenzyme and inhibitor complex structures were 
aligned using LSQKAB and the models superimposed. Figure 4.18 shows the 
three cofactors aligned in this way. 
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Figure 4.18: Superposition of the cofactors from the three MGL1 structures. Green - PLP + 
propargyiglycine, Blue - holoenzyme structure, Red - K238A mutant structure. The figure was 
produced using SETOR. 
There is very little movement of the cofactor in the MGL1 ('2') structure in 
comparison with the others. The cofactors were aligned through their position 
relative to the polypeptide chains but it was evident that there were no significant 
movements of any residue directly interacting with the cofactor. 
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4.2.6 MGL From Other organisms 
MGL activity has been detected in a number of organisms. Much of these data 
are from total cell extracts and are therefore a little unreliable as related enzymes 
such as cystathionine y-Iyase (CGL) are able to catalyse some of the same 
reactions as MGL, albeit at much lower levels. At present there are only four mgl 
genes in the database that have been confirmed biochemically to encode MGL 
enzymes, two each from T. vaginalis and P. putida (Inoue et al., 1995; Hori et a!., 
1996; McKie et al., 1998). These show a high degree of homology to other 
members of the y-family making identification of putative MGL's difficult. Indeed 
the cloning of mgl from T. vaginalis was carried out using degenerate 
oligonucleotides based upon CGL sequences. As mentioned previously, in both 
the bacterial and protozoal enzymes studied biochemically so far a cysteine 
residue (Cys113, T. vaginalis MGL1 numbering) is important for activity and 100% 
conserved (Nakayama et al., 1988; McKie et al., 1998). This residue is not found 
in other y-family enzymes, which was suggestive that the MGL mechanism 
differed from those of other PLP-dependent enzymes such as cystathionine 
synthases and cystathionine Iyases. Moreover, the cysteine residue can be used 
as a marker in identifying putative MGL's. Searching the available data released 
from the various sequencing projects has revealed possible MGL enzymes in just 
a few organisms: Porphyromonas gingivalis, Bacillus anthracis, Treponema 
denficola, Caulobacter crescentus and Shewanella putrifaciens (accessible at 
http: //www. tigr. org). An alignment of these sequences shows their extensive 
similarities (Figure 4.19). 
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Figure 4.19: Sequence alignment of confirmed and putative MGL enzymes. Secondary structure 
elements of MGL1 are indicated. a-helices are represented as coils, ß-strands as black arrows, 
each is numbered as for figure 3.6. Conserved residues are coloured in red and boxed. Black 
triangles indicate those residues proposed to have a role in the catalytic mechanism. Yellow 
triangles indicate residues coordinating the cofactor. The figure was generated by ESPript. All 
numbers refer to MGL1. 
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There are 87 conserved residues amongst all 9 sequences and the level of 
similarity exhibited to MGL1 ranges from 58% against the B. anthracis sequence 
to 85% against MGL2. With the exception of Met87, all residues involved in 
cofactor and substrate binding and those that appear to be involved in catalysis 
are conserved. Met87 is alternatively substituted for an isoleucine and the main 
chain amine group of the residue is involved in the interaction and so the side 
chain is less crucial. Significantly Lys238 and Asp239 are also conserved in 
these sequences but absent from other PLP-dependent enzymes. Thus in 
identifying possible MGL enzymes from the abundance of other PLP-dependent 
enzymes retrieved in a BLAST search of the available databases, Cysl 13, 
Lys238 and Asp239 are critical. Not a single instance was found of any one of 
these residues being present without the other two. 
4.3 DISCUSSION 
Results have been presented in this chapter on rationally designed site-directed 
mutagenesis of MGLI. This technique has been applied to many proteins to 
investigate roles of particular residues. It has also been successfully used on 
MGL from T. vaginalis to investigate the contribution of an active site cysteine to 
catalysis (McKie et al., 1998). For this study mutations were selected based upon 
the structure of MGLI and its comparison to CBL from E. coli (Clausen et al., 
1996). Eight mutants were designed, although one of these was not successfully 
produced, targeting a total of six different residues. Attempts were also made to 
solve the structures of these seven mutants, crystals were grown of three and one 
structure was solved to a resolution of 1.7 A. 
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When searching for other MGL sequences in the databases the homology to 
other members of the y-family of PLP-dependent enzymes was obvious. 
Identifying any of these positively as MGL though was difficult. To attempt to do 
this, we used information from the structure of MGL1 and the results of SDM 
which identified key residues in the active site. Additionally we utilised the 
structures published of CBL and CGS to highlight differences. With this 
information it allowed us to putatively identify ORFs from the genome sequencing 
projects that encode likely MGLs. In the active site of y-family PLP-dependent 
enzymes Tyr58, Arg58, Tyrl 11 and Lys209 (MGL1 numbering) are usually 
present. However key residues in MGL1, Cys113, Lys238 and Asp239, are 
absent. By performing BLAST searches with MGL1 and examining those hits with 
high homology for the presence of these seven key residues, putative MGLs were 
identified. Frequently these organisms had apparent homologues of one or more 
cystathionine-utilising enzymes, but in each case these other enzymes lacked 
Cysl13, Lys238 and Asp239. Only those sequences which had these three 
residues are thought to be MGL enzymes. Interestingly, no example was found in 
any of these organisms of two isozymes of MGL as is found in both T. vaginalis 
and P. putida. 
The technique employed to produce mutants utilises oligonucleotide primers that 
flank the target site by 15 to 20 bases. It was therefore a surprise to isolate a 
large number of putative mutant plasmids whose sequences in these regions was 
not encoded by the primer or original clone. The number of these varied but in 
the case of the C1 13S mutant no correct mutations were isolated. The production 
of this mutant was abandoned because of the work involved in analysing the other 
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seven. It can only be concluded that the cause of these "random" changes were 
due to the oligonucleotides used. Their synthesis may not have been entirely 
specific, such that primer populations incorporating errors were supplied. 
The catalytic mechanism proposed in the previous chapter gives a direct role for 
both Tyrl 11 and Lys209 in catalysis, with the activity being strongly mediated by 
the action of Cys113. Purified MGL1("209S) was inactive according to the assays 
performed which is in agreement with this mechanism. However crystals of the 
enzyme no longer diffracted X-rays after adding substrate, which might suggest 
the retention of some activity. However, this may equally have been produced by 
a conformational change resulting from substrate entering the active site. The 
published structure of CGS from E. coli shows an asymmetry in the B-factors for 
residues in the N-terminal domain which is postulated to reflect a conformational 
change. This may be necessary for the active site of CGS which has to 
accommodate two substrates (L-cysteine and 0-acyl-L-homoserine) but there is 
no evidence for a conformational change in MGL1 when the holoenzyme and 
inhibitor-complex structures are compared. 
It was thought that the mutation MGL1"9) would produce an enzyme with 
changes in substrate specificity and a probable drop in activity. The calculated 
specific activities show a much larger fall in activity than expected, although this 
fall is much larger for homocysteine than cysteine (98% and 71% respectively), 
which was predicted. The k and k/Km values calculated for this mutant also 
agree with this, showing a much larger fall in turnover and affinity for 
homocysteine than cysteine. Because no structural data is available to 
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accompany these results we are unable to say exactly what is responsible for 
these changes. The residue is adjacent to Arg58, changes in which we have seen 
in this chapter result in significant alterations in enzyme activity. Thus the activity 
of the MGL1«`59F) mutant may be due to both a change in the active site and 
movement of Arg58. 
The assay results of both MGL1(' and ('") are difficult to explain. Both exhibit 
substrate inhibition but only the lysine mutant shows the activation/inhibition by 
acetate and similar buffers. The reason for substrate inhibition is unknown but it 
is possible to give some explanation for the lag in activity seen at intermediate 
substrate concentrations ([s]). With a low level of residual activity remaining 
during inhibition by high [s], as the substrate is depleted it eventually drops below 
inhibitory levels. This accounts for the activity seen after a few minutes delay. 
Previously Cysl 13 has been shown to be important for activity and mutation to a 
glycine has resulted in the loss of -90% of homocysteine catabolism. The 
structure of MGL1 shows that the distance from the Sy of Cys113 to the substrate 
is too large for a direct interaction occur. The position of the cysteine only two 
residues from Tyr111 does allow for the possibility that the change in activity is 
due to movement of this residue. To further test the role of the cysteine, 
mutations to serine and proline were designed and also the Lys238 to alanine 
change because of its proposed interaction with Cys113. The loss in activity of 
MGL1 (CI 13P) is very probably due to a change in the active site geometry. The 
glycine mutation at this position would allow a greater freedom of movement for 
the polypeptide chain because of the lack of steric hindrances caused by the 
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absence of a side chain. A proline mutation though would restrict the 
conformations permissible more than any other residue. The restricted geometry 
of the proline permits only certain phi/psi angles and these may well distort the 
neighbouring structure, displacing Tyr111. As can be seen in figure 3.4, an 
alignment of CBL and MGL1 shows the sequences to be quite different in a 
stretch of 18 residues (104 to 121) with only Tyrl 11 being conserved and one 
other similarity. Thus where a proline residue is optimal in CBL it has a severely 
detrimental effect in MGL1. The fact that this mutant crystallised in identical 
conditions to MGLI probably indicates the overall structural changes are not large 
or at least do not affect crystal contacts. It is interesting to note however that this 
mutant has similar levels of activity toward homocysteine as MGL1(y"'F), but 
unlike this change, MGL1 (Cl 13p) exhibits activity toward cysteine. 
The role of Lys238 in the mechanism of MGL1 was proposed to be through the 
combined influence of it and Asp239 to ionise, Cys113. The fall in specific activity 
of this mutant, compared to the parental MGL1, by an order of magnitude is 
matched by the drop in Km and kcat values. The k/Km value however, which can 
be taken as a measure of the specificity of the enzyme for a substrate, is similar to 
the values for parental MGLI. This data alone would indicate the possibility of a 
mutation that resulted in no significant structural change as substrate affinity was 
not substantially affected. The fall in activity though points to the loss of a 
functional group important but not essential for catalysis. These conclusions are 
confirmed by the mutant enzyme structure. The only significant difference is the 
area around residue 238 and the side chain of Cysl13. The electron density 
around the Sy suggests the side chain is oxidised. With the proposed action of 
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Cys113 dependent upon its ionisation (by Lys238 and Asp239) oxidisation would 
prevent this. Thus the data obtained from this mutant agrees with our hypothesis 
on the role of Lys238 and Cysl 13 and the importance of the ionised state in the 
mechanism. 
We are confident that the action of Cysl 13 on the substrate is crucial for optimum 
activity, but it is still difficult to explain. The distance from Cys113 Sy to substrate 
p and y atoms is - 6.5 and 5.0 A respectively. The agreed mechanism of action 
for ß- or y-elimination requires a nucleophilic attack at the p atom, obviously too 
distant to be influenced by this residue directly. Reconsidering the mechanism we 
know that the "quinonoid intermediate" is formed after proton abstraction at Ca. 
The new distribution of 7t molecular orbitals produces a "vinylogous enamine". 
This structure produces a cofactor which is electron rich and basic and can either 
be protonated or push out a leaving group. However the thiol group of 
homocysteine (and cysteine) is a strong nucleophile and it is presumably the 
assistance here by Cys113 that produces the high levels of activity we see. 
Cys113 and its proposed oxidation in MGL1 (K 23"A) is likely to be responsible for the 
orange colour seen in the enzyme preparation, as the structure of the mutant 
reveals there is no movement of the cofactor. Although there appears to be no 
close contact between the cofactor and the side chain of Cys113 it is noteworthy 
that neither of the mutants MGL1(C13P) and MGL1(c"3G) have any yellow colour in 
solution, as seen in unmutated MGLI. However the reason for this colour change 
has yet to be explained. 
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It is tempting to look for answers about Cys113 in the mechanism of NifS enzymes 
and their homologues. These enzymes all have proposed mechanisms with an 
essential active site cysteine forming a persulphide after catalysis of cysteine or 
selenocysteine (Zheng et al., 1994). However they all also predict that the same 
residue takes part in a nucleophilic attack upon the substrate. Unless a large 
conformational change takes place in MGL1, for which there is no evidence in the 
structure, this is highly unlikely. The remaining activity in the MGL1(C130) mutant 
also totally discounts the possibility of it acting as an essential active site 
nucleophile. Thus despite some outward similarities these mechanisms are 
fundamentally different from MGLI. 
The structure of cystalysin from Treponema denticola (Krupka et al., 2000) was 
also examined for help in defining the mechanism of MGL. This enzyme 
catalyses an ap-elimination reaction on cysteine to release H2S, pyruvate and 
ammonia rather than the production of alanine and enzyme bound persulphide by 
NifS-like enzymes. - However in this structure there is no analogous active site 
cysteine. Catalysis is again predicted to be entirely due to the ubiquitous active 
site lysine although here it is under the influence of the PLP phosphate group, a 
water molecule and a tyrosine and alanine residue in the active site. It has to be 
concluded then that after a search of the available literature MGL has a novel 
method of producing a good leaving group from a strong nucleophile. 
The inability to detect any activity with MGL1('209S) is consistent with the finding in 
other mutated PLP-dependent enzymes where the residue is essential. In CBL 
and CGS it has been proposed that the analogous lysine to this is the sole 
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residue involved in catalysis (Clausen et al., 1997,1998). This has been 
considered for MGL1, but thought to be unlikely because of the distance from the 
amine group of the lysine side chain to the proposed position of the substrate Cß. 
Instead it is proposed that Tyrl 11 would fulfill this role. MGL1(Y111F) retains 0.3% 
of its activity towards homocysteine compared with the unmutated enzyme and no 
measurable activity towards cysteine. - Although very low, this is not predicted for 
the loss of an essential catalytic residue. Thus the question to be answered is 
can the very low levels of activity still exhibited by MGL1''1F) be explained in 
terms of the mechanism proposed here? The only way in which the mutant 
activity data can be made to fit our hypothesis is if there is an additional 
mechanism for the ay-elimination of homocysteine. There appear to be only two 
options for this: the action of Lys209, or the action of Cys113. Perhaps it is 
possible that the trace activity retained by the mutant is in fact due to Lys209, as 
proposed by others. The unfavourable position seen for Lys209 in MGL1 may not 
be totally prohibitive for catalysis and may be able to deprotonate the substrate 
CO albeit at very low levels. The action of Cys113 in conjunction with the cofactor 
may also be enough to cleave the Cy-SS bond. It is feasible that the action of the 
electron rich quinonoid intermediate and the ionised Sy of Cys113 (approximately 
3.5 A from the SS of homocysteine) may break the Cy-S8 bond. If neither of these 
possibilities are correct then an alternative role for Tyr111 must be given which 
accounts for the loss of activity. 
An alternative role for Tyrl 11 has already been proposed in which the phenolate 
side chain is critical for transaldimination (Clausen et al., 1998). That is, the 
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conversion from enzyme-PLP (internal aldimine) to substrate-PLP (external 
aldimine) complex. This is the primary step in catalysis and involves the removal 
of a proton from the incoming substrate amine group and passing this to the 
displaced lysine amine (Lys209). It is this conjugate form of PLP-substrate that 
labilises the substrate Ca and allows the reaction to proceed. The role of Tyrl 11 
in this still relies upon the negatively charged side chain hydroxyl and so loss of 
this should also prevent transaldimination. In MGL1 the proposed method for 
transaldimination is controlled by the cofactor itself. The hydroxyl group on C3 of 
the cofactor is generally accepted to be negatively charged. This should then be 
able to shuttle protons from the incoming substrate, four atoms along to the lysine 
amine, although we have no evidence for this. 
Alternatively the activity data of the mutant can be explained in terms of the 
CBLICGS mechanism proposed. That is, transaldimination by Tyrl 11 is 
abolished in the phenylalanine mutant and the remaining low activity levels are a 
result of sub-optimal transaIdimination, possibly by the cofactor. The kinetic data 
agrees with this, producing a k/Km much lower than that for unmutated MGL1 
which indicates a much lower specificity for the substrate: Unfortunately the data 
we have does not allow us to rule out either hypothesis and so further 
investigation is undoubtedly needed to identify the true function (or functions) of 
Tyrl11. 
What is confirmed by the data is not only the importance of Tyrl 11 in activity but 
also its role in inhibition by propargylglycine. The action of the inhibitor on MGL, 
CGS and CGL has been studied biochemically and confirmed a covalent linkage 
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to the enzymes (Washtien and Abeles, 1977; Johnston eta!., 1979). Though 
clear and unambiguous in the inhibitor complex structure the verification of no 
inactivation of MGL1(Y'11ý by the compound confirms the role of the side chain 
hydroxyl group as the site for covalent attachment. 
ýf! 
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CHAPTER 5: INVESTIGATION INTO T. VAGINALIS 
CYSTEINE SYNTHASE 
5.1 INTRODUCTION 
In vitro cultivation of T. vaginalis requires reducing agents for optimal growth. It 
has been shown that thiol blocking reagents act as potent anti-trichomonal 
compounds with cultured parasites (Gillin et al., 1984). Lacking glutathione or an 
analogous molecule such as trypanothione (Ellis et al., 1994), the parasite is 
thought to utilise cysteine as the primary thiol reductant. Despite this there is no 
published experimental evidence for cysteine synthesis by the parasite, either by 
direct sulphydration (the condensation of OAS and sulphide by cysteine 
synthase), or transuiphuration (the conversion of homocysteine to cysteine by 
cystathionine ß-synthase (CBS) and cystathionine y-lyase (CGL)). Very low levels 
of CGL activity in crude lysates has been detected (Thong, 1985) and an 
"activated serine sulphydrase" activity described that has similarities to CBS 
(Thong and Coombs, 1985b). However neither of these have been shown to 
produce cysteine from homocysteine either in vivo or in vitro. The aim of this part 
of the study was to investigate whether the parasite has the ability to synthesise 
cysteine by direct sulphydrylation. 
A single EST clone with substantial amino acid sequence homology to cysteine 
synthase was identified from T. vaginalis. It was discovered through single pass 
automated DNA sequencing of clones from a cDNA library of T. vaginalis strain 
G3. The library was produced using a ZAP-cDNA® synthesis kit (Stratagene) 
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from a total RNA preparation from the parasite. A large number of clones were 
randomly chosen and sequenced. A tBLASTn search of the databases was 
performed with the nucleotide sequences, whereby the cDNA sequence was 
converted into all 6 possible ORFs (3 forward and 3 reverse) and a BLAST search 
performed to find homologues. It was the result of this preliminary search which 
identified the clone as a possible cysteine synthase gene. In order to confirm the 
identity of the protein encoded by this gene it was decided first to verify the 
nucleotide sequence. If this confirmed that the gene possessed high homology to 
other cysteine synthasegenes, then it was to be cloned into a prokaryotic 
expression vector to produce recombinant protein in E. coli for subsequent 
purification and characterisation. The expression vector selected to produce 
recombinant enzyme was chosen to append a hexahistidine tag to the C-terminus 
of the mature protein. It was hoped that this method would be able to repeat the 
success in expression and affinity purification of recombinant T. vaginalis MGL. 
When deciding upon the position of the hexahistidine tag, the published structure 
of 0-acetyl serine sulfhydrylase (cysteine synthase) from S. typhimurium was 
examined., The model shows a disordered C-terminal end in the crystal structure 
(Burkhard et aL, 1998) implying that changes made to this end would have 
minimal effects upon the overall fold. In order to introduce the fewest changes 
into the cysteine synthase ORF and to position the hexahistidine tag at the C- 
terminus of the protein, the vector chosen was pET21 a+ (Novagen). This would 
then allow affinity purification of the recombinant enzyme in an analogous fashion 
to MGL using a metal chelate chromatography method (McKie et al., 1998). Basic 
biochemical characterisation of the enzyme could then be carried out and it would 
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be examined for "activated serine sulphydrylase" activity as previously identified 
in the parasite (Thong and Coombs, 1985b). 
There are commonly multiple isoforms of cysteine synthase present in micro- 
organisms and plants. These may be either cytosolic or targeted to specific 
organelles. However only a single clone was discovered in the several hundred 
clones from T. vaginalis sequenced. It was envisaged that using either antibodies 
raised against the recombinant protein or nucleic acid hybridising techniques, any 
additional gene copies or homologues would be identified. Also with these 
specific probes, the role of the enzyme in the parasite could be investigated. 
5.2 RESULTS 
5.2.1 Sequencing and Genomic Analysis of Cysteine Synthase 
5.2.1.1 Verification of the Putative Cysteine Synthase Gene 
Clone 215 was provided by Dr R Hirt (Natural History Museum, London) and the 
results of preliminary sequencing showed homology to cysteine synthase genes in 
the databases. A BLAST search of the databases showed high levels of 
homology to identified cysteine synthase genes and low homology to 
cystathionine ß-synthase and threonine deaminase, other members of the ß-family 
of PLP-dependent enzymes. To confirm the sequence'of the cDNA clone the 
plasmid insert was fully sequenced in both* sense and antisense directions using 
automated DNA sequencing. - Oligonucleotide primers designed against the 
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flanking plasmid sequence (M13 and T3) and internal gene specific primers 
(OASS2 and OASS3) were used as detailed in section 2.2.12. The sequence of 
the gene is given in figure 5.6. 
The sequence of clone 215 showed the presence of the poly-A tail from the 
reverse transcribed mRNA. This confirmed the 3' end of the ORF was complete. 
After fully sequencing the gene in both directions an ORF of 897 nucleotides was 
evident. Comparison of the amino acid sequence with other cysteine synthase 
enzymes showed that the predicted length of 299 residues was consistent with 
that generally found in other organisms. A TAA stop codon was confirmed by 
repeated sequencing of the clone and assumed to be correct. Upstream of the 
putative start codon were an additional 15 nucleotides. These bases, shown 
below, were then taken to be the 5' untranslated region (5'-UTR) of the mRNA: 
5' - CGAGTCGGCACGAGC - 3' 
This very short UTR is consistent with the findings with other genes isolated from 
T. vaginalis (Quon et al., 1994). However to properly identify the correct start 
codon and ensure a full length cDNA had been isolated, 5'-RACE was attempted. 
Experimental details are given in section 2.2.17. This was carried out in parallel 
to the production of an expression construct as specified in section 5.2.1.1. 
Attempts to isolate the 5'-UTR by 5'-RACE were unsuccessful though. 
Repeatedly, the final products of the reactions were a faint smear visible on an 
agarose gel. This corresponded to dsDNA products of various sizes up to 
approximately 1 kbp. An example of the results obtained is shown in figure 5.1. 
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kbp 0.85 0.5 0.1 
Bill II 111 i"'' P. B(I 
Cý _ Figure 5.1.5'-RACE products of cysteine synthase. Ethidium bromide stained 1% agarose gel showing the final DNA products. Lane A- DNA standards; Lanes B&C- Final PCR products of 
two separate reactions. DNA from 100 to 400 bp is partially obscured by the bromophenol blue 
dye present in the DNA loading buffer. 
From the design of the gene specific oligonucleotide primers (OASS 4 and OASS 
5), the expected size of the fragments produced was >_ 350 bp. Control reactions 
indicated that the conversion of mRNA to cDNA and poly-dC tailing were 
successful and that failure was therefore due to PCR amplification. 
5.2.1.2 Identification of the Copy Number of T. vaginalis Cysteine Synthase 
Gene 
Southern blot analysis of gDNA with the cysteine synthase ORF was performed to 
identify the copy number of the gene, to determine if any homologues are present 
within the parasite genome and also to confirm the presence of the gene and rule 
out contamination by other organisms in the original cDNA synthesis step. 
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As mentioned previously there are often multiple isoforms of cysteine synthase 
present in an organism. Often one isoform is specifically associated with an 
organelle such as chloroplasts or mitochondria, with the possibility of multiple 
isoforms in the cytosol. It was therefore of some interest to examine the 
possibility that this may be the case in the parasite. It was hoped that there would 
be sufficient homology between any isoforms to allow a probe synthesised against 
the known cysteine synthase gene to be used to investigate this. 
Initially restriction digests of T. vaginalis gDNA showed a number of distinct bands 
of various sizes when separated on an agarose gel. This was thought to be due 
to highly repetitive nucleotide sequences within the parasite genome (Wang and 
Wang, 1985). This banding had also been seen in the analysis of mgl (McKie, 
1997). However by performing a second proteinase K treatment of the gDNA with 
the intention of removing bound proteins (for method see 2.2.4), subsequent 
digests produced a heterogeneous smear of DNA when separated on an agarose 
gel. This does not exclude the presence of highly repetitive sequences but 
suggests that incomplete digestion of the gDNA may have been at least partly 
responsible for the bands visible previously. When isolating gDNA, it was 
collected by spooling out the precipitated DNA with a pasteur pipette tip rather 
than by centrifugation. This reduced the amount of small fragments of sheared 
gDNA recovered which could potentially lead to spurious results. 
Thus complete digests of 10 µg of gDNA were resolved by 0.7% agarose gel 
electrophoresis and transferred to Hybond N filters (Amersham) using the 
supplied protocol adapted from the method of Southern (1975). The transferred 
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DNA was UV cross-linked before the filters were used for hybridisation with 
radioactively labelled probes. The probe was synthesised and radioactively 
labelled by a random primer method using the Prime ItTm kit (Stratagene) 
incorporating 50 . tCi 32P-dATP using a partial ORF of EST215 as the probe. This 
fragment was produced by performing an Xhol digest on the plasmid and gel 
purifying the resulting 900 bp fragment to be used. Only 20 bp of the gene 
sequence is omitted in this template and should not reduce the specificity of the 
probe. Hybridisation of the probe and subsequent washing of the filters was 
performed under high stringency conditions of 0.1 x SSC with 0.1% SDS at 65 °C. 
Figure 5.2 illustrates the result of Southern blot analysis of T. vaginalis gDNA 








ift no 5.0 
Figure 5.2: Southern blot of T. vaginalis genomic DNA hybridised with the 900 bp cysteine 
synthase specific probe. Lane A- Hind III digest; B- EcoRV digest; C- EcoRl digest; D- Clal 
digest; E- DNA standards. Film was exposed for 72 hours at -70 °C. 
Multiple bands are visible for each digest with a single band in each lane 
producing a stronger signal compared with the others. The digest by Hindill 
produces a strong signal corresponding to -700 bp which would be obtained if the 
cDNA sequence was digested with the same enzyme. To identify if any of the 
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bands were non-specific or had arisen through incomplete digest of gDNA, the 
work was repeated. The result was identical banding as seen in the figure above. 
5.2.1.3 Sequence Analysis 
In order to identify the cDNA clone isolated from the parasite, the translated 
amino acid sequence was examined more closely for homology to other 
sequences in the database. The results of blast searches consistently indicated 
that the sequence was indeed a cysteine synthase. When aligned against a 
number of these the homology was clear (Figure 5.3). Table 5.1 gives the 
sequence identities and similarities of selected cysteine synthases to the T. 
vaginalis enzyme. 
Organism Identities (%) Similarities (%) 
Aquifex aoelicus 49 67 
E. histolytica Type I 47 65 
S. typhimurium Type B 45 64 
Capsicum annuum 43 62 
Spinicia oleracea 42 60 
S. typhimurium Type A 42 57 
Table 5.1: Sequence homologies of selected cysteine synthase enzymes with putative T. vaginalis 
cysteine synthase. 
179 
1 10 20 30 40 50 60 70 80 
--------------- -+-------- +------ --+---------+---------+ý_ýý--+-------- 
T. vaginalis MIYDNILEIIGNII'IVRINHLIPNP----KVQMYRVLIGFHI'TGSVKDRIRLKMIEl1IIERE 
R. aeolicus MSLKSCLMUVLGEHDEPYRKRRETILKLVGNII'IVRVKKCLPED-IPEDVEIIIHKLFSFHPGGSVKDRPRLSMFLIIHLKR 
E. coli_B MSTLEQTIGNIPIVKLQRMGPDN---- GSEVIILKLFGNNPRGSVKDRRRLSMIVIIIEKR 
S. typhinuriun_B MNTLEQTIGNII'I VKLQRLGPDN---- GSEIIIVKLI GNNI'RG 5VKDRRRLSMIVI IIEKR 
E. Coli_R SKIFEDNSLTIGHII'IVRLNRIGNG-------RILHfVISRNI'SFSVKCRIGRNMINDHEKR 
S. typhinuriun_R SKIYEDNSLTIGHII I VRLNRIGNG------RILHkVI SRNI'SP; VKCNIGRNMIUI IIFKR 
Z. nays_R MGERSPSIRKDVTELIGNII'IVYLNKVTDGCV----GRSRHKIISMIPCSSVIDxIGYSMITUHEEK 
S. oleracea_R MVEEKRFIRKDVTELIGKIPI VYLNTVRDGCV----RRVRHKI I Gill I'CS '. lIJPIGFSMITIIII[KS 
E. histolytica MEQISISSPRKRIYHNILETIGGTPIVELHGVTEHPRIKKGTRILVKLIYFNI'MSSVKURVGFNIVYl1HIKD 
E. dispar MEQISINSPRKRIYHNILETIGGTPFVELHRVTEHPTIKKGTRILVKLIYFNF'MSSVKURVGFNIVYUHIKN 
Consensus .................... i... il. t! GnTPLV. 1.... p......... i. aKII. f#P. LSVKdR. alsni. #Rekr 
81 90 100 110 120 130 140 150 160 




H. aeolicus GLIKEG-KVVIDRTSGNTGIRIRMVGRRLGVPVELRMPHNVtiEIRKKIIKHFGHKLYIIDPLEITDGHILFVRFLVQKYP 
E. coli_B GEIKPG-DVLIEHTSGNTGIRLRMIRRLKGYRMKLLFiPDNm, QlPRRRMRHYGRELIIVTKEQI; MEGHRDLRLFMRNRGE 
S. typhinuriun_B GEIKPG-DVLIERTSGNTGIRLRHIRRLKGYRNKLLFIPDNMSQI F'RRRMRIIY!; IIELII VTKEQ(, E! IIIRDLRLRMSERGE 
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S. typhinuriun_R GVLKPGVE-LVEPTNGNTGIRLRYVRRRR(iYKLTLTMPETW IIRRKLLKnL!. HNLVITEGRK HK lQKREIIVRSDP 
Z. nays_R GLITPGVSVLIEPTSGNTGIGLRFIIRRRK6YKLTLTMPRSMSMIPRIILKIIII; IIELVIIDPLL IiK iVKKREIIQRKTP 
S. oleracea_R GLITPGESVLIEPTSGNTGIGIRFIRRRKGYKLIITMPRSMSLIKRTILRIIFGHELIIIDPRK IK. j+YQKREIIRDKTP 
E. histolytica GRLKPGME-IIESTSGNTGIHICQRGRVFGYRVNIRIPSTMSVII? QMIMKRFGRELIIIEGKKi'11Pi, li1EEVNKMIKENP 
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R. aeolicus EKYYYLDQYNHPRHUKHIIFYSTGIEIIINQTKGRITHFVRGIGIGGIIMITGRRLKIYHPNIQV! --GVQPRYPF------ 
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E. dispar -----PKGPHGIQGIGHGFIPDIYKKEFVDEIIPIKTQIHNKHRRIVVKYIGIHCGHSSGflHILRGLKERGK--SENEGK 
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Figure 5.3: Alignment of cysteine synthase amino acid sequences. Produced using MULTALIN. 
Residues printed in red are >90% conserved and those in blue are >50% conserved. Sequences 
are: T. vaginalis - putative T. vaginalis enzyme; A. aeolicus - type B enzyme from Aquifex aeolicus; 
E. coli_B - type B from E. coli; S. typhimurium_B - type B from S. typhimurium; E. coli A- type A from 
E. coli; S. typhimurium A- type A from S. typhimurium; Z. mays_A - cytosolic type from Zea mays 
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(maize); S. oleracea_A - cytosolic type from S. oleracea (spinach); E. histolytica - type 1 from E. 
histolytica; E, dispar - type 1 from Entamoeba dispar. 
The high degree of similarity and identity between the sequences is evident from 
the figure, despite the diversity of the organisms. The large number of identities 
would prevent the prediction of essential or important residues by sequence 
analysis alone. However the crystal structure of the type A enzyme from S. 
typhimurium is available for us to study (Burkhard et al., 1998). As with all PLP- 
dependent enzymes, the cofactor is bound to the enzyme through the side chain 
amine group of a lysine residue. This is Lys4l in S. typhimurium and is 
unsurprisingly 100% conserved. Also 100% conserved are a number of residues 
involved in cofactor binding: Asn7l, Thr177, Thrl80 and Ser272 (S. typhimurium 
numbering). Although no substrate or inhibitor complex structures were produced 
the authors postulated a model for O-acetyl-L-serine binding. Of the residues 
predicted to interact with the substrate during the first part of the reaction five are 
conserved amongst cysteine synthase enzymes: Thr68, Thr72, Gin 142, Phe143 
and His152 (S. typhimurium numbering). This limited comparison with the 
structure would indicate that the same functional groups are present in the active 
site of the T. vaginalis enzyme. 
In order to further analyse the sequence of the cysteine synthase from T. 
vaginalis, it was decided to produce a graphic comparison of a large number of 
cysteine synthase sequences. It was hoped that the results of this would provide 
more information on the relative relationships between enzymes. Such 
information may be helpful in postulating an evolutionary lineage for the enzyme, 
or more likely and helpful in this case, identify functional homology. A number of 
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cysteine synthase sequences were first obtained from the databases. The 
programme MULTALIN was then used first to produce a sequence alignment and 
then a plot of the relative similarities (Figure 5.4). 
The plot produced by this alignment programme is a display of the "hierarchical 
clustering" used to produce the final alignment (Corpet, 1988). The programme 
uses this technique to produce accurate pairwise alignments of multiple 
sequences which cannot be achieved directly. Thus the plot gives an accurate 
representation of the similarities between sequences but there is no consideration 
given to the codon changes necessary for a specific residue change. Therefore 
the final product does not represent a phylogenetic analysis of the T. vaginalis 
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Figure 5.4: Hierarchical clustering of cysteine synthase amino acid sequences. Figure plotted 
using MULTALIN. Cys K- plant cytosolic or type A, Cys L- plant organelle localised, Cys M- type 
B (cytosolic). Enzyme nomenclature is taken from database submissions. The position of the T. 
vaginalis sequence is highlighted in bold text. All plant sequences are shown in red. 
The simple analysis of a reasonable, but not exhaustive, sample of cysteine 
synthase enzymes from a number of organisms shows that despite the obvious 
sequence homology overall, the trichomonad enzyme does differ significantly from 
183 
most other eukaryotic and prokaryotic examples. Figure 5.4 shows the clear 
subdivision of plant sequences from all others. Bacterial sequences are more 
obviously divisible into subspecies, type A and B. The sequences from both 
Entamoeba species are distinguishable from each other. However the two 
enzymes from both species do not differ significantly and so are not separated in 
the figure. The T. vaginalis sequence shows the least divergence from a type B 
enzyme from A. aeolicus, a hyperthermophilic bacteria (Deckert et al, 1998). It 
also seems to be more similar to type B rather than type A enzymes from E. coli 
and S. typhimurium among others. This is an interesting observation as the type 
B bacterial enzymes are proposed to be preferentially expressed under anaerobic 
conditions in these organisms. 
5.2.1.4 Cysteine Synthase Subcloning into a Prokaryotic Expression Vector 
To confirm that the enzyme encoded by the nucleotide sequence was a functional 
cysteine synthase enzyme, it was decided to clone the gene into a plasmid vector 
for expression in E. coli. Due to the low homology seen at the N-terminus of 
cysteine synthase sequences, it was not possible to align sequences sufficiently 
to be sure that the correct start codon was being used. However whilst 5'-RACE 
experiments were being conducted to confirm this, it was decided to continue with 
production of an expression construct. 
A PCR based strategy was adopted to facilitate rapid and easy cloning of the 
gene into the pET21 a+ expression vector. This involved adding appropriate 
restriction sites to the 5' and 3' end of the cysteine synthase ORF via specific 
oligonucleotide primers. After subcloning of this PCR product into a plasmid 
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vector, the ORF could then be excised by restriction endonuclease digest and the 
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Figure 5.5: Construction of recombinant cysteine synthase expression vector. I- PCR amplification 
of cDNA clone EST 215; II - Ligation of PCR product into plasmid vector pGEM-T and construction of 
plasmid CSpG; III - NdelISall double digest of plasmid CSpG to excise cysteine synthase ORF; IV - 
Ligation of fragment into pET21 a+ vector predigested with Ndel and Xhol to produce expression 
plasmid CSpET; V- Transform plasmid CSpET into E. coli BL21 DE3 for recombinant enzyme 
expression. Primers used and restriction sites are indicated. Z represents the chimeric SaNXhol 
restriction site, the location of the hexahistidine tag is marked in blue. 
The supplied EST clone 215 was used as the template for PCR with Taq DNA 
polymerase using the oligonucleotide primers OASS1 and OASS7 as listed in 
section 2.2.12. Non-proof-reading polymerases such as Taq add an adenine 
base at the Vend of the DNA product. The use of a T-tailed cloning vector 
makes the ligation of these PCR products easier because of a 5' complementary 
thymine overhang. However there is a higher likelihood of incorporating errors 
into the amplified fragment using Taq compared with thermostable polymerases 
which have a proof-reading ability. Therefore replicates were performed to 
ensure a copy without mutations incorporated was synthesised. 
Four separate reactions were carried out and each was ligated into pGEM-T 
(Promega). Positive clones were selected after transformation into commercially 
supplied chemical competent XL1-Blue cells (Stratagene) by blue-white selection 
with X-GAL. Selected positives were confirmed by MOW double restriction 
digest and automated DNA sequencing. The cloned PCR fragment was excised 
from purified plasmid by digestion with Ndel and Sall restriction enzymes and 
separated on a1% agarose gel prior to gel extraction. This fragment was then 
ligated into Ndel/Xhol restricted pET2la+, to produce plasmid CSpET, 
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transformed into E. co/iXLI-Blue cells and antibiotic resistant positive clones 
selected for by growing on LBAmp plates. 
The Ndel site at the 5' end regenerates the ATG start codon and, unlike the Ncol 
used in the cloning of mg11, does not enforce any changes in the ORF (McKie et 
al., 1998). A Safi site was used at the 3' end of the gene to provide a compatible 
overhang to the linearised plasmid. This site was chosen in preference to an Xhol 
site because of an internal Xhol site 20 bp downstream of the start codon. The 
two restriction enzymes have different recognition sites but cleavage results in 
complementary overhangs. Had an Xhol site been used it would have required a 
partial Ndel/Xhol double digest to excise only the 899 bp fragment. There would 
have been difficulty in distinguishing between this and the smaller 879 bp 
fragment resulting from cleavage at the internal Xhol site. Ligating together these 
ends results in the loss of both the Sall and Xhol sites but this was not deemed to 
be detrimental. 
Thus the predicted expressed recombinant protein would possess two residues 
encoded by the chimeric SaMChol restriction site (aspartic acid and glutamic acid) 
and six histidine residues at the C-terminus in addition to the original sequence. 
Positive clones were sequenced to confirm no nucleotide errors had been 
incorporated during the cloning process before transformation of the plasmid into 
E. coil strain BL21 DE3(Novagen) for expression. The complete nucleotide and 
predicted amino acid sequence of the cysteine synthase gene is shown in figure 
5.6. The location of the restriction sites added in generation of the expression 
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construct are indicated. Amino acid differences between the original sequence 
and the final expression construct are shown in bold text. 
NdeI Xhol 
MIYDNILETIGNTPLV 
1 CATATGATCT ACGACAACAT CCTCGAGACA ATCGGTAACA CACCACTCGT 
GTATACTAGA TGCTGTTGTA GGAGCTCTGT TAGCCATTGT GTGGTGAGCA 
Hindill 
RINHLIPNPKVQMYAK 
51 TCGCATCAAT CATCTCATCC CAAATCCAAA GGTCCAGATG TACGCCAAGC 
AGCGTAGTTA GTAGAGTAGG GTTTAGGTTT CCAGGTCTAC ATGCGGTTCG 
HindIII 
LEGFNPTGSVKDRIALK 
101 TTGAAGGTTT CAACCCAACA GGTTCCGTCA AGGATCGTAT CGCTCTTAAG 
AACTTCCAAA GTTGGGTTGT CCAAGGCAGT TCCTAGCATA GCGAGAATTC 
MIEQAEAEGKLHPGSTI 
151 ATGATTGAGC AGGCAGAAGC CGAAGGCAAG CTCCATCCAG GATCAACAAT 
TACTAACTCG TCCGTCTTCG GCTTCCGTTC GAGGTAGGTC CTAGTTGTTA 
IEATSGNTGIGLAMIG 
201 CATCGAGGCT ACATCCGGAA ACACAGGTAT CGGCCTTGCT ATGATTGGCC 
GTAGCTCCGA TGTAGGCCTT TGTGTCCATA GCCGGAACGA TACTAACCGG 
RVKGYNVIIVMSEGVSI 
251 GTGTCAAGGG CTACAACGTC ATCATCGTTA TGAGTGAGGG CGTTTCAATC 
CACAGTTCCC GATGTTGCAG TAGTAGCAAT ACTCACTCCC GCAAAGTTAG 
ERRKMIKAFGAEIILTD 
301 GAACGCCGTA AGATGATCAA GGCCTTCGGT GCTGAAATCA TCCTTACAGA 
CTTGCGGCAT TCTACTAGTT CCGGAAGCCA CGACTTTAGT AGGAATGTCT 
KKLGTDGAIRKVAELV 
351 CAAGAAGCTC GGCACAGATG GCGCCATCCG TAAGGTTGCT GAACTCGTTA 








AGGCAAGTAC TTCAACCCTA ACCAGTTCTC TAACGAATAC 
TCCGTTCATG AAGTTGGGAT TGGTCAAGAG ATTGCTTATG 
AHYKTTAEEIWAQT 
CCCACTACAA GACAACAGCA GAAGAAATCT GGGCCCAGAC 
GGGTGATGTT CTGTTGTCGT CTTCTTTAGA CCCGGGTCTG 
KGTVTHFVAAVGTSGT 
501 AAAGGGAACA GTTACCCACT TCGTTGCTGC TGTCGGCACA TCCGGCACAC 
TTTCCCTTGT CAATGGGTGA AGCAACGACG ACAGCCGTGT AGGCCGTGTG 
LMGVGKNLREKNPEIKI 
551 TCATGGGTGT TGGCAAGAAC CTTCGTGAGA AGAACCCAGA AATCAAGATC 
AGTACCCACA ACCGTTCTTG GAAGCACTCT TCTTGGGTCT TTAGTTCTAG 
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IEAQPTKGHYIQGLKSM 
601 ATTGAAGCTC AGCCAACAAA GGGCCACTAT ATCCAGGGCT TGAAGTCCAT 
TAACTTCGAG TCGGTTGTTT CCCGGTGATA TAGGTCCCGA ACTTCAGGTA 
EEAIVPAIYQADKIDE 
651 GGAAGAAGCT ATTGTCCCAG CTATTTACCA GGCTGACAAG ATTGATGAGC 
CCTTCTTCGA TAACAGGGTC GATAAATGGT CCGACTGTTC TAACTACTCG 
HILIESEEAFAKAREIV 
701 ACATCCTCAT CGAGTCTGAA GAGGCATTCG CCAAGGCACG TGAAATCGTT 
TGTAGGAGTA GCTCAGACTT CTCCGTAAGC GGTTCCGTGC ACTTTAGCAA 
AQEGIFIGMSSGAAMLA 
751 GCTCAGGAAG GCATCTTCAT CGGCATGAGC TCTGGCGCTG CTATGCTCGC 
CGAGTCCTTC CGTAGAAGTA GCCGTACTCG AGACCGCGAC GATACGAGCG 
HindIII 
AQKLAEKIDSGVIVVL 
801 TGCTCAGAAG CTTGCTGAGA AGATTGACAG CGGTGTCATT GTTGTTCTCT 
ACGAGTCTTC GAACGACTCT TCTAACTGTC GCCACAGTAA CAACAAGAGA 
FADRGEKYLSTKLFDTE 
851 TCGCTGATCG CGGTGAGAAA TACCTTTCAA CAAAGCTCTT CGACACAGAA 
AGCGACTAGC GCCACTCTTT ATGGAAAGTT GTTTCGAGAA GCTGTGTCTT 
VEHHHHHH* 
901 GTCGAGCACC ACCACCACCA CCACTGA 
CAGCTCGTGG TGGTGGTGGT GGTGACT 
Figure 5.6: Nucleotide and single letter amino acid code sequence of plasmid CSpET. Changes 
introduced in cloning are shown in bold teed. 
5.2.2 Expression and Purification of Recombinant Cysteine Synthase 
5.2.2.1 Test Induction and Expression of Recombinant Cysteine Synthase 
Small scale test expressions of recombinant enzyme produced in E. coli were 
carried out before proceeding on to larger scale preparations. Single colonies of 
E. coli containing plasmid CSpET were obtained by streaking out cells onto 
ampicillin-containing LB agar plates and growing overnight at 37 T. An overnight 
culture was produced by inoculating 10 ml LB with a single colony and growing 
overnight at 37 °C with shaking. 5 ml of this was added to 50 ml LBAMP and grown 
at 37 OC with shaking until the OD6w reached 0.6-0.8. Recombinant enzyme 
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expression was induced by the addition of 0.2,0.5,1.0 and 2.0 mM IPTG. 5 ml 
samples were taken at hourly intervals from 0 to 4 hours post induction, harvested 
by centrifugation at 3200 g for 15 minutes and stored at -20 °C. Cells were lysed 
as detailed in section 2.3.7. The resulting supernatant was analysed under 













Figure 5.7: Coomassie blue stained SDS-PAGE of E. coli soluble proteins from test inductions of 
recombinant cysteine synthase expression. Image I-0.5 mM IPTG, II - 2.0 mM IPTG. Lanes A- 
protein standards, B-0 hours induction, C-1 hour post-induction, D-2 hours post-induction, E-3 
hours post-induction, F-4 hours post-induction. 
A prominent band of between 30 and 35 kDa was clearly visible in the non- 
precipitated portion of the bacterial lysate after induction. This situation was 
highly similar with all concentrations of IPTG (data not shown for 0.2 and 1.0 mM 
IPTG). There was no apparent increase in recombinant protein production after 3 
hours of induction. The insoluble fraction of the E. coli lysate was not examined 
for recombinant protein due to the high levels of soluble protein evident. 
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The results of these experiments confirmed high level expression of a soluble 
protein of the expected size and provided a set of standard conditions to enable 
purification of the recombinant enzyme. 
5.2.2.2 Routine Expression and Purification of Recombinant Cysteine 
Synthase 
Following the conditions found above, a single E. coli colony containing plasmid 
CSpET was used to inoculate 50 ml LBAmp to provide a starter culture. This was 
grown overnight at 37 °C with shaking and added the next day to 500 ml LBAMP 
and again grown at 37 °C with shaking until reaching an ODD of 0.6-0.8. The 
production of recombinant enzyme was induced by the addition of 0.5 mM IPTG. 
The culture was grown for a further 3 hours before harvesting by centrifugation at 
4000 g at which point the cells were stored at -20 °C until required. The . cell pellet 
was resuspended in -5 ml 50 mM sodium phosphate pH 8.0 with 20 µM PLP and 
lysed by sonication at maximum amplitude with a Soniprep 1000.10 rounds of 
sonication were performed to adequately lyse the cells. Each round was of 10,1 
second pulses with a1 second pause between each pulse and a1 minute pause 
between each round. The cytosolic fraction containing soluble enzyme was 
separated from intact cells and insoluble debris by centrifugation at 10 000. g for 
30 minutes at 4 °C before clarification through a 0.22 µm syringe filter. The 
soluble crude lysate preparation was then loaded onto a pre-equilibrated Ni-NTA 
column and purified in an identical manner to that used for rMGL as detailed 
already in this thesis in section 3.2.1. The purification profile output is shown in 
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figure 5.8. Figure 5.9 shows the results of a routine preparation with samples of 
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Figure 5.8: FPLC profile of recombinant cysteine synthase. The blue line represents the 
absorbance at a wavelength of 280 nm of the column eluate (limit of absorbance is 2.0 AU). The 









Figure 5.9: Coomassie blue stained 10 % SDS-PAGE of a standard purification of recombinant 
cysteine synthase. Lane A- 10 kDa ladder, B-E. coli supernatant, C- column flow through, D- 
first wash, E- 75 mM imidazole wash, F to L- successive 1 ml fractions from linear imidazole 
gradient. 
The flow through collected when loading the column shows the great reduction in 
the prominent band at -35 kDa when compared with the E. coli supernatant. The 
first wash step and the 75 mM imidazole wash step removed a large number of E. 
coli contaminating proteins. Although not easily seen in figure 5.9 this was most 
evident in figure 5.8 where it was shown as a sharp peak, partially obscured by 
the background absorbance of the imidazole containing buffer. Subsequent 
elution at apparent imidazole concentrations of between 90 and 130 mM 
produced a single major band which ran as an -35 kDa protein in direct 
agreement with the predicted mass of the enzyme. Sample homogeneity was 
routinely checked by SDS-PAGE stained with Coomassie blue. The purest 
fractions were pooled and dialysed at 4 °C overnight, at a concentration of 
1 mg/ml, into 100 mM sodium phosphate pH 7.5 with 300 mM NaCl. It has been 
noted for MGL that the presence of imidazole in the storage buffer has a 
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away. The action of imidazole as a chaotrophe is probably responsible for this 
and therefore the decision was taken to remove this after purification of cysteine 
synthase prior to storage. 
This method of purification has been shown to be simple and highly effective in 
the preparation of recombinant MGLI. Approximately 10 mg of highly pure 
recombinant cysteine synthase was produced from a 500 ml culture. The cloning 
strategy used resulted in a recombinant protein with a small C-terminal extension 
which, unlike other larger constructs, is unlikely to interfere with the enzyme's 
activity and so should not need to be removed. 
5.2.3 In vitro Assay of Recombinant Cysteine Synthase 
Enzyme was assayed using the method detailed in section 2.3.8. The following 
sections describe the processes involved in finding the optimal conditions and the 
results of investigations into the kinetics. 
5.2.3.1 Optimisation of Buffer and pH 
The initial step in the optimisation of the cysteine synthase assay was to 
determine the buffer and pH preferences. The enzyme mechanism dictates the 
pH optimum but it is evident by the preferences for certain buffers in in vitro 
assays that the buffer molecule itself can have an effect. Thus the rate of the 
reaction was first checked using fixed levels of substrates while varying the pH 
between 5.5 and 9.5 with a variety of buffers. The pH optimum was apparently 
between 7.0 and 8.5 but it was also possible that the buffer itself played an 
important role (Figure 5.10). 
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between 7.0 and 8.5 but it was also possible that the buffer itself played an 













Figure 5.10: Apparent cysteine synthase activities at different pH. Buffer concentrations were 100 
mM in all cases. Activities are given as nmoles of cysteine produced per reaction using identical 
amounts of enzyme for each assay. Activities are mean values, error bars are S. D. with n=3. 
The apparent pH optimum in these experiments seemed to be around 8.5 with 
little activity below pH 7.0 or above 8.5. It was considered however that the 
buffers may affect the activity. Thus activities were assayed again using HEPES, 
IRIS and sodium phosphate buffers. The results showed that enzyme activity at 
equivalent pH was apparently lowest in HEPES with the highest activity measured 
in sodium phosphate (data not shown). This was then selected as the buffer of 
choice for the in vitro assay and a closer examination of the activity over a pH 
r undertaken. The results of these experiments showed an optimum pH with 
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strength of the buffer was performed. In common with many other assays it was 
expected that 100 mM would provide sufficient buffering capacity and not interfere 
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Figure 5.11: Cysteine synthase activities in sodium phosphate buffer at varying pH. Relative 
activities are given between samples with identical amounts of enzyme and substrate used in each 
assay. Activities are mean values, error bars are S. D. with n=3. 
5.2.3.2 The Use of Thiols in Assaying Cysteine Synthase 
Reducing agents are often added when assaying cysteine synthase in vitro with 
no explanation for their role (for example Warrilow and Hawkesford, 1998). DTT 
or ß-mercaptoethanol are commonly used at concentrations up to 10 mM. 
However these compounds are also omitted from other published protocols (for 
example Masada et al., 1975). These compounds may have a number of effects, 
e. g. involvement in the mechanism directly, stabilisation of the enzyme in some 
way or interaction with substrate or product. In the investigation it was decided to 
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such as a ß-replacement with the thiol and OAS. This concern arises as both 
cysteine synthase and 0-acyl homoserine suiphydrase enzymes have been 
shown to utilise other thiols in vitro such as methanethiol. Experiments were 
conducted with a variety of concentrations of DTT and it was found that initial 
results varied between replicates. It was apparent though that the presence of 
DTT did give an increase in the level of cysteine produced. Both substrates in the 
assay (Na2S and O-acetyl-L-serine) were freshly prepared for each experiment 
and DTT was stored at -20 °C in single use aliquots. Thus the variability in 
results was unexplained simply by reagents deteriorating. 
The role of a reducing agent is likely to be important to both the substrate and 
products of the enzyme reaction. Na2S, the sulphur donor in the formation of 
cysteine, is readily oxidised and cysteine produced may dimerise to form cystine 
under the influence of oxygen in solution. It is assumed that DTT would be able 
to counteract both of these reactions. However the use of DTT in the assays still 
did not prevent considerable variation in the results. To further counteract the 
possible oxidation effects upon substrate and product, the buffer and water used 
in the assays was deoxygenated by "bubbling" with nitrogen gas for 15 minutes 
prior to use. This improved the assay greatly and gave much more repeatable 
















Figure 5.12: Effect of DTT on in vitro cysteine synthase activity. Activites are given as 
absorbance at 560 nm with identical levels of substrates and enzyme. Absorbance values are 
mean values, error bars are S. D. with n=3. 
This experiment appeared to show that a concentration of 1 mM DTT was 
saturating for whatever its function was. The addition of higher concentrations 
seemed to have little further effect. There were no attempts at titrating the amount 
of DTT below 1 mM. At this point the standardised conditions were chosen for 
routine use to investigate the activity of the cysteine synthase. 
5.2.3.3 "Activated Serine Sulphydrase" Activity 
T. vaginalis has been shown to possess what has been termed "activated serine 
sulphydrase" activity due to its similarity to serine suiphydrase activity but 
denoting the substantial increase seen when ß-mercaptoethanol (n-me) is added. 
The reaction produces H2S from L-cysteine in the presence of ß-me, however the 
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other products of the reaction were not examined. There are several possible 
mechanisms occurring: an aß-elimination reaction analogous to that carried out 
by MGL, a NifS-like cysteine desulphurase, or a ß-replacement reaction as used 
in the synthesis of cysteine. T. vaginalis does apparently possess two NifS 
homologues (J Tachezy, personal communication) but it is not possible to say at 
this time whether these are partly or wholly responsible for the "activated serine 
sulphydrase" activity seen. MGL does not exhibit an increase in activity toward 
cysteine in the presence of ß-me (McKie, 1997). Neither is "activated serine 
sulphydrase" activity abolished by propargylglycine, a suicide inhibitor of MGL. 
This was investigated by substrate native PAGE as previously published (Thong 
and Coombs, 1987) and the results indicated that MGL is not responsible for the 
activity. Using the published method (see section 2.3.10), purified recombinant 
cysteine synthase exhibited no detectable cysteine desulphurase activity. 
However, in the presence of ß-me, H2S was produced at significant levels. A very 
brief investigation also confirmed the data from substrate native PAGE, the results 
are summarised in Table 5.2. 
Specific activity 24.5 µmol/min/mg protein 
Km (estimated) 12 mM 
Vmax (estimated) 32 µmol/min/mg protein 
Inhibition by DL-propargylglycine Non-suicide/competitive 
Inhibition by DL-allylglycine Non-suicide/competitive 
Table 5.2: "Activated serine suiphydrase" activity of recombinant cysteine synthase. Km and Vmax 
values were estimated from a limited number of datasets. 
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5.2.4 Analysis of Recombinant Cysteine Synthase Activity 
Cysteine synthase from various sources has been investigated in great detail and 
the mechanism of action well characterised (for review see Tai and Cook, 2000). 
It was planned to examine the inhibitor profile and substrate preferences of the 
enzyme. The inhibitory profile was particularly interesting because of any 
differences that may exist between this and MGL. However, insufficient time was 
remaining in the project for a thorough characterisation of the recombinant 
cysteine synthase. The work carried out is detailed below. 
5.2.4.1 Calculation of Km and Vmax for Cysteine Synthase Substrates 
The primary substrates for cysteine synthase as mentioned are O-acetyl-L-serine 
(OAS) and a sulphur source. The in vivo sulphur group is likely to be hydrogen 
sulphide (H2S) and the in vitro assay utilises commercially available sodium 
sulphide (Na2S). Thus kinetic parameters were calculated for both compounds. 
When setting out to calculate the kinetic parameters for the enzyme, preliminary 
experiments were performed to estimate the likely Km values for both substrates. 
This then allowed the design of experiments which would obtain all the data 
necessary to calculate values with a good degree of accuracy. These preliminary 
experiments carried out in parallel with optimisation of the assay conditions 
showed a likely Km of -6 mM for OAS and -1-2 mM for Na2S. From these 
estimated values, assays were carried out for OAS and Na2S which gave the 
results shown in figures 5.13 and 5.14, respectively. For the determination of 
OAS saturation, Na2S was maintained at a concentration of 5 mM and for Na2S 












Figure 5.13: O-acetyl-L-serine saturation curve of recombinant cysteine synthase. Data points 













Figure 5.14: Na2S saturation curve of recombinant cysteine synthase. Data points are mean 
values, error bars are S. D. with n=3. 
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Both results above show the hyperbolic curves commensurate with Michaelis- 
Menten kinetics. For both substrates it was intended to assay the enzyme in 
triplicate with a range of concentrations from 0.25 to 10 times the Km value. This 
should allow an accurate calculation of Km and Vmax values. The calculations of 
the Km and Vmax were performed using a Hanes plot as shown below in figures 
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Figure 5.15: Hanes plot of OAS for recombinant cysteine synthase. 
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Figure 5.16: Hanes plot of Na2S for recombinant cysteine synthase. 
Thus after optimisation of the assay and investigation of the enzyme's kinetics the 
following results were calculated: 
Specific Activity 42.7 ± 3.6 µmol/min/mg 
O-Acetyl-L-Serine Km 6.9 mM 
Vmax 61 µmol/min/mg protein 
Na2S Km 2.8 mM 
Vmax 33 µmol/min/mg protein 
Table 5.3: Kinetic parameters calculated for in vitro assays of recombinant cysteine synthase. 
Specific activity is given ± S. D. with n=11. 
The enzyme was also assayed to determine if the production of cysteine using L- 
serine as the carbon backbone donor was possible. Assays were performed as 
detailed in section 2.3.9 with the substitution of L-serine for O-acetyl-L-serine. 
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Concentrations of Na2S between 0.5 and 5 mM and L-serine between I and 20 
mM respectively were examined for the production of L-cysteine with 25 µg of 
purified enzyme. The production of cysteine could not be detected with any of 
these conditions. No other O-acyl-L-serine derivatives were commercially 
available to test as carbon donors. 
Recombinant enzyme was also assayed for inhibition by mechanism based PLP- 
dependent enzyme inhibitors allyiglycine and propargylglycine. Both act as 
suicide inhibitors, irreversibly inactivating some enzymes. Assays were carried 
out as detailed in section 2.3.9 with varying concentrations of inhibitors. The 
results of the experiments are given in table 5.4. 




0mM 20.1±1.4 21.0±1.1 
1.0 mm 18.6 ± 0.46 (7.5) 20.7 ± 0.36 (1.5) 
5.0 mM 15.6 ± 0.98 (22) 17.5 ± 0.26 (17) 
10.0 mm 12.9 ± 0.67 (36) 13.9 ± 0.25 (34) 
25.0 mM 9.8 ± 0.9 (51) 11.2±0.49(47) 
Table 5.4: Inhibition of cysteine synthase by allyiglycine and propargyglycine. Rates are given ± S. D. 
with n=3. Numbers gin in parenthesis are percentage activity remaining. 
Neither inhibitor displayed total inactivation of the enzyme even at concentrations 
of 25 mM. Assuming the ratio of D to L forms of compounds is 1: 1, there was still 
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12.5 µmoles of inhibitor present. The amount of enzyme used was approximately 
20 nmoles of monomer per assay. This gives more than sufficient inhibitor for 
total inactivation. 
5.2.5 Stabilisation Studies of Recombinant Cysteine Synthase 
A recovery of around 20 mg of pure recombinant enzyme per litre of starter culture 
was easily obtainable. To ensure the enzyme used for these studies was in 
optimal condition, it was necessary to find suitable short and long term storage 
conditions. Following standard principles, a number of different conditions were 
investigated. It was clearly impossible to examine every possible condition when 
one considers the number of variables involves and therefore it was important to 
make some initial estimates of the most favourable storage conditions. 
5.2.5.1 Temperature Stability 
The conditions chosen reflected general principles of the best methods to store 
enzymes, published data on other cysteine synthase enzymes and also 
information gained from the previous work on MGL. Analysis began with 
temperature stability and then extended to buffer composition and additives. The 
enzyme was examined for retention of activity when stored at 4 °C, -20 °C and -70 
°C with and without glycerol in identical buffer conditions. The results of this 
initial analysis are shown in table 5.5. 
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Time (Days) 
1 3 7 14 21 28 
4 °C 100 108 102 85.6 84.4 79.6 
4 °C, 40% glycerol 110 128 135 133 104 88.2 
-20 °C 19.1 51.7 53.6 27.3 18.4 15.2 
-20 °C, 40% glycerol 93.2 119 115 108 112 107 
-70 °C 90.0 96.3 113 97.4 91.1 74.2 
-70 °C, 40% glycerol 79.3 115 122 114 84.3 87.6 
Table 5.5: Cysteine synthase activities recorded over time after storage under different conditions. 
Data given are means from 2 experiments. Relative activities are given with results of storage at 4 °C 
for 1 day arbitrarily chosen as 100%. 
Subsequent to purification, enzyme was dialysed overnight at 4 °C against 100 
mM sodium phosphate buffer pH 7.5 with 300 mM NaCl and then combined with 
glycerol as appropriate. These experiments began the day following the 
purification of the recombinant enzyme and the activity of the enzyme stored at 4 
°C was arbitrarily chosen as 100% and the relative levels to this value are shown 
above. 
Glycerol is a very commonly used cryoprotectant for storing enzymes and it is not 
surprising that at -20 °C the enzyme without glycerol lost much of its activity 
quickly. This is almost certainly due to the formation of ice crystals and the 
repeated freeze-thaw action. These problems are avoided by the addition of 40% 
glycerol. However, the stored enzyme was not subject to the same losses in 
activity when stored at -70 °C without a cryoprotectant. This may be due to the 
rapid freezing at the lower temperatures moderating the damage done by ice 
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crystals. Due to time constraints, the long term effects of storage at -70 °C could 
not be investigated. The enzyme may behave as MGL2 does, losing more than 
90% of it's activity after storage at -70 °C for longer than 12 months (unpublished 
data). At this point it was decided that for routine storage -20 °C with 40% 
glycerol added would be pursued as there was no evidence at this stage that it 
adversely affected the enzyme activity. 
5.2.5.2- Selecting the Correct Buffer for Storage 
The choice of buffer was made reflecting the published data on the activities of 
other cysteine synthase enzymes. Initially the pH range checked was 6.2-8.0 
using the suiphonic acid derived buffers (Good eta/., 1966). PIPES and HEPES 
were used and an apparent optimum of 100 mM HEPES pH 7.2 was found. 
However the enzyme lost activity over a period of 2 to 3 weeks when stored at -20 
°C in glycerol with these buffers. It is apparent that these buffers adversely affect 
the enzyme and are not suitable for storage for an unknown reason. This 
observation is not unusual though and highlights the need to make a suitably 
broad choice of buffers to sample. In the production of a new construct of MGL2, 
as detailed in section 2.2.16, similar experiments were carried out on the stability 
of the enzyme under different storage conditions (3.2.5). Here it was found that 
the sulphonic acid buffers were particularly favourable when compared to the 
large loss of activity exhibited when TRIS buffers were used. Thus the pH 
preferences indicated by the data were utilised, but a new buffer had to be found. 
Because enzyme used to monitor the effects of temperature on storage had 
retained greater activity while stored in sodium phosphate buffer, it was decided 
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to examine this. Due to a lack of time it was not possible to monitor the effect on 
activity of storage in a number of buffers. Instead enzyme was dialysed into 100 
mM sodium phosphate pH 7.5,300 mM NaCl, 100 µM PLP, 100 µM DTT plus 
glycerol to 40%. This enzyme was then used for the remainder of this work and 
showed no loss of activity over approximately 6 weeks. 
5.2.5.3 Effects of Cofactor and Reducing Agents 
The use of thiol reducing agents and cofactor to retain activity during storage was 
also considered. Previous work on MGL had shown that excess cofactor and 
reductant were required and it was decided that in an analogous fashion, cofactor 
and DTT would be added to cysteine synthase in order to prevent loss of activity. 
Thus 100 µM PLP and 100 IN DTT were added. Extensive investigations were 
not carried out on the merits of including these compounds because of insufficient 
time remaining in the project and also because initial results showed no 
detrimental effects of including them. 
5.2.6 Western Blot Analysis of Cysteine Synthase 
Polyclonal antibodies were raised in a rabbit against purified recombinant 
cysteine synthase. These were to be used in Western blot analysis as time 
permitted. Figure 5.17 shows the result of a Western blot using the antiserum 










Figure 5.17: Western blot using purified cysteine synthase antiserum. Lane A- Purified 
recombinant enzyme probed with antiserum; B-T. vaginalis whole cell lysate probed with 
antiserum; C- 10 kDa protein standards; D- Purified recombinant enzyme probed with pre- 
immune sera; E-T. vaginalis whole cell lysate probed with pre-immune serum. 
The polyclonal antiserum raised against purified recombinant cysteine synthase 
reacted as expected with the recombinant enzyme (Figure 5.17, lane A). This 
migrated to approximately 35 kDa in agreement with the predicted molecular mass 
of 33.8 kDa for a single recombinant enzyme monomer. There was no reaction of 
the pre-immune serum with the purified recombinant enzyme (lane D). The 
antiserum reacted with a large number of proteins in the parasite lysate (lane B) 
and many of these interactions are also seen in with the pre-immune serum (lane 
E). There were at least two additional bands detected by the immune serum 
(comparing lanes B and E). Assuming that the polyclonal antiserum is specific for 
cysteine synthase, this would indicate at least two cysteine synthase proteins or 
fragments present in T. vaginalis. The major band migrated slightly further than 
the recombinant enzyme (lane A) which is consistent with the predicted size of 
32.7 kDa for the enzyme encoded by the isolated cDNA. However, there also 
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appeared to be a second, less intense band which was partially obscured by the 
strong signal of the major band. This appeared to be of the same size as the 
recombinant enzyme. 
5.2.6.1 Expression of T. vaginalis Cysteine Synthase Under Different Growth 
Conditions 
The parasite was cultured under different growth conditions and cysteine 
synthase mRNA and protein levels analysed to determine the effect of 
environmental factors and help elucidate the role of the enzyme in the parasite. 
Culturing of the parasite was performed as detailed in section 2.4.2. Parasites 
were harvested and washed as detailed in section 2.4.4 and cell pellets stored at - 
70 °C. Western blots were carried out as specified in section 2.3.4. The 
preparation and development of Western and Northern blots was done by Dr. GH 
Westrop. 
To help define the role of cysteine synthase in vivo the parasite was cultured 
under various conditions. Medium was supplemented with amino acids to 
examine their effect on the expression of the enzyme. Amino acids chosen for 
this were L-cysteine, L-methionine, L-serine and DL-homocysteine. Previous 
work had shown a decrease in cysteine synthase activity in parasite lysates after 
growth in medium supplemented with 10 mM L-cysteine (P. Suchan, unpublished 
data). Therefore the concentration of amino acids used was 10 mM. Parasites 
were also cultured in conditions to mimic oxidative stress, which the parasites may 
experience as a result of host immune responses. Cultures were produced 
aerobically with exposure to normal environmental oxygen levels and in media 
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lacking the reducing agent ascorbate. Media was also supplemented with 0.2 mM 
hydrogen peroxide (H202) or 2 mM methyl viologen (MV) (a catalyst for the 
production of superoxide radicals). Concentrations of MV and H202 used, were 
decided upon by first titrating them to levels where they inhibited growth of the 
parasite by - 50% (data not shown). The parasite was also grown in the 
presence of 100 µM DL-propargylglycine. Previously this concentration of 
inhibitor has been shown to abolish MGL activity but also result in elevated levels 
of "activated serine suiphydrase" activity (Thong and Coombs, 1987). As the 
isolated cysteine synthase enzyme possesses this activity this constitutes some 
evidence that inhibition of MGL leads to upregulation of enzyme. The effect on 
growth of the parasite has been shown to be small at these concentrations of 
propargylglycine. The culturing of the parasites for these experiments is detailed 
in section 2.4.2. The numbers of parasites harvested from each of the conditions 
are listed below in table 5.6. These cells were used for protein and RNA isolation 
for subsequent Western and Northern blotting as described below. 
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Growth Conditions Parasites (cells x 10 /ml) 
Control (Anaerobic) 1.44 
Aerobic 3.94 
Without Ascorbate 1.70 
10 mM L-Cysteine 2.88 
10 mM L-Methionine 1.36 
10 mM L-Serine 2.80 
10 mM DL-Homocysteine 1.80 
100 µM DL-propargylglycine 0.52 
0.2 mM H202 2.44 
2.0 mM Methyl Viologen 1.40 
Table 5.6: Parasite densities in modified medium. Numbers are counts from a single culture, 
cultures were performed in triplicate. 
Western blots using whole cell lysates were performed using recombinant 
cysteine synthase antiserum: Equal volumes of lysate were loaded in each lane 
(Figure 5.18). 
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Figure 5.18: Western blot using parasites cultured under different conditions. Lanes A- 
Anaerobic, B- Aerobic, C- No ascorbate, D- L-Cysteine, E- L-Methionine, F- L-Serine, G- DL- 
Homocysteine, H- 10 kDa protein ladder, I-0.2 mM H202, J-2 mM MV. 
Two bands were clearly visible in several lanes of the blot confirming the 
presence of at least two likely cysteine synthase enzymes. Due to the equal 
volume loading of lysates, rather than equal cell numbers, it was difficult to 
quantify any apparent changes in enzyme levels present. There was no apparent 
relative difference in the signal from cells grown in aerobic conditions and without 
ascorbate (lanes B and C) compared to anaerobically cultured parasites (lane A). 
Of the medium supplemented with amino acids the largest change appeared to be 
with L-cysteine where there was a significantly reduced signal (lane D). However 
each of lanes D to G had less intense bands than lane A after taking into account 
the cell densities. The parasites grown in the presence of H102 and MV (lanes I 
and J) both appeared to produce more enzyme as was evident from the increased 
intensity of bands. 
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To further examine the effects of culturing parasites under these different 
conditions, Northern blots were performed (Figure 5.19). Blots were hybridised 
with both a cysteine synthase specific probe and also an actin probe. Actin 
expression was assumed to be identical in all cells and could therefore be used to 
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Figure 5.19: Northern blots of parasites grown under different conditions. Image I- Blot 
hybridised with actin probe, Image II - Blot hybridised with cysteine synthase probe. Lanes A- 
Anaerobic, B- Aerobic, C- No ascorbate, D- L-Cysteine, E- L-Methionine, F- L-Serine, G- DL- 
Homocysteine, H- 100 µM DL-Propargylglycine, I-0.2 mM H202, J-2 mM MV. 
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The hybridisation of an actin specific probe (Figure 5.19, I) showed similar levels 
of RNA in all lanes except H. These levels generally reflected the parasite 
numbers harvested from the cultures shown in table 5.6. The variation in lane H 
was proposed to be due to both the lower number of cells used and difficulty in 
isolating a sizable RNA sample (G H Westrop personal communication). A 
comparison of the signal intensities showed that relative to lane A there were a 
number of changes. The most dramatic were a fall in the signals in lanes D and G 
(L-cysteine and DL-homocysteine respectively) and an increase in the signal in 
lane H (propargylglycine). The changes observed in the other lanes were not as 
marked. Although the signal in both lanes I and J (H202 and MV) were much less 
pronounced than lane A, the level of cysteine synthase mRNA was apparently 
higher in lane J. Lanes E and F (methionine and serine) showed similar sized 
bands to each other, although again, these did seem smaller than the control 
lane. The effect of omitting ascorbate from the medium (lane C) was an apparent 
fall in the levels of cysteine synthase mRNA. The effect of cysteine synthase 
expression by culturing the parasites with exposure to normal atmospheric oxygen 
levels was difficult to distinguish from anaerobic growth. Surprisingly the cell 
growth was higher with oxygen present and enzyme levels seemed comparable. 
5.3 DISCUSSION 
A putative cysteine synthase gene from T. vaginalis was cloned into a prokaryotic 
expression vector and recombinant protein produced. The strategy adopted to do 
this, introduced eight additional amino acids into the mature enzyme not encoded 
by the original cDNA sequence. Though not ideal, it would be preferable to retain 
the original sequence intact, the presence of a hexahistidine tag allowed the use 
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of a single column chromatography step for purification. High levels of active, 
soluble enzyme were obtained easily which was apparently stable over a period of 
several weeks. The specific activity of the enzyme is below that published for 
many other cysteine synthase enzymes and the Km values for both substrates are 
higher. There is no reason though to believe that this is due to the method of 
expression or purification of the enzyme. With the possibility of several isoforms 
of enzyme present within the parasite these differences may be a reflection of a 
specific role. 
The enzyme sequence is highly homologous to other cysteine synthases and 
important residues in the active site are conserved. The results of the alignment 
and clustering distinguished the enzyme clearly from plant species and indicated 
it to be more similar to bacterial type B enzymes. The type B enzymes from 
enteric bacteria are proposed to be expressed under anaerobic conditions and 
are able to utilise more reduced substrates such as thiosulphate (Nakamura et al., 
1983,1984). This finding is consistent with the normal environmental growth 
conditions of T. vaginalis in vivo. However with this in mind, it may be that the 
lower activity exhibited by the trichomonad enzyme compared with others may be 
due to inappropriate assay conditions, for example the choice of sulphur donor. 
Deoxygenation and addition of reducing agents was highly effective in increasing 
activity but perhaps this is insufficient. Further biochemical investigation of the 
recombinant enzyme could centre around the substrate profile of the enzyme. 
Additionally the ability of the enzyme to utilise alternative sulphur donors may 
provide an insight on the likely physiological substrate. 
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The failure of 5' RACE experiments to confirm the validity of the proposed start 
codon did not hinder the production of an active recombinant enzyme. The short 
5' UTR isolated with the cDNA clone was consistent with the findings from other 
genes from T. vaginalis. It does not however, possess the consensus sequence 
for the ubiquitous promoter element identified and analysed (Quon et al., 1994; 
Liston and Johnson, 1999). Therefore there are concerns arising from the 
inability in confirming the entire gene sequence at the 5' end and thus the correct 
start codon. Not least of these is the possibility that a truncated enzyme may 
have biochemical characteristics considerably different from the full length 
enzyme in vivo (e. g. lower catalytic activity, changed substrate affinities). 
The results of Southern blot analysis were consistent with the presence of a 
single copy of this cysteine synthase gene. The appearance of other lower 
intensity bands suggested, however, that T. vaginalis contains closely related 
homologues. The identical pattern seen in a repeated experiment makes non- 
specific interactions very unlikely, despite the obvious hybridisation to the DNA 
markers. This observation is a consequence of the large amount of DNA bound 
and is a common effect seen in this laboratory with a number of unrelated probes. 
The concern that the multiple bands may be present because of incomplete 
digestion of the gDNA prior to transfer was addressed. As mentioned in the text, 
efforts were made to ensure that this was not the case. The second proteinase K 
treatment of gDNA prior to the restriction digest abolished the discrete bands 
seen previously (not shown due to poor image reproduction). However the 
variation in the number of bands seen in the different lanes does still seem to 
point to the possibility that one or more of the digests is incomplete. Nevertheless 
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the data from the Southern and Western blot experiments indicated the likelihood 
of multiple cysteine synthase isozymes in T. vaginalis. The high stringency 
conditions of hybridisation and washing should have prevented any low affinity 
binding and implied that these proposed homologues of the cysteine synthase 
were likely to have considerable sequence similarity. It is unlikely that the probe 
hybridised with PLP-dependent enzymes from the a or y families, as the 
sequences are typically quite diverse. Also the position of the bands did not 
correspond to those identified for mgll and mg/2 (McKie et al., 1998) and so 
hybridisation to these can be excluded. The identity between these proposed 
cysteine synthase homologue sequences is likely to be greater than 70% as no 
cross reaction is seen between mgl1 and mg! 2 which share this identity. As was 
described in section 5.2.1.3, the similarities between cysteine synthase 
sequences can be very high and so this allows for the possibility of very similar 
isoforms. 
The polyclonal antisera produced against recombinant cysteine synthase reacts 
strongly with the purified enzyme and also with at least two proteins in the 
parasite lysates. The apparent size of the strongest signal in the parasite lysate 
corresponded to the predicted size of the native enzyme from the cDNA 
sequence. Additionally, although unclear, there was a second species of a 
slightly larger size also identifiable in the lysate. This was most obvious in figure 
5.17 where two bands were clearly seen in lanes D, E and G. Assuming that 
there is no cross reactivity with other non-cysteine synthase enzymes, then this 
indicated the likelihood of at least one other isoform. It is also possible, however, 
that this band represented an immature form of the enzyme with a targeting signal 
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sequence still attached to the mature protein. The visualisation of two bands was 
then shown independently in Western blots using parasites grown under various 
conditions (Figure 5.18). In both blots there was a high level of background. This 
was a consequence of the large amount of immune sera used in primary antibody 
binding. Dot blots had been used to estimate the primary antibody dilution 
required, suggesting a dilution of 1: 4000 was sufficient, but it is likely that a higher 
dilution is likely to be optimal. There was insufficient time remaining to titrate 
these levels. 
The results of culturing parasites with different stimuli was quite successful. The 
parasites exhibited varying levels of expression which was evident in mRNA and 
protein levels. The Western blot results could be improved significantly by 
eliminating much of the background with lower amounts of immune sera. The 
success of this technique though should be extended to examine other proteins 
(specifically MGL) and other stimuli. The results and possible future work will be 
discussed in the final chapter. 
During the course of this study, additional work by others identified cysteine 
synthase activity in parasite lysates confirming the presence of at least one 
functional enzyme. The work also showed that after subcellular fractionation, 
activity was localised to the cytosolic and hydrogenosomal fractions of the 
parasite (P Suchan, unpublished). Western blots have now confirmed the 
presence of at least two isoforms of cysteine synthase in T. vaginalis. It has also 
been seen previously that "activated serine sulphydrase" activity is attributable to 
multiple proteins (Thong and Coombs, 1987). Recombinant cysteine synthase 
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was shown to have this activity and thus presumably the enzyme accounts for two 
of the proteins responsible. Along with the continued attempts to identify the 5' 
UTR of the cysteine synthase gene it would be desirable to attempt to clone this 
second cysteine synthase gene in the future. Other work that could be carried out 
would include subcellular localisation of enzyme activity by immunomicroscopy. 
This may prove difficult though, if it is not possible to distinguish between the two 
enzymes using the polyclonal antisera. 
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CHAPTER 6 GENERAL DISCUSSION 
6.1 INTRODUCTION 
The overall aim of this study was to investigate sulphur amino acid metabolism in 
T. vaginalis. A variety of approaches were employed to achieve this. Discussions 
upon the experimental results obtained have been given in relevant chapters. In 
this chapter it is intended to relate these results and other data to the situation in 
vivo. 
Prior to this study, with little, if any, experimental data available, it was possible to 
suggest a number of fates for the products of MGL's action and thus roles for the 
enzyme in vivo. These possible functions included: 
1. The production of ATP from the a-keto acids, as detailed in section 1.6.3.3 
2. The use of ammonia for combating the low pH of the vagina 
3. Utilising sulphide for deoxygenation of the environment via conversion to 
sulphate 
4. The use of free thiols as reducing agents or free radical scavengers in the cell 
or to cause damage to host cells as an immune evasion strategy or method to 
obtain extra nutrients. 
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There is some experimental evidence that the a-keto acid product of 
homocysteine and methionine catabolism, 2-oxobutyrate, can be utilised to 
generate ATP (GH Coombs, unpublished). The contribution of this energy 
generation pathway may be very different though for in vivo and in vitro growth. It 
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would seem most likely that the a-keto acid backbone can be used successfully to 
produce ATP when necessary, but is not essential and probably not utilised when 
more abundant energy sources, i. e. sugars such as glucose, are available. 
There is, at present, no experimental evidence for the use of either NH4+ or H2S to 
modify the extracellular environment beneficially. The parasite is sensitive to 
oxygen though (Paget and Lloyd; 1990) and so the possible use of H2S in this way 
is still worthy of investigation. 
The use of the thiols, released by the action of MGL, is probably fundamental to 
the enzyme's role in the parasite. The abundance of these thiols in cultured 
parasite preparations is immediately evident by the smell. Experiments using 
radiolabelled 35S compounds have shown little specific incorporation of the 
isotope within the parasite (Thong, 1985). The measurement of thiols released by 
parasites cultured in complete MDM has revealed high quantities of CH3SH 
released but no detectable H2S (Thong et a/., 1987). CH3SH levels were elevated 
when medium was supplemented with L-methionine but no H2S was detected 
even when high levels of DL-homocysteine were added. Methionine could be 
substituted for compounds such as methyl-L-cysteine and L-ethionine and similar 
levels of CH3SH were released. This implies that H2S, the thiol product of MGL 
catabolism of homocysteine, does not escape the parasite cell. However, the 
detection of the two thiols was achieved differently, CH3SH using DTNB (5,5'- 
dithio-bis-2-nitrobenzoic acid) and H2S with lead acetate. It may be that the lack 
of any detectable of H2S was due to the compound rapidly oxidising or dimerising. 
This may not have reacted with lead acetate to form lead sulphide and thus no 
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H2S would have been detected. CH3SH rapidly dimerises to form dimethyl 
sulphide (CH3S2CH3) which loses its disulphide upon reaction with DTNB and is 
thus detected. Thiols such as H2S and CH3SH are both active reducing agents 
and toxic in high concentrations, but with no experimental evidence for their use in 
the parasite, possible functions remain speculative. 
It has been well established through the use of irreversible inhibitors, that MGL is 
not essential for growth in vitro (Thong and Coombs, 1987). The growth rate is 
reduced at high concentrations of propargyiglycine, but there are no 
morphological changes. However, at this point it is well worth considering the 
nature of propagating parasites in sterile cultures. Such parasites are provided 
with all the nutrients required for apparent optimum growth and simultaneously 
exposed to minimal stress. This is undoubtedly significantly different from the 
conditions found within the host's uro-genitary tract. For example, in vivo the 
parasite will be exposed to damaging host immune responses and the nutritional 
demands may not be so readily met. In this situation, MGL may play a critical role 
and therefore be suitable for investigation as a possible target for chemotherapy. 
6.1.1 MGL in Iron-Sulphur (Fe-S) Cluster Production 
With biochemical information and the structure of MGL1 available, we are able to 
postulate a catalytic mechanism for the enzyme (see section 3.2.10). The 
structure also revealed a possible role for the enzyme in vivo. The position of 
Cys113 in the active site of MGL1 is very similar to that of a cysteine residue 
found in NifS-like enzymes, whose role in vivo is the production and repair of Fe-S 
clusters. Iron-containing proteins play central roles in T. vaginalis metabolism (for 
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example, pyruvate: ferredoxin oxidoreductase, ferredoxin and hydrogenase), but 
there is as yet no experimental evidence on how Fe-S clusters are produced. 
There is an unconfirmed report that there are 2 nifS gene homologues in the 
parasite (J. Tachezy, personal communication), but MGL could nevertheless also 
have a role. As there are established in vitro assays for NifS enzymes measuring 
the production of functional Fe-S clusters (Zheng et al., 1993), it should be 
straightforward to verify whether MGL has this ability. 
6.1.2 Sulphydration and Transsulphuration in T. vaginalis 
The results presented in chapter 5 of this thesis confirm the presence of a 
functional cysteine synthase enzyme in T. vaginalis. Despite the presence of 
direct suiphydration in the form of cysteine synthesis, there remains no firm 
evidence for a functional transsulphuration pathway. The previously reported low 
CGL activity in the parasite was detected in whole cell lysates (Thong, 1985) and 
no homogenous protein preparation or gene has been isolated. Indeed, the 
isolation of mgl genes utilised degenerate oligonucleotide PCR with primers 
designed to highly conserved regions of CGL sequences (McKie, 1997). As no 
CGL (or CGS, CBL or CBS) homologue was isolated using this approach or 
identified from the sequencing of cDNA clones, this points to the absence of these 
. enzymes in the parasite. 
This proposed lack of CGL in T. vaginalis (along with the presence of 2 mgI 
genes), shows a further similarity to the situation in P. putida. In this bacteria, 
MGL is postulated to have an alternative pathway to the standard reverse 
transsulphuration pathway (conversion of homocysteine to cysteine via 
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cystathionine) (Vermeij and Kertesz, 1999). In this hypothesis, the breakdown of 
homocysteine by MGL yields H2S which is the substrate for cysteine synthase. In 
addition, CH3SH from the catabolism of methionine is proposed to be converted 
by an unknown process to H2S and so also to provide the thiol group for cysteine 
synthesis., The results of culturing parasites with propargylglycine described in 
this thesis are explainable in terms of this proposal. Inhibition of MGL leads to an 
increased expression of cysteine synthase, presumably in an attempt to 
compensate for the lack of thiol donors available and so maintain cellular cysteine 
levels. The hypothesis is also consistent with the results of culturing the parasites 
in excess cysteine; where there was a decrease in the expression of cysteine 
synthase. This may not only reflect L-cysteine specific feedback inhibition of 
cysteine synthase gene expression but also the overall concentration of thiols. 
There may be a demand for cysteine as a specific amino acid and also for thiol 
containing compounds as general reductants. These general reducing agents 
may include both low molecular weight thiols (e. g. H2S, CH3SH) and amino acids. 
The response to high levels of homocysteine was a fall in levels of cysteine 
synthase expression but not of the same magnitude as seen with excess cysteine. 
Thus exogenous homocysteine may have satisfied the requirements of the 
parasite for thiols but there still remained the need for cysteine for other purposes, 
such as protein synthesis. 
It would be very interesting to examine the effects of the same conditions upon 
MGL levels. -Experiments are planned to reproduce Western and Northern blots 
using MGL antibodies and nucleotide probes. The working hypothesis described 
would predict decreased levels of MGL expression when the parasites are 
225 
exposed to high levels of cysteine, due to a reduced demand for thiols in cysteine 
synthesis., The predicted response to elevated levels of methionine or 
homocysteine would be little or no change in MGL levels. It would be much more 
interesting to deplete the medium of one or more sulphur containing amino acids 
and examine the response then. 
6.1.3 Thiols as Reducing Agents or Free Radical Scavengers 
Despite the presence of an active cysteine synthase, there may be a role for 
compounds such as H2S and CH3SH as reducing agents for the parasite. It should 
be remembered that the parasite shows sensitivity to both intra- and extracellular 
thiol blocking'reagents (define) which act as potent anti-trichomonad compounds 
in culture (Gillin et al., 1984). However from the observation that these thiols are 
mostly excreted from the cell they may be required extracellularly. It is possible 
that extracellular reducing agents may be required and the transport of small 
thiols across the cell membrane to satisfy this need is easier and more 
energetically efficient than excreting, for example, cysteine. 
Determining the MGL levels under different growth conditions may also prove 
informative in indicating whether these low molecular weight thiols (H2S and 
CH3SH) function as reducing agents or free radical scavengers. Only when the 
parasite was cultured with propargylglycine did we see any dramatic upregulation 
of cysteine synthase activity. This was a little surprising, given that compounds 
such as H202 and methyl viologen were used to induce oxidative stress. It would 
be interesting to see if there was an upregulation of MGL under these conditions. 
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This may indicate that the thiol products of MGL are used as a protective 
response to damaging oxygen free radicals. 
6.1.4 Low Molecular Weight Thiols in Haemolysis 
Several examples of cysteine desulphurase enzymes have recently had their 3- 
dimensional structures solved and have already been discussed in chapter 3 of 
this thesis. One of these, cystalysin, has been shown to be responsible for 
haemolytic activity in the oral pathogen Treponema denticola (Chu et al., 1997; 
Krupka et al., 2000). It is unclear whether the protein itself or the H2S it produces 
from the aß-elimination of cysteine is responsible for this damage to host red 
blood cells. The'toxicity of compounds such as H2S and CH3SH to mammalian 
cells has been documented (Beauchamp et al., 1984) and T. vaginalis is also 
haemolytic (Krieger et al., 1983; Dailey et al., 1990). The hypothesis that the 
action of MGL may be responsible for the haemolytic activity of T. vaginalis would 
appear to be simple to test. For instance, MGL activity can be inhibited by using 
propargylglycine and the haemolytic activity of the cells measured. However the 
cysteine desulphurase activity of cystalysin has been shown to be elevated in the 
presence of ß-mercaptoethanol. This has similarities to the "activated serine 
sulphydrase activity" seen in T. vaginalis and although cysteine synthase has 
been shown to exhibit this activity, it is not certain that it is solely responsible. It 
has been shown that several enzymes can be resolved from parasite lysates with 
this activity, one or more of which may be cystalysin (Thong and Coombs, 1987). 
Thus, although culturing parasites in the presence of propargylglycine may 
eliminate haemolytic activity due to MGL, haemolysis may remain due to another, 
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unidentified factor. However, such an experiment would give some information 
upon whether or not MGL may be involved in haemolysis. 
6.2 Future Work 
A number of experiments that could be carried out immediately in attempts to 
answer specific questions have been mentioned already. MGL could be assayed 
for its ability to repair or construct functional Fe-S clusters and also to cause 
haemolysis. Parasite growth under various conditions could also be repeated and 
examined for its effect upon MGL expression. There are also a number of other 
stimuli that the parasites could be exposed to such as excess or reduced levels of 
iron, variations in pH or high levels of D-cysteine. It may also prove very useful to 
use a defined medium for culturing trichomonads (Linstead, 1981). The ability to 
easily omit medium components would be highly useful in examining the roles of 
enzymes in culture. The knowledge of exact levels of reducing agents, for 
example, could be exploited by examining which compounds could be substituted 
for others. With the probes for examining MGL and cysteine synthase expression, 
these experiments could prove highly informative. 
In the longer term, the continued sequencing of the parasite EST library is likely to 
be particularly fruitful. The identification and characterisation of other genes may 
give further insights into the metabolism of sulphur amino acids. A continuing 
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